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Preface
An agreement has been signed by the Dutch Expert Committee on Occupational
Standards (DECOS) of the Health Council of the Netherlands and the Nordic
Expert Group for Criteria Documentation of Health Risks from Chemicals (NEG).
The purpose of the agreement is to write joint scientific criteria documents, which
could be used by the national regulatory authorities in both the Netherlands and in
the Nordic countries.
The document on health effects of tetrachloroethylene was written by Karel de
Raat, TNO Food and Nutrition Research, the Netherlands, and has been reviewed by
DECOS as well as by NEG.
The joint document is published separately by DECOS and NEG. The NEG
version presented herein has been adapted to the requirements of NEG and the
format of Arbete och Hälsa. The editorial work and technical editing has been
carried out by Jill Järnberg, scientific secretary of NEG, at the National Institute
for Working Life in Sweden.
We acknowledge the Nordic Council of Ministers for its financial support of
this project.
G.J. Mulder G. Johanson
Chairman Chairman
DECOS NEG
Abbreviations
ATP adenosine triphosphate
ALP alkaline phosphatase
ALT alanine aminotransferase
ASP aspartate aminotransferase
BAEP brain stem auditory evoked potentials
CNS central nervous system
ECD electron capture detection
EEG electroencephalogram
EPA US Environmental Protection Agency
FID flame ionisation detection
GC gas chromatography
HSE UK Health and Safety Executive
γ-GT γ-glutamyl transferase
LD50 lethal dose for 50% of the exposed animals at single administration
LDH lactic acid dehydrogenase
MS mass spectrometry
NIOSH US National Institute for Occupational Safety and Health
NOAEL no observed adverse effect level
NTP National Toxicology Program
5’-NU 5’-nucleotidase
OR odds ratio
PDA protein-droplet accumulation
PER perchloroethylene, tetrachloroethene
PMR proportional mortality ratio
SG-6-P serum glucose-6-phosphatase
SGOT serum glutamic oxaloacetic transaminase
SGPT serum glutamic pyruvic transaminase
SIR standardised incidence ratio
SLDH serum lactic acid dehydrogenase
SMOR standardised mortality odds ratio
SMR standardised mortality ratio
SOCT serum ornithine carbamyl transferase
SPMR standardised proportional mortality ratio
STEL short-term exposure limit
TBAR thiobarbituric acid-reactive substance
TCA trichloroacetic acid
TCE trichloroethanol
TLV threshold limit value
TWA time-weighted average
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11. Introduction
At ambient temperatures, tetrachloroethylene (perchloroethylene, PER) is a
colourless liquid with an ethereal odour. PER is a commercially important
chlorinated hydrocarbon solvent and chemical intermediate. The compound
causes a reversible depression of the central nervous system, which has lead in the
past to its use as a human anaesthetic.
A criteria document on tetrachloroethylene was written for the Nordic Expert
Group for Criteria Documentation for Health Risks from Chemicals (NEG) in
1979 (203). The present document is a co-production between NEG and the Dutch
Expert Committee on Occupational Standards (DECOS) hereafter called the
committees.
2. Identity, properties and monitoring
2.1 Identity
2.1.1 Structure
C C
ClCl
ClCl
2.1.2 Chemical names and synonyms/registry numbers
IUPAC name: tetrachloroethene
Common name: tetrachloroethylene
CAS registry number: 127-18-4
RTECS: KX3850000
UN: 1897
EEC: 602-028-00-4
EINECS: 204-825-9
Synonyms: carbon dichloride, ethylene tetrachloride,
per, perc, perchloroethylene, 1,1,2,2-tetra-
chloroethylene, PCE
22.2 Physical and chemical properties (1, 124, 132)
Molecular formula: C2Cl4
Molecular weight: 165.83
Boiling point (100 kPa): 121°C
Freezing point (100 kPa):  -22.4°C
Density (20°C): 1.62 g/ml
Vapour pressure (20°C/100 kPa): 1.9 kPa
Percentage of vapour in saturated
air (20°C/1 bar):
1.8
Vapour density (air=1; 100 kPa): 5.8
Solubility in water: 150 mg/l
Solubility in organic solvents: completely soluble in ethanol and diethylether
Physical form: liquid
Odour: ethereal
Odour threshold 5 ppm (34.5 mg/m3)
Conversion factors 25°C, 1 atm: 1 ppm = 6.89 mg/m3
1 mg/m3 = 0.145 ppm
2.3 Analytical methods
2.3.1 Environmental monitoring
Several methods are proposed for the determination of the concentrations of
gaseous PER in air. The compound is always collected by adsorption. Sorbents
used are: activated charcoal or Tenax1, the former being desorbed by elution with
organic solvents (e.g. carbon disulfide), the latter by elution of the heated sorbent
with an inert gas, followed by condensation. The desorbed material is fractionated
by gas chromatography (GC). Detection and quantification are based on flame-
ionisation detection (FID) or mass spectrometry (MS), while the identification of
the compound is based on retention time and mass spectra.
ISO method 9486: (E)
A known volume of air is passed through a glass or metal tube packed with
activated charcoal. The organic vapours are adsorbed onto the charcoal. The
collected vapours are desorbed by using a suitable solvent and analysed with a
GC equipped with a FID or another suitable detector. This method can be used
for the measurement of concentrations of airborne vapours of PER between
approximately 1 mg/m3 and 1 000 mg/m3 (about 0.2 ml/m3 to 200 ml/m3) when 10
litres of air are sampled. Organic components, which have the same or nearly the
same retention time as PER in the GC analysis will interfere. Proper selection of
GC columns and program conditions will minimise interference (131).
                                    
1
 A polymeric material used for the sorption of gaseous organic compounds from air. Desorption
can be achieved by heating; i.e., without the need of dissolving the sorbed compounds in a
solvent.
3NEN method 2947/2964
Air is drawn through a tube with two sections, both containing activated coconut
charcoal to adsorb gaseous PER. The compound is subsequently desorbed with
carbon disulfide (containing an internal standard) and is determined by GC, using
FID. The method was validated over a range of 2.5-1 600 mg/m3 and has a detec-
tion limit of 238 µg/m3 (61, 64).
NEN method 2948/2965
The sample is collected by adsorption on Tenax (200 mg) and analysed by thermal
desorption of volatile components into a GC, using FID. The method is validated
over the range of 0.02-400 mg/m3 and has a detection limit of 0.1 µg/m3 (62, 65).
NEN method 2950
The sample is collected on an indicator tube and analysed by reading the colour
change. The method has been validated over a range of 140-1 150 mg/m3. The
coefficient of variation was 25% (63).
NIOSH method S335 and S336
Air is drawn through a tube with two sections, both containing activated coconut
charcoal to adsorb gaseous PER. The compound is subsequently desorbed with
carbon disulfide (containing an internal standard), followed by GC with FID. A
calibration curve is employed and a correction is applied for desorption efficiency.
This method is validated over the range 655-2 750 mg/m3, using a 3 litres sample
(24.5 °C, 101 kPa). The coefficient of variation for the total method over the
above range was 5.2%. The limit of detection depends on the analyte (206).
IARC method 5
Air is drawn through a tube with two sections, both containing activated coconut
charcoal to adsorb the gaseous compound. The compound is subsequently desor-
bed with carbon disulfide (containing an internal standard), followed by GC,
using FID. A calibration curve is employed, and a correction curve is applied for
desorption efficiency. This method is validated over a range of 136-4 060 mg/m3
using a 3 litres sample. The breakthrough volume is 21 litres at 2 750 mg/m3. The
detection limit depends on the analyte and lies normally in the useful range (171).
IARC method 12
Air is drawn through a cartridge containing 1-2 grams of Tenax. The cartridge is
placed in a heated chamber and purged with an inert gas, which transfers the
volatile compound from the cartridge onto a cold trap and subsequently onto a
high-resolution (capillary) GC column, which is held at low temperature (e.g.
–70°C). The column temperature is then increased and the component eluting
from the column is identified and quantified by MS. Component identification is
normally accomplished by a library search routine, using GC retention times and
mass-spectral characteristics. The limit of detection is generally in the order of
0.1-1.0 µg/m3 (233).
4BIA method 8690
The “Berufsgenossenschaftliches Institut für Arbeitssicherheit” has published a
method using Dräger active coal tubes, type B and GC using FID. The limit of
detection is 1.2 mg/m3 for an air volume of 40 litres (246).
2.3.2 Biological monitoring
For biological-monitoring purposes, the concentrations of PER are determined in
expired air or blood. Concentrations in expired air can be determined in the same
manner as those in ambient air. PER is removed from blood or tissues by evapora-
tion or by extraction with organic solvents. Evaporated PER can be concentrated
with Tenax before analysis with GC/MS or GC with electron-capture detection
(ECD); analysis can also be performed without prior concentration (head-space
analysis). The solvent extracts are also analysed by GC/MS or GC with ECD.
IARC method 24
This method can be used for the determination of PER in expired air. The breath
sample is dried over calcium sulphate and led through a Tenax GC cartridge. The
adsorbed PER is subsequently thermally desorbed and led into a GC/MS. The
detection limit of the method is 0.33 µg/m3, and the linear range for the analysis
depends mainly on the adsorption breakthrough-volume and on the sensitivity of
the MS (221).
IARC method 25
This method is suitable for the determination of PER in blood and tissues. The
volatile PER is recovered from a blood sample by warming the sample and
passing an inert gas over it. Tissues are first macerated in water, then treated in the
same manner as blood. PER is trapped on a Tenax GC cartridge, then recovered
by thermal desorption and analysed by GC/MS. For a 10 ml blood sample, the
limit of detection is about 3 ng/ml. Detection limits of about 6 ng/g are typical for
5 g tissue samples. Upper limits for these samples equal approximately 104 times
lower limits (220).
IARC method 27
PER concentrations in blood can be determined with this method. The specimen
is extracted with n-hexane and the concentration of PER in the organic phase is
determined by GC, using ECD. The limit of detection is 5 µg/l (219).
DFG method 1
Method for the determination of PER in blood. An organic matrix is prepared
from the sample. The volatile compound is removed from the matrix by increasing
the temperature. The headspace of the matrix is then analysed with GC (ECD).
The detection limit is 1.2 µg/l (6).
53. Sources
3.1 Natural occurrence
PER is reported to be produced by algae and one micro-algae (124).
3.2 Man-made sources
3.2.1 Production (3, 123, 124, 132)
World production of PER amounted to 680 kilotonnes in 1972, and to 1 000 kt in
1974. For 1979 the annual production is estimated to be 50-100 kt in Eastern
Europe, about 55 kt in Japan, and 250 kt in Western Europe. Germany, France,
Italy, and the United Kingdom are major European producing countries; Austria,
Scandinavia, Spain, Switzerland, and Benelux being minor ones. In 1981, annual
production in the USA was estimated to be about 350 kt. The most recent produc-
tion estimates are presented by IARC (124). They amount to 280, 83 and 169 kt
for Western Europe, Japan and the United States, respectively. The data in this
publication show a decreasing trend for PER production over the last 5-10 years.
PER was first prepared in 1821 by Faraday by thermal decomposition of
hexachloroethane. The original commercial production method involved a four-
step process starting from acetylene and chlorine. Nowadays, PER is produced
mainly by oxyhydrochlorination, perchlorination, and/or dehydrochlorination of
other hydrocarbons or chlorinated hydrocarbons. Raw materials include 1,2-
dichloroethane, methane, ethane, propane, propylene, propylenedichloride, and
various other chlorinated materials such as 1,1,2-trichloroethane.
PER is produced in the following grades: purified, technical, US Pharmaco-
poeial, spectrophotometric, and dry cleaning. The dry-cleaning grade meets the
specifications for technical grade, differing only in the amount of stabiliser added
to prevent decomposition. Stabilisers, which include amines or mixtures of
epoxides and esters, are added to prevent decomposition by hydrolysation. Thus
stabilised, PER is transported in tanks and drums.
3.2.2 Use (3, 132)
PER is a commercially important chlorinated-hydrocarbon solvent and chemical
intermediate. It is mainly used as a solvent for cleaning and for vapour degreasing
in metal-cleaning. It is also used for processing and finishing in the textile
industry, as an extraction solvent, as an anthelminthic, as a heat-exchange fluid, in
grain fumigation, and in the manufacture of fluorocarbons.
PER has been found in air, soil, surface water, seawater, sediments, drinking
water, aquatic organisms, and terrestrial organisms. Industrial spillage is the main
source of environmental pollution with PER, while distribution is to a large extent
determined by evaporation from surface water.
6Table 1. Use of PER in kilotonnes; reproduced from (124).
Year Metal cleaning
(vapour degreasing)
Metal cleaning
(cold cleaning)
Dry cleaning Precursor of
chemical
synthesis
Other
Western Europe
1980 71 10 150 34 20
1984 61 5 133 36 15
1987 50 5 122 65 15
1990 45 5 115 60 10
Japan
1980 10 26 20
1983 12 23 29
1987 11 25 63
1990 13 20 69
United States
1971 50 163 32 38
1974 54 193 39 45
1977 59 181 39 28
1980 45 172 50 59
1984 34 136 70 39
1987 27 127 84 14
1990 16 111 45 6
An overview of use-patterns, presented originally in (124), is reproduced here
as Table 1.
4. Exposure
4.1 Environmental levels
4.1.1 Water (3, 123, 124, 132)
Rainwater has been found to contain up to 150 µg PER/m3. Average and
maximum concentrations in seawater samples were 12 µg/m3 and 2 600 µg/m3
respectively, while the maximum concentration in sediments was 4 800 µg/m3.
Surface water from the Atlantic Ocean contained 0.2-0.8 µg PER/m3. In Western
Europe, levels of 10-46 000 µg/m3 were found in ground water. In the Nether-
lands, maximum levels of 22 000 µg/m3 were measured. Concentrations up to
473 µg/m3 were found in surface water samples taken from Lake St. Clair
(Canada/Michigan).
PER was detected in the influent of a sewage-treatment plant at a level of 6 200
µg/m3; concentrations in the effluent of the plant before and after chlorination
amounted to 3 900 µg/m3 and 4 200 µg/m3 respectively. The compound has also
been detected in the effluents of chemical production plants, an oil refinery, and
textile plants.
7In Germany, the United Kingdom, and the USA, municipal drinking water
contained an average of 1 300 µg PER/m3, or less. The maximum concentration
found in a drinking-water survey in 100 cities in Germany was 35 300 µg/m3 in
1977, the average being 600 µg/m3.
4.1.2 Food
An overview of PER concentrations in food is presented in Table 2.
4.1.3 Air
Indoor and ambient air
Median level of PER in about 400 Dutch homes was 4 µg/m3, while maximum
levels varied between 49 and 205 µg/m3. A median outdoor level of 2 µg/m3 was
measured in this study (163).
In a study performed in Turin, Italy (120 samples taken during 10 consecutive
days, 24 hours each, during approximately one year; 31 measurements during
winter and 28 during summer), it was found that contamination of air was higher
in winter than in summer, the mean atmospheric concentrations being 8.70 µg/m3
and 4.75 µg/m3, respectively. It was found that the indoor/outdoor concentration
ratio was higher in winter that in summer, median concentration ratios being 2.15
and 1.38 respectively (93).
It has been estimated that 80-85% of the PER used annually in the United States
is released into the atmosphere. A major portion of the atmospheric releases is
attributed to evaporative losses during dry cleaning. Other atmospheric emissions
result from metal-degreasing, production of fluorocarbons, and other chemicals,
use in textile industry, and miscellaneous solvent-associated applications (3).
In Germany, annual mean levels of 6 ppb (41 µg/m3) and 10 ppb (69 µg/m3)
were detected downwind of a chemical laundry and a rubber factory, respectively
(132).
According to the Toxics Release Inventory 1988 (an annual compilation of
information on the release of toxic chemicals by manufacturing facilities in the
United States (207)), an estimated total of at least 32.3 million pounds of PER was
released into the air from manufacturing and processing facilities in the United
States.
General-population exposure from inhalation of ambient air varies widely with
location. While background levels lie generally in the lower ppt range (1 ppt = 6.9
ng/m3) in rural and remote areas, values in the higher-ppt and lower-ppb range (1
ppb = 6.9 µg/m3) are found in urban and industrial areas and areas near point
sources of pollution (3).
Surveys of the air in 9 cities in the USA showed concentrations between 0.2 and
52 µg/m3, with averages between 2 and 4 µg/m3. In 14 cities in Germany average
concentrations were between 1.7 and 6.1 µg/m3 (132).
8Table 2. Concentrations of PER in food products, adapted from (3, 124, 132).
Country Food samples Concentration
(µg/kg)
Switzerland Milk and meat products 3-3 490
United Kingdom Dairy products 0.3-13
Meat 0.9-5
Margarine 7
Oils 0.01-7
Instant coffee 3
Tea 3
Fruit and vegetables 0.7-2
United Kingdom Olive oil (81 out of 98 samples) <10
Olive oil (17 samples) 1-17
United States/Pennsylvania,
samples from a food-processing plant
Tap water
Chinese style sauce
0.0004
0.002
Quince jelly 0.0022
Crab apple jelly 0.0025
Grape jelly 0.0016
Chocolate sauce 0.0036
United States 93 out of 231 samples 13 (1-124)
Cereals 22 (1-108)
Corn oil 21
Pork and beans 2
Peas 2
Onion rings 5
Fried potatoes 9
Baked goods 12 (3-48)
Peanut butter 3
Pecan nuts 120
Dairy products 9 (2-30)
Milk chocolate 20
Meat products 13 (1-124)
Baby foods 2.5 (1-5)
Bananas 2
Grapes 1
Avocados 14
United Kingdom Fish 0.3-11
Fish liver 1-41
Molluscs (dry weight) 4 (1-15)
United States Clams 3
Oysters 10
Germany, supermarket near dry-cleaning shop Margarine 110
Herb butter 7
Butter 21
Flour 25
Corn starch 36
Cheese spread 36
Germany, in dry-cleaning shop Fruit sherbet 2
Chocolate-coated ice cream 1 330
Chocolate- and nut-coated ice-
cream
4 450
Ice-cream confection 18 750
Germany, in apartment above dry-cleaning shop Butter 58 000
9Workplace air
Exposure levels for organic solvents at Dutch workplaces were measured by the
Dutch Ministry of Social Affairs and Employment (55). During cleaning activities
in dry-cleaning establishments, metal industries (cleaning machinery parts and
degreasing activities), and offset-printing offices, breathing zone air levels of up
to 51 ppm (352 mg/m3), 39 ppm (269 mg/m3), and 16 ppm (110 mg/m3) were
observed, respectively.
A US National Institute for Occupational Safety and Health (NIOSH) survey of
44 dry cleaning facilities showed exposures for machine operators to range from
4.0 ppm (28 mg/m3) to 149 ppm (1 027 mg/m3). Geometric mean exposures for
machine operators, pressers, seamstresses, and in front counter-areas were 22, 3.3,
3.0, and 3.1 ppm (152, 23, 21 and 21 mg/m3), respectively. A study of the dry
cleaning industry in the United Kingdom indicated exposure levels similar to
those observed in American studies (3).
An 8-hour time-weighted average (TWA) of up to 4 000 mg/m3 can occur in
dry-cleaning establishments. In the United Kingdom, over 90% of 493 8-hour
measurements in 131 dry-cleaning establishments revealed concentrations below
680 mg/m3, and over 50% of these samples revealed concentrations below 200
mg/m3. Similar results were obtained in a survey of 46 dry-cleaning establish-
ments in Germany (132).
4.2 Human exposure
4.2.1 General population
The most important routes of exposure to PER for members of the general popu-
lation appear to be inhalation of the compound in ambient air and ingestion via
drinking water. Available data indicate that dermal exposure is not important for
most people.
The breath of residents, living above 12 dry-cleaning shops in the Netherlands,
was found to contain a mean concentration of 5 mg/m3, while the breath of resi-
dents, living adjacent to the shops, contained 1 mg/m3 (132).
In Turin, Italy, blood samples of 30 volunteers (15 females, 15 males) contained
a mean concentration of 1.33 µg/l (1 330 µg/m3) and 0.46 µg/l (460 µg/m3) during
winter and summer, respectively (93).
In the USA the average daily intake by the inhalation route, assuming ambient
concentrations of 0.3-2.5 ppb (2.1-17.3 µg/m3) and inhalation of 20 m3/day, is
estimated to be 41-204 µg/day. The average daily intake from water, assuming
concentrations of 0.3-3 µg/l and ingestion of 2 litres water/day, is estimated to be
0.6-6 µg/day (3).
In Switzerland and Germany total daily intakes via food were calculated to be
160 µg/day and 87 µg/day, respectively (132).
4.2.2 Occupational population
NIOSH estimated that nearly 500 000 United States’ workers are at risk of
exposure to PER in over 20 000 dry-cleaning establishments and in a large
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number of other industries producing or using the chemical. The National
Occupational Exposure Survey (NOES), conducted by NIOSH from 1981 to
1983, came to an estimation of 688 110 workers employed at 49 025 plant sites,
which were potentially exposed to PER in the United Sates during this period.
Between 1977 and 1979, breathing-zone air samples were collected from 144
workers at 44 out of an estimated 25 000 dry-cleaning establishments in the USA.
Machine-operators experienced the highest exposures, with 8-hour TWAs
between 27 and 1 010 mg/m3. Machine-operators in 9 plants had 8-hour TWA
exposures exceeding 340 mg/m3, while in 7 plants 15-minute peak exposures
exceeded 680 mg/m3. Other workers were exposed to a maximum 8-hour TWA of
251 mg/m3.
At a railway works, where PER was used as a cleaning agent, 94% of 104
8-hour measurements exceeded 680 mg/m3 with peaks up to 1 290 mg/m3 (132).
4.3 Summary
The environmental levels of PER vary strongly, depending on matrix and location.
Surface water from the Atlantic showed relatively low values of 0.2-0.8 µg/m3,
while other seawater concentrations may reach levels as high as several mg/m3.
Similar concentrations have been found for marine sediments. Ground water may
reach even higher levels; in this matrix concentrations between 10 and 49 000
µg/m3 have been observed. Average drinking-water concentrations lie around
1 000 µg/m3. However, much higher values (35 500 µg/m3) have been measured.
Background ambient-air concentrations amount to a few ng/m3. In urban areas,
1 000 times higher levels may be encountered, in particular downwind of certain
industries.
The general population is exposed by inhalation of ambient and indoor air and
via the food. For inhalation a range of 41-204 µg/day is reported. The intake via
the food shows similar values. Much higher levels are observed for people living
near dry-cleaning shops.
When PER is used in occupational settings, concentrations in air vary strongly,
depending on process, amount used, and hygienic measures. Most observations
for dry cleaning and metal degreasing lie within a range from several tens to
several hundreds of mg/m3.
5. Kinetics
5.1 Absorption
5.1.1 Respiratory
Humans
Respiratory absorption of PER has been investigated in a number of human-
volunteer studies (16, 81, 108, 192, 194, 214, 215, 222, 257, 260). Alveolar
retention was determined by Monster et al. (192) and Fernandez et al. (81) by
11
Table 3. Blood/air, tissue/air and tissue/blood human partition coefficients for PER (89).
Blood and tissue/air partition coefficient Tissue/blood partition coefficient
Blood/air 12
Fat/air 1 450 Fat/blood 125
Kidney/air 59 Kidney/blood 5
Muscle/air 70 Muscle/blood 6
Liver/air 61 Liver/blood 5
comparing concentrations in inhaled air and exhaled air. Results of these studies
show the alveolar retention to decrease from about 90% immediately upon the
start of exposure, to about 50% after an exposure period of 8 hours. Over a period
of 4 hours, lung clearance decreased from 6.7 to 3.8 l/minutes (192). These rather
high absorption values are to be expected, in view of the high solubility of PER in
blood and adipose tissues (194) and the partition coefficients of the compound
(89), which are listed in Table 3. The decrease of retention with duration of expo-
sure is caused by the concomitant increase of the PER blood concentrations.
Benoit et al. (16) investigated retention during steady-state absorption (defined
as the absorption when the concentration of PER in exhaled air in unit time is
constant) in 7 human volunteers. They found retention coefficients ranging from
0.78 to 0.93 when the subjects were exposed to concentrations of 50-92 ppm (345-
634 mg/m3).
The actual absorption of PER by the respiratory tract equals the product of
retention and ventilation volume (volume of breathed air). Monster et al. (192)
calculated the human absorbed amounts, which are listed in Table 4 based on their
experimental observations.
The strong stimulating effect of exercise on absorption shown in this table was
also found by Hake and Stewart (108). These authors reported a fourfold increase
in PER blood concentrations upon an exercise of 30 minutes.
The influence of the fat content of the body on absorption has been investigated
by Monster et al. (192). Their results show that the absorption depends stronger
on lean body mass than on the amount of adipose tissue.
Table 4. Estimated absorption of PER by 6 human volunteers exposed for 4 hours to 72
or 144 ppm (469 or 992 mg/m3) PER at rest, or for 4 hours to 142 ppm (978 mg/m3) PER
combined with 2 half-hour periods of exercise equal to 100 W (192).
Subject Absorption in mg
72 ppm (469 mg/m3)
rest
144 ppm (992 mg/m3)
rest
142 ppm (978 mg/m3)
rest + exercise
A  370  670  1 060
B  490  940  1 500
C  530  1 000  1 400
D  500  1 210  1 510
E  390  880  1 320
F  450  970  1 120
12
Experimental animals
Pegg et al. (218) exposed rats for 6 hours to 10 ppm (69 mg/m3) or 600 ppm
(4 134 mg/m3) of 14C-labeled PER and determined the radioactivity in exhaled air,
urine, and carcass. As in humans, excretion occurred largely via exhalation (Sec-
tion 5.4). As the exhaled air could not be analysed during exposure, the study does
not allow a quantitative estimation of the respiratory absorption. However, it did
show that considerable absorption occurs, as 8.9 and 467.1 µmol PER equivalents
of radioactivity was recovered for the 10 ppm and 600 ppm exposure group
respectively, from exhaled air, faeces, urine and carcass together, during a period
of 72 hours after termination of exposure. Schumann et al. (244) reported, that
under comparable conditions, 2.44 µmol could be recovered over a period of 72
hours after 6 hours of respiratory exposure of mice to 10 ppm (69 mg/m3) of PER.
Again, this value only shows that considerable respiratory absorption does indeed
occur. It cannot be used to derive a reliable quantitative estimate for absorption.
5.1.2 Dermal
Humans
Stewart and Dodd (258) investigated the dermal absorption of PER in 5 human
volunteers. One of the thumbs of the subjects was kept immersed in the solvent
for 40 minutes, during which inhalation of the solvent was excluded. The mean
peak concentration in alveolar air amounted to 0.31 ppm (2.14 mg/m3) and was
reached less than 10 minutes after termination of exposure. The mean concent-
ration decreased to 0.20 ppm (1.38 mg/m3) over a period of 5 hours; the overall
mean was 0.23 ppm (1.59 mg/m3). The absence of data on the concentration of
PER and its metabolites in urine and blood prevents the dermal absorption to be
estimated on the basis of these results. However, comparison with the results of
human respiratory absorption studies (Section 5.1.1) makes clear that the alveolar
concentrations observed in this study, would have been reached by respiratory
exposure to about 0.2-0.6 ppm (1.4-4.1 mg/m3). It may, therefore, be concluded
that a much longer dermal exposure to fluid PER or a much larger exposed skin
surface would be necessary to achieve a body burden that equals the body burden
observed in human respiratory absorption studies (Section 5.1.1). However,
assuming that the skin area of the thumb is 15 cm2, the maximum alveolar air
concentration of 0.31 ppm from the 40-minute exposure can be used to calculate
the alveolar air concentrations occurring when 2 000 cm2 (hands and fore-arms)
of skin is exposed for 1 hour. The calculation would be as follows:
(2 000/15)·(60/40)·0.31 = 62 ppm. Based on a respiratory absorption under
steady-state conditions of 50% this would correspond to a respiratory exposure
of 124 ppm. It is then assumed that the relative respiratory absorption is not
concentration dependent, that the toxicokinetics is not exposure-route dependent
and that dermal absorption is linearly related to surface and exposure time.
Aitio et al. (2) investigated the blood-concentration of PER after dermal expo-
sure in 2 human volunteers. A hand was immersed in the solvent to the wrist for 5
minutes. Respiratory exposure was prevented. The blood concentration appeared
to depend strongly on the arm used for blood sampling. Concentrations were
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much lower in the contralateral arm (the hand of which was not immersed) than
in the ipsilateral arm (the arm with the immersed hand). It took more than 2 hours
for the concentrations in both hands to become equal. This difference suggests
that the low concentrations of PER observed in the exhaled air by Stewart and
Dodd (258) are not necessarily solely determined by poor dermal absorption, but
also by tissue absorption after PER has penetrated through the skin.
The very slow decrease of the alveolar-air concentration in Stewart and Dodd’s
study is important in this context. Comparison with the respiration studies (Sec-
tion 5.1.1) suggests higher alveolar elimination rate after exposure via inhalation.
The comparison of dermal and respiratory absorption can, therefore, not only be
based on mean and maximum concentrations in the alveolar air; the overall area
under the elimination curve should be taken into account as well. The available
data do not allow for such a comparison. Nevertheless, the committees regard it as
probable, that the influence of differences in elimination rate will not be so strong
as to refute the conclusion above, i.e. respiratory exposure will much sooner lead
to high body burdens than dermal exposure.
The dermal absorption of PER vapour was investigated by Riihimäki and Pfäffli
(234). The amount of PER exhaled by 3 volunteers after exposure to 600 ppm
(4 134 mg/m3) of the compound via inhalation and via the skin together and via
the skin alone was compared. Exposure lasted 3.5 hours and concentrations in
exhaled air were followed up to 50 hours after termination of exposure. It appea-
red that the amount of PER vapour, which entered the body via the skin was only
1.1% of the amount absorbed via inhalation. A dermal (with respirator) absorption
of 48 mg was found, compared to an estimated respiratory absorption of 4.22 g.
The authors concluded that the contribution of dermal absorption to the body
burden is strongly exceeded by respiratory absorption.
Experimental animals
Tsuruta (272) has investigated the dermal absorption of PER in mice. An amount
of 0.5 ml of PER was applied to 2.9 cm2 of clipped skin of the abdominal region
for a period of 5-15 minutes. The compound was determined by GC in the expired
air and an extract of the blended whole body. The sum of PER in expired air and
whole body was regarded to be equal to the absorbed amount of PER. They found
a total absorption of 177 µg over a period of 15 minutes, 173 µg of which was
eliminated via the exhaled air. This amount is equivalent to 24.4 nmoles/min/cm2.
The same author (273) investigated the dermal absorption in an in vitro system
with rat skin, and compared the results with those of his in vivo study with mice.
A clear linear correlation was found between the results obtained with the two
systems for a series of halogenated compounds. However, in vitro absorption rates
were markedly lower. In particular this holds for PER, which was absorbed at a
44-fold lower rate (0.067 nmoles/min/cm2) in the in vitro system than in the in
vivo system.
Jakobson et al. (134) investigated the dermal absorption of PER in guinea pigs.
These authors followed the concentration in the blood (carotid artery) of the
anaesthetised animals during exposure. One, two or four 3.1 cm2 areas of clipped
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skin were exposed to 1 ml of solvent for 6-12 hours. A maximum blood concent-
ration of 1.1 µg/ml was found after 0.5 hour, followed by a slow decrease to 0.63
µg/ml after 6 hours of exposure. Elimination from the blood after termination of
exposure was not investigated. This prevents quantitative conclusions to be drawn
on the dermal absorption of PER, because the blood concentrations are the resul-
tant of dermal absorption and elimination through excretion and biotransforma-
tion, excretion via the exhaled air being by far the most important process which
contributes to the elimination of PER.
5.1.3 Oral
Humans
A number of human oral PER poisonings have been described (3, 148), most of
them being the result of the use of the compound as an anthelminthic drug. The
systemic nature of the effects observed (Section 6.1.2) and the presence in blood
and urine of PER or its metabolites trichloroacetic acid (TCA) and trichloroetha-
nol (TCE), show that PER is readily absorbed by the human gastrointestinal tract.
However, these studies do not allow for more quantitative conclusions, because
data on exposure or concentrations in biological samples were too incomplete and
simultaneous respiratory and dermal exposure and absorption may have contri-
buted to effects or concentrations in biological samples.
Experimental animals
Studies with experimental animals indicate a rapid and virtually complete
absorption of PER following oral administration (3, 38, 45, 85, 189, 218).
5.2 Distribution
5.2.1 Respiratory
Humans
Inhalation experiments with human volunteers by Stewart et al. (257) show that
upon repeated exposure (101 ppm (696 mg/m3); periods of 7 hours per day for 5
consecutive days), the PER concentration in the expired air increases compared to
one exposure of 7 hours. The explanation for this phenomenon is accumulation of
the compound in the fat tissues of the body. This accumulation will give rise to an
increase of blood concentrations, which in their turn will lead to an increase of the
PER concentrations in the expired air.
Accumulation was also indicated by the long decay period of the concentrations
in expired air after termination of exposure (257). After 10 days, the expired air
still contained more than 1 ppm (6.89 mg/m3). Prolonged decay is also revealed
by other human volunteer studies; although in most of them shorter exposure
periods were applied, while exposure was not repeated (81, 106, 192).
The accumulation is predicted by kinetic modelling (106). It is largely the result
of the very high fat/blood partition coefficient, the much lower air/blood partition
coefficient (89; Table 3) and the relatively poor perfusion of the fat tissues, which
together result in a relatively slow absorption by, and removal from the fat tissues,
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compared to the exchange of PER between blood and air in the lungs and between
blood and non-fat tissues and well perfused tissues. The model of Guberan and
Fernandez (106) predicts that half of the body burden of a 70-kg person after 8
hours of respiratory exposure to 100 ppm (690 mg/m3) of PER, will be present in
the fat tissues.
No tissue analyses have been performed in human volunteer studies. However,
two case studies of fatal respiratory PER poisonings give an impression of the
amounts of PER that can occur in tissues after short-term respiratory exposure to
high concentrations. Brain and lung tissue, blood, stomach content, and urine of a
deceased dry cleaner were analysed by Lukaszewski (169) with GC/MS. The
following concentrations were found: brain, 36 mg/100 g; lungs, 0.3 mg/100 g;
blood, 4.4 mg/100 ml; urine, and stomach content, below detection limit. Levine
et al. (165) found 240 mg/kg in the liver, 71 mg/kg in the kidneys, 69 mg/kg in
the brain and 30 mg/kg in the lungs of a deceased dry cleaner.
Experimental animals
Savolainen et al. (240) studied the distribution of radioactivity in rats following
respiratory exposure to 200 ppm (1378 mg/m3) of radiolabeled PER for 4 days,
6 hours per day. PER appeared to be primarily distributed in the fat tissues, in
particular the perirenal fat. A 145 times higher concentration were found in the
perirenal fat (4495 nmol/g after 6 hours at day 4) than in the blood (31 nmol/ml
after 6 hours at day 4; corresponding concentrations for cerebrum, cerebellum,
lungs and liver were 143, 92, 74 and 161 nmol/g respectively).
Pegg et al. (218; Section 5.1.1) found that respiratory exposure of rats to 10 or
600 ppm (69 or 4134 mg/m3) of 14C-labeled PER for 6 hours resulted in 4.3 and
2.2 percent of the radioactivity being present in the carcass respectively, the
distribution being investigated 72 hours following termination of exposure. The
distribution over various tissues is presented in Table 5.
The fact that these authors did not find a predominant distribution towards the
fat tissue, can most probably be attributed to the 72 hours between termination of
exposure and determination of distribution. During this period a large part of the
PER accumulated in the fat will most probably be eliminated by expiration. The
radioactivity in the other tissues may be due to bound metabolites (Section 5.3).
Table 5. Distribution of radioactivity (µmol-eq/g) over various rat tissues 72 hours after
respiratory exposure to 14C-labeled PER (218).
Tissue 10 ppm (68.9 mg/m3) 600 ppm (4134 mg/m3)
Liver 0.0047 0.096
Kidney 0.0018 0.167
Fat 0.0018 0.082
Brain NDa ND
Lung 0.0012 0.066
Heart 0.0009 0.045
Adrenal ND ND
a
 ND - not determined.
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Schumann et al. (244) compared the distribution upon respiratory exposure in
rats and mice (same exposure conditions as in (218)): 10 ppm (68.9 mg/m3)
resulted in 3% of the recovered radioactivity in the carcass 72 hours after termina-
tion of exposure. Much higher binding to the liver tissue was observed for the
mouse than for the rat (maximum difference: 9.2 times per gram hepatic protein).
In the mouse, excretion in urine was predominant over excretion in the expired
air. In the rat, the reverse was found. This difference is caused by a much faster
oxidative metabolism (Section 5.3) in the mouse. Consequently, less unmeta-
bolised PER will be accumulated in the fat tissues and subsequently eliminated by
expiration in this species.
Ghantous et al. (92) studied the distribution of PER and trichloroethylene and
metabolites in pregnant mice by means of whole-body autoradiography and GC,
with special emphasis on the foeto-placental unit. A strong accumulation and
retention of radioactivity in the amniotic fluid was observed, which could be
identified as TCA. The results suggest that this compound is partly formed from
the parent compound after the latter has been transported to the foeto-placental
unit. Furthermore, absorption of radioactivity was observed in brains, fat tissues,
nasal mucosa, blood, liver, kidneys and lung. Volatile radioactivity (assumed to be
the parent compound) was distinguished from non-volatile radioactivity (assumed
to represent polar metabolites). The former accumulated in particular in fat tissues
and the brains. Immediately after exposure (which lasted 10 minutes) non-volatile
compounds were found in liver, kidneys, lungs, nasal mucosa and blood. A strong
increase was observed within a period of 4 hours, during which non-volatile radio-
activity did also appear in the eyes and the intestinal tract.
5.2.2 Dermal
Humans
Accumulation of PER in fat tissues upon dermal absorption (to fluid PER) is
suggested by the low decay rate of the concentration in the expired air which was
observed by Stewart and Dodd (258) in human volunteers. As in the case of
respiratory exposure, the low decay rate can be explained by the low perfusion of
the fat tissues combined with the high fat/blood partition coefficient and the much
lower air/blood partition coefficient.
Slow decay was also observed by Riihimäki et al. (234) after dermal exposure
to a PER vapour concentration of 600 ppm (6 134 mg/m3) during 3.5 hours.
Experimental animals
Tsuruta (272) determined the presence of PER in the whole body and in expired
air of mice which were dermally exposed to the compound for 15 minutes. They
found 173 µg to be retained by the body; 3.95 µg was expired during the exposure
period of 15 minutes.
Further pertinent experimental data on the distribution of PER after dermal
exposure were not found in the literature.
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5.2.3 Oral
Humans
No studies were found, which provide information on the distribution in humans
after oral exposure.
Experimental animals
Pegg et al. (218) found retentions of 3.3 and 1.2% of recovered radioactivity in
the carcasses of rats 72 hours after oral administration (by gavage) to 1 and 500
mg PER/kg body weight, respectively. The distribution obtained, demonstrated
the preference of PER for fat tissues for the 500 mg/kg body weight group. Even
72 hours after termination of exposure, the fat tissues showed the strongest radio-
activity. In case of the 1 mg/kg body weight group, no clear differences were
found between liver, kidneys and fat, probably, because the fat contains unmodi-
fied PER, which is eliminated by expiration, while the other tissues may also
contain bound metabolites (Sections 5.2.1 and 5.3).
In the study of Schumann et al. (244) 0.5% of the recovered radioactivity was
found to be retained in the carcasses of mice, 72 hours after a single gavage
exposure to 500 mg/kg body weight. Again a much stronger hepatic-protein
binding is observed for the mouse, which is most probably the result of the higher
metabolism rate in this species.
In their drinking-water study, Frantz and Watanabe (85) found a retention value
for the carcass of 0.9% 72 hours after a 12-hour-long period in which rats received
a saturated solution of PER as drinking water.
Vemmer et al. (281) investigated the distribution of PER in pigs which received
PER in their food. Their results confirm the high affinity of PER for fat tissues,
compared to well perfused tissues as liver, kidney and muscles.
Marth (175) investigated the transport of PER through the body with mice after
oral exposure. Two separate mechanisms were identified. PER absorbed to the
phospholipid cell membrane of the red blood cells, which leads to an increased
fragility of these cells and premature destruction. The fragments of these cells,
loaded with PER, are phagocytised in the spleen, resulting in the accumulation of
PER in this organ. Besides the red blood cells, PER is transported by the chylo-
microns in the blood to the adipose tissue. Thereby, the compound inhibits
lipoprotein lipase, and thus the breakdown of the chylomicrons.
Dallas et al. (44) investigated the time dependence of the PER concentrations
in various organs in rats and dogs after a single bolus of 10 mg/kg body weight,
which was administered by gavage. The results of this study are summarised in
Table 6. The species differences, which are revealed by Table 6 are attributed by
the authors to a markedly higher rate and magnitude of exhalation and metabolism
in the rat.
18
Table 6. Toxicokinetic parameters in rat and dog after a single oral gavage treatment with
10 mg PER/kg body weight (44).
Dog
Tissue Area under the curve
(µg·min/ml)
Half-time
(min)
Cmax
(µg/g)
Tmax
(min)
Liver  1 851  2 448 6  60
Kidney  1 606  1 572  5  60
Fat  55 838  494  43  720
Heart  1 849  1 775  6  60
Lung  1 001  2 289  2 60
Muscle  1 907  1 625  3  60
Brain  3 238  4 641  11  60
Blood  782  865  2  90
Rat
Tissue Area under the curve
(µg·min/ml)
Half-time
(min)
Cmax
(µg/g)
Tmax
(min)
Liver  1 673 331  12  10
Kidney  1 057 395  6  10
Fat  49 964 695  36  360
Heart  806 396  3  15
Lung  627  342  2  60
Muscle  798  310  2  60
Brain  1 377  327  5  15
Blood 332  384  1  15
Cmax: maximum concentration
Tmax: time at which the maximum concentration is reached
5.3 Biotransformation
The biotransformation of PER has been reviewed by Dekant et al. (50), Clement
International Corporation (38), European Centre for Ecotoxicology and Toxico-
logy of Chemicals (69), and Agency for Toxic Substances and Disease Registry
(ATSDR) (3).
5.3.1 Metabolites detected in humans
The toxicokinetic studies with human volunteers, which are described in the
foregoing sections of this chapter, unambiguously show that the major part of
absorbed PER is not transformed by metabolism, but excreted in unchanged form
via exhalation, regardless of exposure route and exposure conditions (16, 81,
106, 108, 190, 192, 222, 234, 257, 258, 260). Compared to the amounts of PER
absorbed, the metabolised amounts can justly be called small (195).
The major metabolite detected in human blood and human urine is TCA (81,
125, 129, 191, 192, 194, 225, 252, 296). The study of Ohtsuki et al. (212) with dry
cleaners and workers in textile processing plants (removal of glue from silk cloth)
indicated that saturation of biotransformation occurred upon respiratory exposure
to 100 ppm (690 mg/m3). Exposure to 50 ppm (345 mg/m3) for 8 hours resulted in
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the excretion of less than 2% of the compound via urine in metabolised form.
Lauwerys et al. (162) did not find TCA in urine of laundry workers exposed to
8.9-37.5 ppm (61.3-258.3 mg/m3), while PER could be detected in expired air
(0.2-10 ppm or 1.4-68.9 mg/m3, 30 minutes after work) and blood (0.4-3.1 mg/l,
30 minutes after work).
Some authors reported the occurrence of other metabolites in human urine
instead of, or next to TCA. Ikeda et al. (129) found TCE and TCA in urine of
volunteers exposed to PER: equal amounts of both metabolites in workers
exposed to 20-70 ppm (138-482 mg/m3) of PER, while an increase of exposure to
200-400 ppm (1 378-2 756 mg/m3) resulted in a TCE/TCA ratio of 2/3.
Monster (191, 194) demonstrated TCA in blood and urine of dry cleaners and
metal cleaners; in the latter biological fluid he found TCE as well. TCE in urine of
PER-exposed humans is not necessarily a metabolite of PER. Often humans are
exposed to a combination of chemicals, among them trichloroethylene (191). The
latter compound is present as impurity in most commercial PER batches used for
cleaning purposes. Even rather low concentrations of this compound in PER
might lead to detectable TCE concentrations in urine, as trichloroethylene is
metabolised to a much greater extent than PER (75% versus 2%; 190). Also the
PER batches used in volunteer studies might be contaminated to a sufficiently
high level with trichloroethylene, to give rise to TCE in urine.
The study of Meuling and Ebens (186) can be referred to as an example in this
context. These authors could fully explain the presence of TCE in urine of laundry
workers from the presence of trichloroethylene as an impurity in PER, the esti-
mated exposure to this impurity and literature data on the formation rate of TCE
from trichloroethylene. Moreover, it is doubted whether biotransformation of PER
does indeed yield TCE as metabolite (296). Finally, it is doubted whether the
presence of TCE can be deduced from results based on the Fujiwara reaction
(231), as is done in some studies.
LaFuente and Mallol (160) found an enhanced excretion of thioethers in
occupationally exposed women. They speculate this to be the result of the
conjugation with glutathione of an epoxide formed from PER. Exposure to other
compounds, which gave rise to an increase of thioethers could not be excluded.
Birner et al. (20) investigated the biotransformation of PER in 4 humans
occupationally exposed during dry cleaning to 50 ppm (345 mg/m3). GC/MS
analysis of urine samples at the start and the end of the workweek revealed the
presence of TCE, TCA and N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine. The
concentrations of the latter compound were found to be more than 1 000 times
lower than those of the first two (2.2-14.6 pmol/mg creatinine versus 13.5-65
nmol/mg creatinine). Whereas the concentrations of TCA/TCE increased during
the workweek, those of N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine did not
change. However, a clear increase was found for the concentrations of the latter
compound when the daily working period increased from 4 to 8 hours.
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5.3.2 Metabolites detected in experimental animals
In most studies with experimental animals, the majority of the PER absorbed after
oral ingestion, inhalation or dermal exposure was found to be eliminated un-
changed via the exhaled air (Section 5.1 and Section 5.4). However, the ratio
between the amount of exhaled unchanged PER and the amount of metabolised
PER appeared to be species dependent. In particular, mice metabolise PER to a
much greater extent than other investigated species. This is clearly revealed by the
studies in which binding of radioactivity to liver proteins is investigated (244).
According to Stott and Watanabe a 6 hours respiratory exposure to 10 ppm (68.9
mg/m3) leads in the rat to a total metabolised amount of 10.5 µmol/kg liver
protein, whereas in the mouse this amount is 89.5 µmol/kg liver protein (263).
The major metabolite identified in blood and urine of experimental animals is
TCA. Besides, several other metabolites have been found. An overview of the
results of studies with experimental animals, which indicate the identity of PER
metabolites, is presented in Table 7.
Very pure PER was used in the studies of Dekant et al. (48), which would
refute the hypothesis that the presence of TCE is only the result of trichloro-
ethylene being an impurity of PER.
The absence of TCA in the urine samples of the study of Pegg et al. (218) is
striking. While exposure of rats in other studies gives clearly rise to TCA, only
oxalic acid was found in the study of Pegg et al. (218).
5.3.3 Metabolites detected in vitro
The results of studies in which the biotransformation of PER has been investi-
gated in vitro (i.e., in isolated cells, tissues or organs) are summarised in Table 8.
5.3.4 Biotransformation pathways
The presence of TCA and other metabolites in body fluids, blood and tissues of
man and other animals can be explained by assuming the biotransformation of
PER to occur via two different and unlinked metabolic pathways.
Epoxidation
The most important pathway (in terms of amount of PER metabolised) starts with
the epoxidation of PER by cytochrome P450 (i.e. mixed function oxidases) to
tetrachloro-oxirane (first postulated by Yllner (295)). The presence of oxalic acid
in urine is consistent with the formation of the oxirane. The oxirane has, however,
never been detected in metabolism studies. It is probably rapidly converted to
other, more stable compounds. Apparently, its half-time is too short to allow its
detection in the experimental systems used so far.
Involvement of cytochrome P450 is indicated by the work of Costa and
Ivanetovich (42, 43), who demonstrated a clear-cut stimulation of biotransforma-
tion by pretreatment of animals with inducers of this enzyme.
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      Figure 1. Oxidative biotransformation pathway of PER, adapted after (3).
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The oxirane undergoes rearrangement to trichloroacetyl chloride, which
compound is subsequently oxidised to TCA. TCE could be formed through the
reduction of TCA.
Dekant et al. (50) identified trichloroacetylethanolamide, as another, minor
metabolite, which is most probably formed via trichloroacetyl chloride by the
reaction of the latter compound with phosphatidylethanolamine.
The presence of oxalic acid can be explained by the hydration of the oxirane
by epoxide hydratase, leading to the vicinal diol, which is subsequently converted
via oxalic acid dichloride to oxalic acid. A side product of this pathway is oxalyl-
ethanolamide, which is formed through the reaction of oxalic acid dichloride with
phosphatidylethanolamine.
The biotransformation of PER via the oxirane is largely located in the liver,
which is expressed in the binding of metabolites to macromolecules and the role
of this organ as target for PER toxicity and carcinogenicity.
The epoxidation pathway is depicted in Figure 1.
Conjugation
Originally it was believed that PER is only metabolised in mammals via epoxi-
dation (126).
More recently, however, it became clear that direct conjugation of PER with
glutathione plays a role as well (48, 49, 50). This is not to say that this pathway is
important in quantitative terms. The amount conjugated is rather small compared
to the amount epoxidised (102, 104). The importance of this pathway lies in the
fact that it offers one of the two explanations for the occurrence of kidney tumours
in male rats, the other being protein-droplet formation due to binding of PER to
α2u-globulin.
Conjugation of PER takes place in the liver (50, 102, 104, 209). The conjugate
is converted to 1,1,2-trichlorovinylcysteine by glutamylpeptidase and cysteine-
glycinase, followed by transformation to the mercapturic acid 1,1,2-trichlorovinyl-
N-acetylcysteine by the enzyme N-acetyltransferase (48). 1,1,2-trichlorovinyl-
cysteine may however also be converted by β-lyase in the kidneys (47, 49, 103) to
dichlorothioketene and dichlorothioacetyl chloride (47) and dichloroacetic acid
(69, 104). It is assumed that the first two of these products are cytotoxic and bind
to the DNA (5, 49, 104).
So far, conjugation of PER could not be detected in human liver. The β-lyase
catalysed cleavage of trichlorovinylcysteine is more important in rats, in particular
males, than in mice and humans (69, 102, 104).
The conjugation pathway will lead to an increase of the thioether concentrations
in urine, thereby providing an explanation for the results of LaFuente and Mallol
(160). The study by Birner et al. is the only one providing direct evidence for
glutathione conjugation products in human urine (20).
The conjugation pathway is depicted in Figure 2.
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5.4 Elimination
5.4.1 Humans
The foregoing sections of this chapter reveal that in humans, PER is primarily and
slowly eliminated as such via exhaled air. On the basis of animal experiments it
may be assumed that a fraction will be exhaled as CO2. Minor fractions will also
be excreted in the urine as TCA, possibly TCE, oxalic acid and mercapturic acid.
A number of studies which provide quantitative information about the elimination
of PER in humans, are summarised in Table 9. It should be emphasised, that in
most experiments listed in Table 9, the elimination was measured by determining
concentrations of PER in exhaled air or blood. The presence of exhaled metabo-
lites was not taken into account. As is demonstrated with experimental animals
(189, 218), CO2 may be one of the exhaled metabolites. The study of Morgan et
al. (197) is the only one which provides a complete balance, as 38Cl-labelled
PER was used. Nevertheless, also in this study, part of the inhaled “material” may
be exhaled undetected in the form of a chlorine-free compound. This notwith-
standing, the studies based on the analysis of PER alone (e.g. 81, 192, 193, 284,
286) clearly show that the contribution of metabolites to the respiratory exhalation
can only be small to insignificant.
The human elimination pattern found for PER can be explained from the slow
metabolism of the compound (Section 5.3), together with its air/blood and
blood/fat partition coefficients (89, 190) and the poor perfusion of the adipose
tissue (191). Generally, two elimination phases are discerned for solvents like
PER (18). A relatively rapid phase, which represents the clearance of the PER
already present in the blood at the moment the exposure terminates. The rate-
limiting factor of this phase is the air/blood partition coefficient. When the PER
already present in the blood is depleted, the blood/fat partition coefficient
becomes the rate-limiting factor, because it is much lower than the air/blood
partition coefficient.
The slow metabolism of PER allows this compound to be absorbed by the fat
tissues before significant biotransformation to more polar components can occur.
Furthermore, being much slower than the elimination of PER in the blood via the
lungs, biotransformation does not contribute to any great extent to the elimination
of the compound in the blood. Finally, the poor perfusion of the adipose tissue is
assumed to be important in this context, because it adds to the slow elimination of
PER from this tissue, and thus to the slow elimination in general (191).
Monster et al. (192) discern a phase between the two mentioned here above.
Analysis of their results lead them to estimate a separate half-time for the muscles,
between the relatively short one for the vessel-rich compartment of the body and
the long one for the poorly perfused adipose tissue.
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5.4.2 Experimental animals
Studies with experimental animals in general confirm the results of human studies
in a qualitative sense, i.e. most studies point to exhalation of unchanged PER as
the most important elimination pathway (Section 5.4.1). Species differences can
be attributed to biotransformation, the most notable example being the mouse
(244). This species has a much more rapid oxidative biotransformation than other
species investigated, including man (Section 5.3), leading to a large part of the
absorbed PER being eliminated as TCA.
5.5 Possibilities for biological monitoring
The feasibility of biological monitoring of human exposure to PER has been
investigated by several authors (106, 130, 135, 162, 191, 193, 194). Four
biological exposure parameters may in principle be used: the concentrations of
PER in the exhaled air and in blood, and the concentrations of TCA in blood and
urine.
In his review paper Monster (191) mentions two extra parameters: the concent-
rations of TCE in urine and blood. However, as has been put forward before, it is
doubtful whether this parameter really reflects exposure to PER. TCE might be a
metabolite of trichloroethylene, which occurs as impurity of PER or is used in the
same room as PER (252, Kezic S. Personal communication).
The PER concentrations in exhaled air show a strong linear correlation with the
concentrations in blood (192)2 and can thus be used as a reliable, non-invasive
parameter for the concentrations in blood.
The latter concentrations are directly determined by the amount of PER
absorbed in the various tissues. Analysis of PER decay rates for exhaled air and
blood, shows that, besides the blood itself (or the vessel-rich compartment), two
other compartments have to be discerned: muscle tissue and fat tissue (192). The
contributions of these compartments to the concentrations in exhaled air will
depend on the exposure history of the subject in question and on the time elapsed
since termination of exposure.
As has been put forward in the previous section, the PER originally present in
the blood is eliminated rather rapidly. If the period between monitoring and
termination of exposure becomes relatively long, only the adipose tissue will
contribute. In between, the muscle compartment contributes to the elimination.
The slow elimination rate of the PER which is present in the adipose tissue,
combined with the long time necessary for the concentrations in this tissue to
reach equilibrium (81, 241, 257), makes it possible to use the PER concentrations
in exhaled air and blood as parameters for a TWA of exposure over several days,
in particular when the first (rapid) elimination phase has completed before taking
the samples.
It may be expected that biotransformation will not affect the reliability of
biological monitoring studies, which are only based on PER concentrations in
                                    
2
 These authors found the blood-exhaled-air ratio to be 23 in a study with volunteers.
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blood and exhaled air, as the amount metabolised is only marginal (192, 193).
Furthermore, it has unambiguously been shown that exhalation of the unaltered
compound is by far the most important elimination route; most percentages
mentioned in the literature approach 100% (81, 108, 192).
However, the slow biotransformation of PER does not imply that the concent-
rations of metabolites cannot be used for biological monitoring purposes. PER
exposure gives rise to clearly detectable TCA in blood and urine. Part of the
PER, which is already present in the blood, which is eliminated from the muscle
compartment, or which is eliminated from adipose tissues will be metabolised.
The concentrations of the metabolites in blood and urine will, therefore, reflect the
concentrations in the various compartments, and, thereby, the history of exposure.
Nevertheless, there are four reasons to use PER concentrations for biomonito-
ring instead of metabolite concentrations: 1) The part of PER metabolised
does not correlate linearly with PER concentrations in blood. At certain PER
concentrations in the air (about 100 ppm (690 mg/m3)) the metabolic capacity
seems to reach saturation (212). This means that TCA concentrations are not a
reliable measure for exposure to higher concentrations; 2) TCA itself does also
accumulate upon repeated exposures to PER, which complicates the relation
between solvent and metabolite (192); 3) The use of TCA concentrations will
lead to an extra source of noise, due to the interindividual variation of metabolic
capacity; 4) PER will in many cases be contaminated with trichloroethylene,
while the latter compound or trichloroethane will in some cases be used con-
currently with PER in the same room. Being the major metabolite of trichloro-
ethylene or trichloroethane as well, TCA simultaneously indicates exposures to
all three compounds (252, Kezic S. Personal communication). Moreover, while
biotransformation of PER is only marginal compared with exhalation of the
unchanged compound, it is a much more important elimination pathway for
trichloroethylene (190). It is impossible to discriminate exposures to the three
compounds on the basis of TCA concentrations alone, while PER concentrations
unambiguously point to PER exposure.
Several studies yielded quantitative indications about the relation between
exposure and biological parameters. Guberan and Fernandez (106) estimated the
relationship between exhaled air and respiratory exposure with the aid of a
mathematical model. Some of their results are presented in Table 10.
Pezzagno et al. (222) investigated the relationship between PER absorption and
PER concentrations in urine in 15 volunteers. They found strong and significant
linear correlations, which indicate that also PER concentrations in urine can be
used for biological-monitoring purposes. Monster and Houtkoper (193) found in
their study with human volunteers that concentrations of PER in the blood can
best be used for monitoring purposes. They calculated coefficients of variation for
the individual absorption during 4 hours exposure, as determined with the
biological parameters (concentrations in blood). The lowest coefficients were
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Table 10. Relationship between respiratory exposure to PER and PER concentrations in
exhaled air (table reproduced from 106).
Day of the week Post exposure timea
0 min 30 min 1 hour 2 hours 15 hours
Monday 0.60 0.32 0.28 0.23 0.06
Wednesday 0.62 0.34 0.30 0.24 0.08
Friday 0.63 0.35 0.31 0.25 0.08
a
 The table lists the concentrations in the exhaled air as fractions of the constant concentration in
ambient air for different days of the week, after at least 4 weeks of exposure.
found for the PER concentrations in blood (23 and 22% at 2 and 20 hours after
exposure has ended). The authors point out that higher coefficients may be
expected in the real-life occupational situation. The results of Lauwerys et al.
(162) suggest that if the blood concentration does not exceed 1 mg/kg, 16 hours
after exposure, the time-weighted exposure over the working day of dry cleaners
is likely to have been below 50 ppm (345 mg/m3). Monster et al. (194) showed
that the concentration of PER and TCA in blood measured 15-30 minutes after
work at the end of the workweek are good indicators for the time-weighted expo-
sure to PER over the preceding week, followed by the TCA concentrations in
urine. They estimated values of 13.2 and 33 µmol per litre for PER and TCA in
blood respectively, when time-weighted exposure was 50 ppm (345 mg/m3). PER
concentrations in exhaled air were estimated to be 920 µmol/m3 at these exposure
conditions. In their study, the lower 95%-confidence limits of the biological para-
meters determined after exposure to up to 50 ppm (345 mg/m3) were estimated
to be 8.3 µmol/l PER in blood, 20 µmol/l TCA in blood, 515 µmol/m3 PER in
exhaled air and 3 µmol TCA/mmol creatinine in urine.
Ohtsuki et al. (212) estimated the lower 95%-confidence limits for total tri-
chlorocompounds in urine, at exposure to 50 (345 mg/m3) and 100 ppm (690
mg/m3) (TWA), to be 30 and 61 mg/l, respectively.
Jang et al. (135) found that 1.6 mg/l PER in blood and 2.9 mg/l TCA in urine
correspond with a time-weighted exposure to 50 ppm (345 mg/m3).
5.6 Summary
5.6.1 Respiratory absorption
Virtually all PER to which humans are exposed via the respiratory tract at the
alveolar level enters the circulation. However, upon increasing concentrations of
the compound in the blood the absorption decreases concomitantly. Respiratory
absorption percentages well above 90% have been observed immediately upon
exposure to 72 or 144 ppm (496 or 992 mg/m3), while this percentage may de-
crease to about 50%, hours after exposure has started. Determinations during
steady state still revealed absorption percentages of 78 to 90% when exposure
amounted from 50 to 92 ppm (345 to 634 mg/m3).
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5.6.2 Dermal absorption
Dermal absorption of liquid PER cannot be quantified using studies with humans.
However, concentrations in exhaled air during and following dermal exposure
permit semi-quantitative comparison with inhalation. This shows that immersion
of the thumb in fluid PER corresponds with a steady-state respiratory exposure to
about 0.2-0.6 ppm (1.4-4.1 mg/m3). From the same data it can be calculated that
immersion of hands- and forearms for 1 hour would correspond to a respiratory
exposure of 124 ppm for 8 hours.
Exposure to vapour only leads to a marginal dermal absorption in comparison
with the respiratory absorption after inhalation of the same vapour; dermal
absorption accounted for 1.1% of total absorption in the study of Riihimäki and
Pfäffli (234).
Dermal absorption rates of 24.4 and 0.067 nmoles/min/cm2 have been found for
fluid PER in mice in vivo and in an in vitro rat system.
5.6.3 Oral absorption
The concentrations of PER or its metabolites in human blood and excreta after
accidental oral exposure, indicate that PER is readily absorbed by the human
gastrointestinal tract. However, more quantitative conclusions cannot be reached
based on these data. Animal studies indicate a rapid and virtually complete oral
absorption.
5.6.4 Distribution
Due to its marginal elimination by biotransformation and its high fat/blood
partition coefficient, PER accumulates in the adipose tissues. It is unknown how
long exposure must last or must be repeated, for an equilibrium to be reached.
However, an increase was still observed after 5 daily periods of 5-hour respiratory
exposure.
Analyses of human tissues after fatal exposure have revealed high concentra-
tions in brain, kidneys, liver and lungs (from 30 to 240 mg/kg).
Tissue analyses in animal studies show clear-cut accumulation of PER in the
adipose tissues. A deviating distribution is shown for the mouse, which can be
explained by the higher biotransformation rate of PER in this animal.
One study indicates that PER is either transported in chylomicrons or in the
phospholipid membranes of the red blood cells. Premature destruction of these
cells leads to phagocytosis in the spleen, and, thereby, accumulation of PER in
this organ.
5.6.5 Biotransformation
In humans and most experimental animals, the major part of PER is not trans-
formed by metabolism, but excreted unchanged via exhalation. For humans, the
biotransformed part of PER is estimated to be only 1-2%.
The major metabolite in humans is TCA. Doubt exists as to TCE being a
metabolite of PER. The presence of this compound in body fluids can also be
explained by simultaneous exposure to trichloroethylene, either as impurity of
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PER or as solvent used in the same room as PER. One study demonstrated the
presence of N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine in human urine, albeit in
very low concentrations (less than 0.001 times the concentrations of TCA/TCE).
Other metabolites detected in humans, experimental animals or in vitro systems
are: oxalic acid, dichloroacetic acid, ethylene glycol, trichloroacetyl amide, tri-
chloroacetylaminoethanol, thioethers and CO2.
Two biotransformation pathways are discerned:
An oxidative one in the liver, the first step of which is the epoxidation by
cytochrome P450 to oxirane, resulting in TCA as major metabolite.
A conjugation pathway in the liver, the first step being the conjugation of PER
with glutathione. This reaction is catalysed by glutathione transferase. It leads to
trichlorovinylcysteine, which can be cleaved in the kidneys by β-lyase into
cytotoxic and genotoxic metabolites.
The first pathway is by far the most important one in quantitative terms.
5.6.6 Elimination
PER is primarily eliminated via exhaled air, independent of exposure route. Half-
times for respiratory elimination vary from 1 to 72 hours. This large variation
most probably reflects the differences in elimination rate between PER in the
blood, the adipose tissues and other tissues. The longest half-times are measured
when the PER originally (immediately after termination of exposure) present in
blood and non-adipose tissues is depleted, and the elimination rate is limited by a
slow transfer from fat tissues to blood, due to a high fat/blood partition coefficient
and poor perfusion of the adipose tissues. Other pathways do not significantly
contribute to the elimination.
5.6.7 Biological monitoring
Concentrations of PER itself or its major metabolite TCA in body fluids can be
used for biological monitoring purposes, in addition to the concentration of PER
in exhaled air. The available data indicate that PER concentrations in blood and
exhaled air give a reliable impression of the TWA exposure over several days, in
particular when the rapidly eliminating PER (present in blood immediately after
termination of exposure) has been allowed to be eliminated first. TCA can be
regarded to be a less suitable indicator compound, as it is also the major metabo-
lite of trichloroethylene and trichloroethane, compounds which are often present
as impurity in PER or can be used in the same room as PER. Furthermore, the
use of TCA may be hampered by interindividual differences in PER biotrans-
formation.
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6. Effects
6.1 Observations in humans
6.1.1 Irritation and sensitisation
A few case reports show PER to be a clear-cut skin-irritant for humans (108, 185,
187, 205). Extensive erythema and blistering were reported for a worker who had
lain unconscious in a pool of solvents for about 5 hours (166).
A worker who had been unconscious for half an hour with PER-soaked clothes
showed the same symptoms. Considerable reduction of the symptoms occurred
within 5 days, although after 4 months there was still dryness, staining and irrita-
tion of the injured areas (196).
Three case reports point to sensitising properties. Skin sensitisation in a worker
is described by Vail (276); a closed patch test with PER and 1% of PER in oil
produced a positive response. The second report is concerned with the induction
of PER-dependent asthma in a woman. It is described in Table 11. Finally, PER
sensitisation of the skin was confirmed with patch testing in a woman wearing
garments contaminated with PER by dry cleaning.
6.1.2 Case studies
Therapeutic oral exposure
The anthelminthic properties of PER were propagated for the first time in the
1920s. Subsequently, the compound has been regarded for a long time as an
effective anthelminthic drug with relatively mild and transient side effects
(compared to other anthelmintics) (141). It has, in particular, been used in South-
East Asia and the Pacific for treatment of hookworm infections. Large numbers of
patients have been treated with the substance. Oral doses of up to several milli-
litres per patient have been prescribed. The UK Health and Safety Executive
(HSE) (119) mentions some case studies, which however, do describe clear
effects. Vertigo, inebriation, giddiness, nausea, and sleepiness at doses of 4.5 or 6
g/patient were reported by Kendrick (141). In two other studies, similar doses
have caused loss of consciousness lasting approximately 2 hours (239, 294).
Haerer and Udelmann (107) report a severe psychosis upon oral treatment with
PER. Anaphylactic reactions have been observed in children treated with 0.25
ml/kg twice daily for two days (228). Two lethal therapeutic treatments are
mentioned in the HSE review (96, 164).
Occupational exposure: Acute exposure
Several accidental occupational exposures to PER are summarised by the US
Environmental Protection Agency (EPA) (74) and HSE (119). Some will be
touched upon here, based on these reviews and a number of original publications.
Saland (238) reports the case of nine firemen exposed to high levels of PER
fume for three minutes. All nine became lightheaded and uncoordinated. Liver-
function changes were induced which persisted until 63 days after exposure.
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A case of virtual whole-body exposure is described by Patel et al. (217).
Exposure lasted 7 hours. Effects were: loss of consciousness, coma, acute
pulmonary oedema, and hypotension. Kidney and liver function were reported as
normal. Normal liver- and kidney-function tests have also been reported in a case
of respiratory overexposure, which resulted in clear depression of the central
nervous system (CNS), such as to make mechanical ventilation necessary (217).
Stewart et al. (259) found an impaired liver function arising 9 days after an
acute narcotic exposure to PER, which they attributed to the exposure.
Stewart (256) found a transient increase in serum glutamic oxaloacetic trans-
aminase (SGOT) and a delayed elevation of urinary urobilinogen in a subject
acutely exposed via inhalation to an anaesthetic concentration of PER.
Hake and Stewart (108) present the case of a dry-cleaning operator who was
exposed by lying in a “pool” of PER for 12 hours. Apart from unconsciousness,
the exposure led to a mild seizure and some temporary liver and kidney damage.
Liver and kidney tests were negative after 21 days.
Breath analyses were carried out in the three publications of R.D. Stewart.
Therefore, these allow the observed effects to be related with a measure of
exposure, as the concentrations in expired air are directly and linearly linked with
the concentrations in blood (Section 5). In the Hake and Stewart (108) case,
concentrations decreased from about 600 ppm (4 134 mg/m3) a few hours after
termination of exposure (the concentration immediately upon exposure was not
measured, but must have been much higher) in a bimodal way to 100 ppm (690
mg/m3) after about half a day, 10 ppm (68.9 mg/m3) after about 15 days and 4
ppm (27.6 mg/m3) after about 25 days (read from the published graph by the
reviewer).
Two publications report fatalities due to acute exposure (165, 169). The first
concerns exposure during repair in a dry-cleaning shop, the second exposure
during recycling of dry-cleaning PER by distillation.
Occupational exposure: Long-term exposure
A number of cases concerning long-term occupational exposure are summarised
by EPA (74) and by Eberhardt and Freundt (68). Key data of these studies are
listed in Table 11.
6.1.3 Volunteer studies
Four male volunteers were exposed to 472 and 911 ppm (3 252 and 6 277 mg/m3)
of PER vapour for 130 and 95 minutes, respectively (35). The 472/130 combina-
tion gave rise to the following effects: eye irritation, secretion from mucous
membranes, sensory changes, slight feeling of elation. The neurological effects
became more severe at the 911/95 combination, when lassitude, mental fogginess,
and exhilaration were experienced/observed. Increase of the highest concentration
to 1 450 ppm (9 991 mg/m3) after 95 minutes lead to inebriation. Increase to 1 940
ppm (13 367 mg/m3) forced the subjects to leave the exposure room after 7.5
minutes; they reported “ringing in the ears” at this concentration (35).
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Table 12. Human-volunteer experiments carried out by Rowe et al. (236).
Exposure regimen Symptoms
4 persons, 930-1 185 ppm
(6 408-8 165 mg/m3), 1-2 min
Marked irritation of the eyes and the upper respiratory tract. 2
minutes exposure (1 person) lead to considerable dizziness.
Rapid and complete recovery.
2 males, 513-690 ppm
(3 535-4 745 mg/m3), 10 min
Irritation of eyes and nose, dizziness, tightness and numbness
about the mouth, some loss of inhibitions. Good motor co-
ordination requires effort. Complete recovery within an hour.
4 males, 206-356 ppm,
(1 419-2 453 mg/m3) up to 2 h
Lightheadedness, burning sensation in the eyes, congestion of
the frontal sinuses, thickness of the tongue, irresponsibility,
nausea, impaired motor co-ordination, effort required for
motor co-ordination. Recovery within 1 hour, except one
subject, who felt unwell for several hours.
4 persons, 206-235 ppm
(1 419-1 619 mg/m3), 45-120 min
Eye irritation and congestion of nasal sinuses with discharge
within 20-30 min, dizziness (inebriation), sleepiness.
6 persons, 83-130 ppm
(572-896 mg/m3), 1 h
No adverse effects reported, except for eye irritation when
peak concentrations occurred during dosage of liquid PER in
the exposure room.
Rowe et al. (236) subjected human volunteers to various exposure regimens.
Only the effects of exposure to PER vapour were investigated. The experiments
and results are concisely presented in Table 12.
This study confirms the finding of Carpenter (35) and suggests a no-observed-
adverse-effect-level (NOAEL) of about 100 ppm (690 mg/m3) or lower for acute
and overt neurological effects and for eye irritation. The neurobehavioral findings
of Rowe et al. (236) are based on a limited number of volunteers using rather
crude qualitative observational methods (no neuropsychological tests, electro-
encephalogram (EEG), etc.).
Stewart et al. subjected groups of 6 male volunteers to different exposure
regimens (260). Three experiments were carried out. Concentrations of PER
were measured in blood and expired air. The effects observed/experienced in
these experiments are listed in Table 13. No effects were found on SGOT and
serum glutamic pyruvic transaminase (SGPT) activities, as well as urobilinogen
excretion (260). This study suggests a NOAEL of 100 ppm (690 mg/m3) for
neurological effects and exposures lasting longer than 30 minutes.
Stewart et al. (257) exposed 16 volunteers for 7 hours to 100 ppm (690 mg/m3);
5 volunteers of the group received this treatment for 5 consecutive days, the other
11 only once. Effects investigated were: subjective symptoms reported by the
exposed themselves; a neurological examination, including a modified Romberg
test (test of balancing ability); haematological parameters and biochemical
parameters measured in blood or serum, including the activities of SGOT, SGPT
and serum alkaline phosphatase (ALP) and serum lactic acid dehydrogenase
(SLDH); “complete” urine analysis, including urobilinogen, 17-ketosteroids,
41
Table 13. Effects of respiratory exposure to PER on human volunteers (260).
Concentration
(ppm and mg/m3)
Time after start of
exposure (min)
Symptoms
75-80 (517-551) 1-4 Very slight eye irritation (a mild burning
sensation); subjects became unaware of irritation
after a few minutes of exposure.
100-120 (689-827) 4-6 Slight soft palate irritation and dryness noticeable.
200 (1 378) 6-30 Romberg test normal
210-244 (1 447-1 681) 30+ Slight lightheadedness; increased effort necessary
to maintain a normal Romberg test.
17-hydroxycorticosteroids, catecholamines, and creatinine.
Most of the exposed reported one or more of the following subjective symp-
toms: mild eye, nose or throat irritation, frontal headache, flushing, sleepiness,
difficulty in speaking. These effects decreased upon repeated exposure, which
points to adaptation.
Three of the 16 subjects showed an abnormal Romberg test within the first 3
hours of exposure, while a number of other tests (Crawford manual dexterity,
Flanagan co-ordination, arithmetic and inspection) were normal. A NOAEL lower
than 100 ppm (690 mg/m3) is suggested by this study on the basis of neurological
endpoints.
In the study of Hake and Stewart (108), two to four female or male volunteers
were subjected for 5 days (1, 3 or 7.5 hours/day) to 0, 20, 100 or 150 ppm (138,
689 and 1 034 mg/m3). Effects investigated were: subjective effects reported
by the volunteers themselves as well as neurological, behavioural, and physio-
logical effects (no complete overview of all effects investigated is presented).
EEG scanning by a neurologist suggested altered patterns indicative of cortical
depression. No effects were found on visual evoked response, equilibrium, math
skills (tested for males only), time discrimination, inspection, and reaction time.
Co-ordination scores (Flanagan test) were significantly decreased in the 100 and
150 ppm group. Various subjective symptoms were reported (not specified); but
these disappeared entirely as exposure progressed. No effects on physiological
parameters (includeing pulmonary function; other parameters not specified) were
found (108). A NOAEL of 20 ppm (138 mg/m3) is indicated by this study on the
basis of neurological endpoints. However, due to the very limited number of
persons studied, the reliability of this NOAEL is rather low.
Six female and six male volunteers were exposed to ethanol (0, 0.75, 1.5 ml of
100-proof vodka per kg), diazepam (ValiumR; 0, 6 or 10 mg/day, once a day when
appropriate), or PER (0, 25 or 100 ppm (172 or 690 mg/m3) of PER; 5.5 hours/day
for 11 weeks), or to combinations, this, to study the interactions between either
ethanol ingestion or diazepam ingestion and respiratory exposure to PER (261, see
also 108). Exposure was checked by analysis of biological samples. A series of
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neurobehavioral and neuropsychological tests as well as EEG recordings were
carried out at peak blood levels of the two drugs during PER exposure. Although
the drugs alone did yield the expected effects on one or more of the investigated
endpoints, no interactions with PER were observed, indicating that they do not
aggravate possible effects of PER or that PER does not aggravate the effects of
these drugs. A slight statistically significant effect of PER was only found in the
Flanagan co-ordination test, on a limited number of days. However, this effect
was considered to be inconsistent by the authors. No clear PER-exposure related
effects on the EEGs were observed (261, see also 108).
Groups of 11 male volunteers (23-35 years) were exposed for 4 days, 4 hours/
day, to 10 or 50 ppm (68.9 or 345 mg/m3) of PER (4). Visual evoked potentials
and brain-stem auditory evoked potentials (BAEP) were measured during expo-
sure. In addition visual contrast sensitivity was determined psychophysically in
some volunteers. The 50-ppm group showed increased visual evoked potential
peak latencies during exposure (statistically significant from the 10 ppm group).
No effects on BAEP were found. A tendency of increased visual contrast sensi-
tivity threshold levels was observed. A significant (p<0.03; r = -0.45) blood-
concentration dependence of one visual evoked potential peak latency (N150) was
established. The study was undertaken to see whether the suggestions of two case
reports for effects of PER on visual capabilities could be substantiated. The study
indicates effects of PER on the visual system. For the investigated effects, 10 ppm
(68.9 mg/m3) can be regarded as a NOAEL in case of 4-hour exposure of young
healthy males (4).
The committees decided that due to the poor presentation and statistical analysis
of the data, the study has only a limited value for the evaluation of the human
neurotoxicity of PER.
6.1.4 Epidemiological studies
Genotoxicity
The occurrence of cytogenetic effects was investigated in lymphocytes of two
groups of 5 factory workers, differing in supposed PER exposure (127). Exposure
varied from 30 to 220 ppm (207-1 516 mg/m3), with a geometric mean of 92 ppm
(25 determinations) for the highly exposed group, and from 10 to 40 ppm (68.9-
276 mg/m3), for the low exposure group (no further details presented). The
differences in exposure were confirmed by the urine analysis. The persons in the
high exposure group were much longer employed than those in the low exposure
group. The highly exposed group was involved in degreasing with PER; the other
group was employed in the same workshop, without exposure that could directly
be attributed to working with PER. Technical PER was the sole solvent used in
the workshop. Personal air sampling and urine analysis were carried out for
exposure assessment. Besides cytogenetic effects, a number of haematological and
liver-function parameters were studied. The same endpoints were studied in a
group of 9 non-exposed workers.
No significant increase of cytogenetic effects was observed. Also liver-function
tests and haematology did not show a relation with PER exposure (127).
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The value of the study is deemed limited by the ATSDR (3) because of the
small number of subjects involved and the wide exposure range.
Fender investigated the occurrence of cytogenetic effects in lymphocytes of 9
women employed in dry cleaning shops in Berlin and 9 control women with office
jobs (80). The dry-cleaning group was exposed to 144-348 mg/m3 of PER. The
exposed group had twice as many cells with aberrations than the control group
when gaps were not taken into account. When the cells with gaps were included,
this difference increased markedly. Dicentric chromosomes occurred 13 times as
much in the cells of the exposed groups. It is reported that the PER was contami-
nated with 0.11-0.43% (volume) of trichloroethylene. The authors state further:
“Technical PER is usually contaminated with trichloroethylene” (80).
In its report on PER, the German MAK Committee summarised two more
studies on the genotoxic effects of PER exposure in humans. The first dealt with
the frequency of sister chromatid changes in smoking and non-smoking, exposed
workers and controls (250). No effect of the exposure was found within the
groups of smokers and non-smokers. In the second study (32), no effects on the
frequency of chromosome aberrations and sister chromatid exchanges in lympho-
cytes was found when 38 workers in dry-cleaning shops were compared with 45
controls. The possible effects of smoking were taken into account.
Reproduction toxicity
In a study by Bosco et al. (27), 67 women working in 53 dry-cleaning shops were
interviewed on their obstetrical history. Exposure was indicated by elevated TCA
concentrations in their urine. 102 pregnancies were reported, of which 46 occurred
when the women were not involved in dry cleaning, and the remaining part when
they were involved in dry cleaning. Endpoints considered were: live births, birth
weight, spontaneous abortion, and birth defects. No significant differences were
found between the two groups of pregnancies. The most marked difference was a
more than four times as high frequency of spontaneous abortions (8.9% versus
2.2%) in the “PER-exposed” group (p<0.10). The low power of the study is
demonstrated by the fact that such a difference did not reach significance. The
authors conclude that “the study ... indicates the absence of overt reproductive
pathology. Given the small sample size, however, these findings should be con-
sidered as merely tentative” (27).
A nested case-referent study (266) was carried out to investigate the effect of
paternal exposure to solvents (among them PER) on pregnancy outcome (sponta-
neous abortion and malformation). “Cases” were spontaneous abortions or
malformations selected from a medical register. Data on paternal pre-conception
exposure and maternal post-conception exposure were obtained from “The
register of biological exposure measurements” (workers ever monitored by the
Finnish Institute for Occupational Health from 1965 to 1983; concentrations of
PER in blood were taken as a measure for exposure to this compound) and
questionnaires.
Odds ratios (ORs) pointed to a significant effect of spontaneous abortion due
to paternal exposure to solvents in general (OR: 2.7, p<0.01), xylene (OR: 1.8,
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p<0.05), “thinners” (OR: 1.7, p<0.05), dusts (OR: 2.3, p<0.01) and smoking (OR:
0.6, p<0.05). For PER an OR of 0.5 was found (p>0.05).
No effects of maternal exposure to solvents were found on spontaneous
abortion. Matching for confounders and stratification according to intensity of
exposure did not lead to an effect for halogenated hydrocarbons, while the effect
for dusts disappeared; the effect increased for solvents in general.
No significant effects of the investigated exposures on congenital malforma-
tions were observed (266).
The power of this study is low, due to the small numbers of cases involved
(spontaneous abortions: OR=2, 34%, α=0.05). This holds in particular for the
congenital malformations; so no firm conclusions may be drawn based on the
absence of significant effects with respect to this endpoint.
However, the study suggests that a risk for spontaneous abortions due to
paternal PER or halogenated-solvent exposure, if present, is relatively low
compared to that of other paternal solvent exposures.
Stratification according to paternal occupation confirms this conclusion, as
metal workers (supposed to be exposed to chlorinated solvents for degreasing) had
an insignificant OR of 1.3, while that of painters was 3.3 (p<0.001) (266).
Olsen et al. present a series of nested case-reference studies on the obstetric
history in women doing dry-cleaning work (213). The studies were carried out
in the four Nordic countries, and to a certain extent common procedures were
followed. It was attempted to identify all women who had worked for at least one
month in a dry-cleaning shop during part of the 1970s and 1980s. Information on
exposure during pregnancy were collected with interviews or questionnaires, in
three countries the information was obtained from the women, in Norway it was
obtained from employers. The following cases were selected: birth weight less
than 1500 g, congenital malformations, perinatal death or spontaneous abortion.
Total number of cases was 20. The small number of exposed cases limited the
power of the study. The results suggest an increased risk of spontaneous
abortions, in particular in Finland. The study is inconclusive to the extent that it
cannot be explained why this effect is in particular manifest in Finland (213).
A case-referent study was carried out by Windham et al. to investigate the
effects of maternal exposure to solvents on spontaneous abortion (292). “Cases
(n=852) were women 18 years of age or older, who had a spontaneous abortion by
20 weeks gestation, for which a pathology specimen was submitted to one of the
11 hospital laboratories in Santa Clara County, California”. For each case, two
controls were selected. Exposure and confounders were assessed by telephone
interviews. Five cases reported exposure to PER, versus two controls, which
results in a crude OR of 4.7 (95% confidence interval: 1.1-21.1).
The OR for the any solvent (including PER) group was 1.2 (95% confidence
interval: 0.87-1.6). Other solvents with high ORs were trichloroethylene (3.1;
0.92-10.4) and “thinners” (2.3; 1-5.1). The authors conclude that “this study
and others suggest that exposure to certain solvents, particularly perchloroethy-
lene, trichloroethylene and aliphatic hydrocarbons, may confer excess risk of
spontaneous abortion.” The committees feel that the word “suggest” should be
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emphasised in this citation, as the conclusion is based on very small numbers
(292).
Semen quality of 34 dry cleaners was compared to that of 48 laundry workers
(76). Breath concentration of PER was used as a measure for PER exposure.
Furthermore an exposure index was established on the basis of a questionnaire.
The first measure gives a reliable impression of PER exposure in the week
preceding sampling, while the second can be regarded as a more rough estimate,
which covers, however, a larger part of spermatogenesis. The two groups clearly
differed in exposure according both measures.
Although on the whole, the semen quality of both groups was lying within
normal limits (“by standard clinical measurements”), the following differences
between the two groups suggest an effect of PER exposure on semen quality: 1)
higher number of round sperm (p<0.002); dose related; this effect is associated
with infertility; 2) sperm tends to be less narrow (p<0.02); dose related; and 3)
greater amplitude of lateral head displacement (p<0.09); dose related; this effect
possibly reflects alterations in the functioning of the cell-plasma membrane.
The exposure measures are not presented in detail, but it was noted that 6
laundry workers had breath PER concentrations higher than 100 µg/m3; for 4 dry
cleaners these concentrations were lying below this concentration. Further, it was
not clear whether the described effects are due to exposure to PER alone or to a
mixture of compounds.
The authors conclude that “these results suggest that occupational exposure to
PCE (PER) can have subtle effects on sperm quality. Additional analyses are
required to determine whether these effects are associated with changes in
fertility” (76).
The female partners of workers participating in the aforementioned study (76)
were examined for reproductive outcome (77). 17 partners of dry cleaners and 32
partners of laundry workers participated in the study.
 No differences were found for number of pregnancies and live births and rates
of spontaneous abortion. Standardised fertility ratios were almost identical for the
two groups.
However, the partners of the dry cleaners “were more than twice as likely to
have a history of attempting to become pregnant for more than 12 months or to
have sought care for an infertility problem.” Furthermore, partners of laundry
workers tended to be pregnant within the first two cycles for a larger percentage
than partners of dry cleaners.
The authors regard these results too little outspoken and the sample size to
inadequate, to allow for definitive conclusions (77).
Nephrotoxicity
In a study by Franchini et al. (84) 57, mostly female persons, working in 29 dry-
cleaning shops, were compared with control groups consisting of 50 females and
30 males or 16 females and 65 males, for proteinuria, albuminuria, urine lysozyme
activity and urine β-glucuronidase activity, as parameters of renal changes. The
authors calculated the exposure concentration via biological monitoring to be 10
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ppm (68.9 mg/m3). Since, the latter two parameters were significantly enhanced,
the authors conclude that “the damage seems to be very weak and tubular, rather
than glomerular” (84).
Lauwerys et al. (162) compared 26 persons (24 females and 2 males) working
in dry-cleaning shops with a non-exposed population of 31 females and 2 males,
for several biochemical urine parameters (β2-microglobulin, albumin and retinol-
binding protein). Exposure was determined by personal air monitoring, analysis of
breath and blood for PER and analysis of urine for TCA. TWA exposure varied
from 8.9 to 37.5 ppm (61.3-258.3 mg/m3), with a mean for all samples of 20.8
ppm (143.3 mg/m3). No effects on the parameters were found (162).
Biochemical markers of kidney damage were examined in 16 female workers
from five dry-cleaning shops (283). Thirteen non-exposed females served as a
control group. Exposure was investigated with personal passive diffusion samp-
lers and personal active charcoal tube samplers. Urine was investigated for β2-
microglobulin, creatinine, glucose, lysozyme, lactic acid dehydrogenase (LDH),
and total proteins. The exposure levels varied between 9 and 799 mg/m3, the mean
level amounting to 157 mg/m3 (all TWA).
The only significant effect of exposure was an increased lysozyme activity. No
correlation with concentration was found, neither was there an effect of duration
of exposure.
The authors conclude that “in view of these limitations and results of other
authors, the existence of a chronic nephropathy at low exposure levels remains
very hypothetical” (283).
Nine men and 41 women working in dry-cleaning shops were compared in a
cross-sectional study with 50 sex- and age-matched controls for 23 biochemical or
immunochemical parameters of renal damage, 20 in urine and 3 in serum (200).
Exposure was determined by measuring PER concentrations in blood of the
exposed, in air samples (environment and breathing zone). Air concentrations
ranged from traces to 85 ppm, giving rise to blood concentrations of 9-900 mg/l;
the median values were 14.8 ppm and 143 mg/l for air and blood, respectively.
The authors found that, based on the values of these parameters, the memberships
of the groups was correctly predicted for 93% of the examined persons. If only 13
instead of 23 parameters were used this percentage decreased to 87%. Comparison
of means yielded significant (p<0.05) differences for albumin, transferrin, brush-
border antigens (BB50, HF5 and BBA), tissue non-specific ALP and fibronectin
in urine and anti-glomerular basement membrane antibodies and laminin frag-
ments in serum. Like the Vyskocil study (283), no significant effects on β2-
microglobulin were found. The results point to both, glomerular as well as tubular
changes due to the exposure. The study does not suggest a correlation between
duration or intensity of exposure and renal damage (200).
Hepatotoxicity
The study by Lauwerys et al. (see under “Nephrotoxicity”) did not reveal effects
of exposure on the enzymes SGPT and γ-glutamyl transferase (γ-GT) in serum,
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indicating the absence of effects on the liver by PER at the measured low
exposure levels (162).
Gennari et al. studied iso-enzyme patterns in a group of 141 workers from 47
small laundries and dry-cleaning shops in Bologna, exposed to PER, and a control
group of 130 subjects from among staff and students of the University of Bologna,
Italy (91).
Both clinical examination and questionnaire results ascertained that all the
study subjects showed a) no history or current signs of liver disease, b) no alcohol
intake exceeding 8 g daily, c) no use of drugs known to affect enzyme activity,
and d) no clinical condition or habit likely to affect enzyme activity.
Exposure to PER was assessed measuring TCA in urine at the end of the work
shift, after at least 5 consecutive days of exposure. Environmental PER measure-
ments showed that in all instances, the mean value for 8 working hours was lower
than the ACGIH 1989/1990 threshold limit value (TLV)-TWA of 50 ppm. The
TLV-short-term exposure limit (STEL) of 200 ppm was not exceeded in any of
the measurements.
Total γ-GT activity was higher in the exposed group (12.36 ± 6.90 U/l versus
8.76 ± 4.94 U/l, p <0.01). Also the γ-GT-2 isoenzyme fraction was higher in the
exposed group (6.79 ± 5.74 U/l versus 3.48 ± 3.29 U/l, p < 0.01).
No correlation existed between serum γ-GT activity and PER exposure level or
duration. No differences in enzyme activity of other enzymes measured (alanine
aminotransferase (ALT), aspartate aminotransferase (ASP), ALP, LDH, 5’-
nucleotidase (5’-NU) was mentioned by the authors (91).
The control group and the exposed group are likely to be different in lifestyle,
especially nutrition, but also with respect to the consumption of alcohol (although
this latter feature was controlled for). However, γ-GT is known to be a very
sensitive marker of exposure to alcohol and also of various other clinical and non-
clinical conditions, and the method of controlling for the consumption of alcohol
used in this study, seems susceptible for introducing confounding. In addition,
both a dose-effect-relationship and (probably) effects on other enzyme activities
are absent. At this stage, therefore, it is considered premature to conclude that the
finding of a slightly higher serum γ-GT (isoenzyme) activity within normal limits
should be considered a biologically significant adverse health effect of PER
exposure.
Cancer
This section is largely based on references (3, 12, 69, 74, 119). However,
most of the original publications have been consulted for verification and for
comparison of conclusions.
A number of studies on drinking-water for evaluating the carcinogenicity of
PER have been published (11, 39, 133, 161, 279); all summarised in (124). These
studies will not be described here in detail because there are sufficient occupa-
tional exposure studies in which the carcinogenicity of PER has been studied.
Further, oral exposure of the general population is less relevant in the context of
occupational exposure to PER. Moreover, these drinking-water studies did not
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provide clear evidence for the carcinogenicity of PER due to the lack of clear
differences in cancer incidences and the impossibility to differentiate between
effects of PER and effects of other chlorated hydrocarbons present in drinking-
water.
The publication by Kaplan (137) is concerned with a retrospective cohort
mortality study involving 1 597 members (285 deaths) of four unions, who had
been employed in dry-cleaning shops for at least one year before 1960. Comp-
arison of standardised mortality ratios (SMRs) of the cohort with the overall
mortality rates of the United States’ population revealed significant excesses of
urinary-tract cancers (observed 5, expected 2.84 and 2.92 for whites and blacks,
respectively; SMRs: 203 and 198) and colon cancers (observed 11, expected 6.98
and 6.77; SMRs: 182 and 187). The author did not draw definitive conclusions
because of the small numbers within the cohort (137).
In 1987 the cohort was expanded to 1 690 (493 deaths) workers with 42 267
person-years-at-risk (30). A subcohort was defined which consisted of 615 (137
deaths) workers exposed almost exclusively to PER. In the main cohort, a signi-
ficant excess of urinary-tract cancer deaths was observed, i.e. 12 (8 bladder and 4
kidney) against 4.7 expected; SMR: 255, 95% confidence limits: 132-450; only
the excess of bladder cancer was significant. However, no excess of urinary-tract
cancer was found in the PER-only subcohort. When latency time and employment
time were taken into account, the results indicated an occupational aetiology for
bladder-cancer mortality.
Although the absence of an increased risk in the PER-only subcohort does not
prove the absence of an association with urinary-tract cancer for this compound, it
suggests a contribution by other factors (exposures). The authors hypothesise
Stoddard solvent (a mixture of petroleum solvents similar to gasoline) to be a
possible factor. Stoddard solvent has extensively been used before the introduc-
tion of PER (in the 1950s), and many years thereafter. Other solvents that have
been used are tetrachloromethane and trichloroethylene, although subjects known
to be exposed to the former were excluded from this study.
In view of the findings in experimental animals (Section 6.2), it is important to
note that no cases of liver cancer were found in the main cohort, while cancers of
the lymphatic and hemopoietic systems were significantly lower in the main
cohort.
Smoking was not accounted for as a confounder in this study. The authors
recognise this and mention smoking as an etiologic factor for urinary-tract cancer.
However, based on the influence of smoking on urinary-tract cancer incidence and
mortality, which is observed in other studies, they regard a substantial contribu-
tion of smoking to the urinary-tract SMR to be impossible.
The authors conclude: “.... the confounding exposure to petroleum solvents
complicates any conclusions regarding the association between PER exposure and
cancer of the urinary tract”. The committees add that the absence of risk in the
PER-only subcohort strongly suggests other factors to contribute to the risk
observed in the main cohort.
49
The results of a second update of this study have been published in 1994 (237).
In general, this update confirmed the conclusions of the first publication and the
first update. Most notable was the increase of oesophagus cancer in both the
main cohort and the PER-only subcohort. In the latter, an SMR of 7.17 (95%
confidence limits: 1.92-19.82) was found for the decedents with more than 20
years of latency time who had been employed for at least 5 years in dry cleaning.
A contribution of smoking and drinking to the SMR of oesophagus cancer could
be excluded on the basis of the SMRs for lung cancer and liver cirrhosis. Again,
the PER-only group did not show an elevated SMR for urinary-tract cancer.
Neither was there an elevated liver-cancer SMR.
Blair et al. (22) determined SMRs for a cohort of 11 062 members of a dry-
cleaners union, which were employed between 1945 and 1977. Incidences of
laryngeal cancer, bladder cancer and lymphoma were elevated in workers
employed before 1963 (SMRs: 256, 156 and 199, respectively). For black male
subjects with medium or high PER exposure, oesophagus cancer was significantly
elevated (SMR: 280); in a subcohort of black male workers with more than 15
years of union membership the SMR for this type of cancer increased to 463. The
study clearly suggests an occupational cancer risk of dry cleaning. However, it
does not indicate a risk of PER exposure, as the risk was partly associated with
employment before 1963, when other solvents than PER (tetrachloromethane,
trichloroethylene and Stoddard solvent) were predominantly used. Oesophagus
cancer is strongly related with smoking and drinking. These confounding factors
were not taken into account. However, if they had contributed to oesophagus-
cancer incidence, an increase of lung-cancer mortality or liver-cirrhosis mortality
would have been detected, which was not. Again, no enhanced liver-cancer risk
was found (22).
Proportional mortality ratios (PMRs) were calculated for 279 trade-union
decedents in the period 1957-1977, which had exclusively worked in dry-cleaning
shops (21). Elevated PMRs were found for lung cancer (PMR: 170; p<0.05),
cervix uteri (PMR: 208; p<0.05), skin cancer (PMR: 429; p<0.05), leukaemia
(PMR: 227) and liver cancer (PMR: 235). Breast cancer showed a deficit (PMR:
69), which, together with the increased risk for cervix cancer, points to an
influence of socio-economic status. Smoking histories were not taken into account
(21). It is impossible to conclude a carcinogenic effect of PER from these
findings, because the possible confounding effect of smoking and the exposure to
other solvents in use during the occupational life of the decedents (tetrachloro-
methane, trichloroethylene and Stoddard solvent). Another limitation of the study
is related to the use of the PMR as a measure for risk. Eighty-seven deaths were
due to cancer, while only 67.9 were expected. This difference is not necessarily
the result of a “stronger carcinogenicity” of life style or occupation; it is probably
caused by less mortality from other, non-cancer causes. If the latter suggestion
is indeed valid, more cancer deaths have to occur within the group decedents.
Consequently, some cancers will yield higher than expected PMRs, without
necessarily being related to occupational exposure.
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Another PMR study has been conducted by Katz and Jowett (139). The group
of decedents consisted of 671 female white laundry and dry-cleaning workers,
which had died in the period 1963-1977. PMRs were calculated for 25 causes of
death. Two control populations were used: all occupations and lower-wage
occupations, both taken from the same region. The distinction was made, to
enable a correction for possible effects of the low socio-economic status of
laundry and dry-cleaning workers.
Notwithstanding this correction, elevated PMRs were found for unspecified
cancers of the genitalia (PMR: 467; 4 observed against 0.9 expected; p≤0.01) and
kidney cancer (PMR: 253; 7 observed against 2.8 expected; p<0.05). Furthermore
non-significant increases of bladder cancer and skin cancer were found (bladder
cancer: PMR: 190; 5 observed against 2.6 expected; skin cancer PMR: 263; 7
observed against 2.8 expected). A significant PMR for cervix uteri cancer (PMR:
195; 10 observed against 5.1 expected; p<0.05), decreased to statistical insigni-
ficance (PMR 140; 10 observed against 7.1 expected).
Smoking was not corrected for, and this factor might thus explain the elevated
kidney and bladder cancer risk. However, in that case an increased lung-cancer
risk would have been observed, which was not the case (PMR: 95; 10 observed
against 10.6 expected).
Laundry workers are not or much less exposed to organic solvents, let alone
PER. The committees points out that the inclusion of these workers in the group
of decedents will certainly have lead to a reduced sensitivity of the study as
regards the detection of cancer caused by PER or other dry-cleaning solvents.
This study did reveal a PMR of 100 for all cancer deaths (141 observed against
141.5 expected).
The value of this study is limited by the fact that many of the decedents will not
have been solely exposed to PER; exposure to other dry-cleaning solvents in
earlier phases of their occupational life may very well have contributed to the
elevation of the PMRs for some cancers (139).
Standardised mortality odds ratios (SMORs) were calculated for a group of
440 laundry and dry-cleaning workers deceased in the period 1975-1981, with
stratification on sex, race and age of death (58). No excess death was found for
all cancers, while the SMORs were statistically significantly increased for
respiratory-tract cancer (39 observed against expected 23.8; SMOR: 1.8), cancer
of the lungs (37 observed against 22.6 expected; SMOR: 1.7) and kidney cancer
(7 observed against 1.9 expected; SMOR: 3.8). Breast, bladder and liver cancers
were markedly less frequent than expected. Again, smoking habits were not
accounted for. The inclusion of deceased laundry workers will have resulted in a
reduced sensitivity.
In this case, the subjects had died later than in the other studies, which suggests
more exclusive PER exposure for the dry cleaners. However, the authors point out
that petroleum solvents account for over 50% of the solvents used, which affects
the validity of the study as to the human carcinogenicity of PER (58).
Nakamura again, used death certificates as study material (201). It concerned
1 711 members of the “All-Japan Laundry and Dry-Cleaning Association”, who
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died in the period 1971-1980. For 294 of the members information of smoking
and drinking habits as well as exposure was obtained from the families by
questionnaire. No excess of overall cancer mortality was observed. Standardised
proportional mortality ratios (SPMRs) were found to be significantly increased for
the small intestine (SPMR: 170; 18 observed against 10.6 expected; p<0.05). No
clear (and significant) elevated SPMRs were observed for the urinary tract and
kidneys, with the exception of bladder cancer in males who died at 75 years or
older (SPMR: 455; 5 observed against 1.1 expected; p<0.01). The authors point
out that prior to 1985 only 30% of the Japanese dry-cleaning shops used PER as
solvent, which makes it impossible to draw conclusions on the human carcino-
genicity of PER on the basis of this study. Furthermore, the sensitivity of the
study was reduced by the inclusion of death certificates of laundry workers.
In a case-referent study (253) bladder-cancer cases were drawn from a national
bladder-cancer study conducted by the US National Cancer Institute in 1978. The
total investigated population consisted of 103 subjects who had been employed for
at least 6 months in dry-cleaning or laundry shops, 5 776 subjects who had
worked in other occupations which might lead to exposure to similar chemicals
and 1 869 subjects who had not been exposed to such chemicals. A relative risk of
1.31 (95% confidence limits: 0.85-2.03) was found for non-smokers employed in
dry-cleaning or laundry shops, which does not indicate an association of bladder
cancer with this employment. Smoking habits were taken into account in this
study. The authors calculated the power of their study to reject the null hypothesis
in case of a real relative risk of 2. The outcome was 40% for non-smokers and
former smokers and only 20% for smokers (253). Again, the sensitivity of the
study for solvent-related cancers will have been limited by the inclusion of
laundry workers.
The case-referent study by McLaughlin et al. (182) was concerned with renal
cancers occurring in Swedish laundry and dry-cleaning establishments. 7 405
cases of renal cancer between 1960 and 1979 were identified in the Cancer-
Environment Registry. Standard incidence ratios (SIRs) were 0.99 (18 cases) and
0.86 (25 cases) for male and female workers, which does not indicate an associa-
tion between employment in laundry or dry-cleaning shops and the occurrence of
renal cancer. As laundry workers were included, a dilution of dry-cleaning-related
cancers may have occurred.
A retrospective cohort study was carried out by Spirtas et al. (254). The cohort
consisted out of 14 457 aircraft maintenance workers, exposed to over 20 different
solvents. For PER an elevated number of deaths in female workers was observed
due to multiple myeloma or non-Hodgkin’s lymphoma, who had been exposed to
the solvent for more than one year during their work. The ATSDR concludes that
“confidence in these data is low primarily because multiple and overlapping
exposure to more than one chemical was considerable. In addition, the levels of
tetrachloroethylene to which the workers were exposed were not provided, and
lifestyle factors such as smoking and consumption of alcohol were not assessed”
(3).
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A Finnish cohort exposed to PER, trichloroethylene and trichloroethane and
consisting of 2 050 male and 1 924 female workers was followed from 1967 to
1992 for the occurrence of cancer (7). Individual exposure was biologically
monitored. In case of PER, this was done by measuring the concentrations of this
compound in blood samples. PER monitoring data were available for the years
1974-1983.
The overall cancer incidence did not differ from that of the Finnish general
population. Excess incidences were observed for cancers of the cervix uteri and
lymphohaematopoietic tissues for the complete cohort. No excess of specific
cancer incidences could be linked with PER exposure (7).
The epidemiological evidence for the induction of renal-cell cancer by PER
exposure was reviewed by McLaughlin and Blot (181). The following is a citation
of the summary of this review:
“There is little evidence of an increased risk of renal-cell cancer and exposure
to TCE (trichloroethylene) or PCE (PER). The few studies with elevations in risk
suffer from important methodological shortcomings. Although it is virtually
impossible using epidemiology data to rule out conclusively a small increase in
risk of renal-cell cancer, the totality of epidemiological evidence clearly does not
support a causal association with TCE or PCE” (181).
A PMR study was carried out by Walker et al. (287). The causes of 8 163
deaths of people formerly employed as laundry and dry-cleaning workers in 28
states of the USA were analysed. Comparison with the PMR of the general
population in the same states yielded the following results. Black men had higher
PMRs for total cancer cases (PMR=131; 95% CI: 105-159) and for oesophagus
cancer (PMR=215; 95% CI: 111-376). In the subpopulation of white men, cancer
of the larynx yielded a higher PMR (318; 95% CI: 117-693). The value of this
study is reduced by the fact that no separate dry-cleaning and laundry deaths
were analysed. Moreover, increased PMRs are not necessarily the result of real
increases of incidence. They may very well be associated with decreases in other
causes of death. Nevertheless, the study again suggests an enhanced risk of
oesophagus cancer in black males (287).
A case control study suggested an increased risk of oesophageal cancer upon
working in dry cleaning (280). However, this result was only based on 2 cases
of a total of 404 cases. The authors conclude: “These findings could easily be
explained by chance; nevertheless, they are consistent with previous reports ...”.
Moreover, it is stated in the discussion section of the publication: “The main
limitation of this study is the low prevalence in the population of a history of
working in dry cleaning, with the consequent low statistical power to detect a true
association” (280). The committees like to emphasise this statement.
The possible association between renal-cell cancer and exposure to trichloro-
ethylene and PER was investigated in a case control study with 59 cases and 84
controls (278). Whereas a high odds ratio was found for trichloroethylene, no
cases with PER exposure were identified. The control group included two
individuals with a history of PER exposure.
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Neurotoxicity
Volunteers who worked in various dry-cleaning or laundry jobs were subjected
to the following tests: feeling tone checklist, Wechsler digit span, Wechsler digit
symbol, Neisser letter search, critical flicker fusion, Santa Ana dexterity test,
choice reaction time, simple reaction time (275).
The exposed group consisted of 18 dry-cleaners (9 males and 9 females), while
9 laundry workers participated as controls. Exposure was extensively investigated
by analysing breath samples and environmental monitoring. TWAs were
calculated for the subjects for the 5 days of testing. Mean TWA for the complete
dry-cleaning group amounted to 18 ppm of PER (124 mg/m3), while the males
(who are often machine operators) had a mean TWA of 32 ppm (220 mg/m3).
Significant differences were found for two of the 11 measured endpoints (electric
diagnostic rating score: p<0.1; total neurological score: p<0.05). Multiple
regression analysis suggests these effects to be rather related with exposure to
Stoddard solvent than to PER exposure (275). The power of this study is limited
by the small number of subjects involved.
In a cross-sectional study (82) 60 female workers of dry-cleaning shops were
compared with 30 female workers from a cleaning plant, which did not use
solvents, as regards the dopaminergic control of prolactin secretion and the
performance in neurobehavioral tests (finger tapping, simple reaction times, digit
symbol and shape comparison tests). PER concentrations varied from 1 to 67 ppm
(6.89-461.6 mg/m3) (median: 15 ppm or 103.4 mg/m3). During the menstrual
cycle, PER-exposed workers showed increased basal levels of serum prolactin as
compared to their matched controls. These endocrine changes suggest involve-
ment of the CNS, since prolactin release is under control of pituitary dopamine.
The PER-exposed workers also showed a poorer performance in the tests. Within
the exposed group, no significant correlations with relevant exposure measures
were found (82).
Nervous-system effects were investigated in a group of 65 dry-cleaners (70).
On the basis of analysis of PER in breath and air, subjects were classified in a
low-, moderate- or high-exposure zone, with respective mean air levels of 11.2,
23.3 and 40.8 ppm (77.2, 160.5, 281.1 mg/m3) PER. In addition, an index of
lifetime exposure to PER was determined for each participant. All subjects
underwent extensive testing, using a broad set of neurophysiological and neuro-
behavioral tests, including the following endpoints: visual reproduction, pattern
memory, pattern recognition, simple attention, psychomotor performance,
executive function/complex-attention, test-taking effort, mood and verbal skills.
Decreased performances were observed for visual reproduction, pattern memory,
(number correct and latency) and pattern recognition in employees in the high
exposure group (70).
The results suggest that 3 years of exposure to PER levels below 50 ppm
(345 mg/m3) may cause permanent nervous system effects. However, the
committees agree that this single study cannot at the moment be used for the
setting of an occupational exposure limit. However, it points to the need of
further investigations.
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Miscellaneous
Workers (n=106) exposed to PER in a railway repair shop were compared with
101 controls (78). The exposed had been involved in cleaning of machine and
engine parts with PER for at least two years. Estimation of exposure was based on
environmental monitoring. Environmental concentrations were often exceeding
400 ppm (2 756 mg/m3), 74.3% of the analyses pointed to concentrations lying
between 0.2 and 50 ppm (1.4-345 mg/m3). The comparison of the two groups
concerned: subjective symptoms, biochemical, and clinical symptoms of nephro-
toxicity and hepatotoxicity, histology of liver biopsies, neurological symptoms
(abnormal reflexes, sensory disturbances, motor disturbances).
No indications for PER-related liver or kidney damage or neurological effects
could be obtained, this notwithstanding the fact that there was a clear elevated
frequency of complaints (subjective symptoms) in the exposed group. In particular
dizziness and dermal irritation were much more often complained about by the
exposed (78).
The occurrence of subjective symptoms was compared for dry-cleaning workers
and workers not exposed to PER (33). The exposed group consisted of 56 dry-
cleaning workers with a mean TWA of 20 ppm (138 mg/m3) (measured by passive
personal-air sampling). The non-exposed were from the same “factories”, but they
were employed in workshops where no dry-cleaning took place. In addition,
several biochemical liver- and kidney-function as well as haematological para-
meters were determined.
Statistically significant differences between the exposed and the non-exposed
group were observed (33). Altogether, these differences suggest neurotoxicity
and local irritation. However, the subjective character of the symptoms warrants
caution in the interpretation of this result. No indications for haematological
effects or impaired liver or kidney function were found.
6.1.5 Summary
Case studies
• Application of PER as anthelminthic drug has revealed a relative low acute
oral lethality of the compound for humans. Several grams of PER can be
tolerated without serious acute toxicity.
• Only two lethal occupational PER intoxications have been described. Doses
were not determined; exposure occurred largely via the respiratory tract.
• The following effects of acute respiratory occupational exposure (sometimes
combined with dermal exposure) have been described: depression of the
central nervous system (lightheadedness, dizziness, loss of consciousness,
coma, seizures), pulmonary oedema, hypotension, temporary liver and kidney
damage. The reports do not allow the establishment of effective dose levels.
• Two cases of skin irritation are described which can be attributed to PER
exposure.
• One case of asthma has been described, which appears to be related with PER
exposure.
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• Case studies indicate that long-term respiratory exposure leads to a wide
variety of neurological symptoms. In most cases, symptoms disappeared
some time after cessation of exposure. However, some studies point to less
reversible, even progressive symptoms. One study points to cerebral atrophy.
When concentrations were measured, they were lying between 200 and 400
ppm (1 378 and 2 756 mg/m3). Furthermore, the relationship with PER
exposure is too uncertain to use these case reports as basis for evaluation.
• Long-term exposure case studies point to hepatotoxicity, expressed as liver
enlargement, jaundice, biochemical effects and histopathological effects.
These effects were also observed between 200 and 400 ppm (1 378-2 756
mg/m3).
• One case indicates that PER is transferred to breast milk and may cause
jaundice in breast-fed babies at high exposure levels.
Volunteer studies
• Respiratory exposure to concentrations of PER lower than 100 ppm (690
mg/m3) leads almost immediately to transient eye, nose and throat irritation in
human volunteers.
• Repeated respiratory exposure of human volunteers for several hours per day
to concentrations of PER lower than 100 ppm (690 mg/m3) gave rise to
transient neurological symptoms, such as headache, sleepiness, difficulty of
speaking and reduced co-ordination scores. The overall NOAEL (i.e. for all
effects) of these studies was 20 ppm.
• One volunteer study suggests a NOAEL of 10 ppm (68.9 mg/m3) based on
increased latencies of visual evoked potentials.
• The group sizes were generally very small in the volunteer studies, which
reduces the reliability of the NOAELs.
Epidemiological studies
• Two epidemiological studies show that persons exposed during their work
(first study: 74.3% of environmental concentrations between 0.2 and 50 ppm
(1.4-345 mg/m3), many exceeding 400 ppm (2 756 mg/m3); second study:
mean TWA of 20 ppm (138 mg/m3)) complain more often about subjective
symptoms related with neurotoxicity than controls, although this appears not
to be accompanied by effects on objective neurological parameters deter-
mined in one of the studies.
• Another study associates working in dry-cleaning shops with decreased
performance in various neurological/psychomotor tests, although the effects
correlated with previous exposure to another dry-cleaning solvent, i.e.
Stoddard solvent and not with PER exposure.
• A study of female dry cleaners exposed to 1-67 ppm (6.89-461.6 mg/m3) of
PER indicated effects on neurobehavioral endpoints and prolactin secretion,
suggesting involvement of the CNS.
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• A study concerning chronic exposure of dry-cleaners for at least 3 years to
levels of PER below 50 ppm (345 mg/m3) suggested permanent alterations in
neurobehavioral and neuropsychological tests.
• Significant elevated serum γ-GT activity was found in a group of dry-cleaners
and laundry workers, as compared to university students and staff. In addi-
tion, a shift in the isoenzyme pattern of the enzyme was observed. However,
the study does not allow these effects to be unambiguously attributed to PER
exposure.
• Three epidemiological studies show effects of dry cleaning on renal function.
The nature of the effects measured, points to glomerular as well as tubular
impairment.
• Several epidemiological studies were focused on the cancer mortality of dry-
cleaners and other workers exposed to PER. On the whole, these studies do
not lead to definitive conclusions about the carcinogenicity of PER exposure.
They suggest that dry cleaning or other occupations accompanied by solvent
exposure, give rise to an elevated cancer risk, although no typical cancer
pattern emerges.
• In most studies a substantial exposure of the exposed group to other solvents
in addition to PER could not be excluded. In particular Stoddard solvent is of
importance, because it was the main solvent used before PER was introduced
and some time thereafter. In addition, trichloroethylene and tetrachloro-
methane can be mentioned as solvents, which have been used for dry cleaning
and could have influenced the outcome of the studies. Furthermore, the value
of most studies is affected by the fact that life-style-related factors, in parti-
cular smoking, were not or not adequately accounted for. Moreover, laundry
workers are often included in the exposed groups, which leads to a dilution of
possible effects, as these workers are not exposed to PER.
• One study defined a subcohort of PER-only subjects, which showed a statisti-
cally increased mortality due to oesophagus cancer. Incidences of lung cancer
and liver cirrhosis suggest that this effect cannot be attributed to smoking and
alcohol consumption. Oesophagus cancer was also found to cause excessive
mortality in one other study, which did not comprise a PER-only cohort.
• In view of the outcome of animal experimental studies (Section 6.2), it is
reassuring that no consistent increases of liver or kidney cancer were found.
• The committees conclude that the results warrant further investigation of the
incidence of certain cancers, in particular oesophagus and bladder cancer, but
that they do not allow the conclusion that working with PER leads to an
enhanced cancer risk.
• Two epidemiological studies suggest an increased risk of spontaneous
abortions among female dry cleaners. However, a possible contribution of
PER cannot be distinguished from contributions of other solvents used in
dry cleaning.
• Effects on semen quality have been observed for dry cleaners. As exposure to
other solvents will be less important in this study, it suggests an important
human reproduction toxic effect of PER. Furthermore, this study suggests a
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fertility problem, as the female partners had more difficulty in becoming
pregnant. Although the study does not allow a definite conclusion, it certainly
warrants further investigation.
6.2 Animal experiments and in vitro systems
6.2.1 Irritation and sensitisation
Using the official Draize method, PER turned out to cause severe skin irritation in
rabbits (60), while no macroscopic changes of the skin were found in guinea pigs
(152), although microscopic examination did indicate skin damage (degenerative
changes in the epidermis, junctional separation and cellular infiltration in the
dermis) in the second species.
An eye-irritation study with rabbits showed PER to be a mild irritant (60). The
compound caused discharge with epithelial damage and epithelial keratosis. No
details about the dose are presented in this study. In another study (101) PER
was directly sprayed into rabbit eyes from a distance of one foot. This treatment
resulted in the following effects: blepharospasm, a granular and optically irregular
appearance of the corneal epithelium and loss of patches of epithelium. Complete
recovery occurred within 2 days.
No dermal sensitising properties were observed in the guinea pig when the split
adjuvant technique was applied (230).
Although PER has amply been investigated for toxic properties upon respira-
tory exposure, no indications for irritation or sensitisation of the respiratory tract
have been obtained for experimental animals.
6.2.2 Toxicity due to acute exposure
Inhalation
The results of acute inhalation studies will be treated separately for each of the
effects caused by PER.
Inhalation: Lethality
LC50 values have been determined for rats and mice. A number of them are listed
in Table 14.
In the study of Holmberg et al. (116), the time required to kill half of the
Table 14. LC50 values.
LC50Species Duration
(h) ppm (95% CIa) mg/m3 (95% CIa)
Reference
Rat 6 4 100 (3 899-4 387) 28 250 (26 900-30 200) (25)
Rat 8 5 027 (3 334-7 571) 34 600 (22 300-52 200) (226)
Mouse 2 5 800 40 000 (87)
Mouse 4 5 200 36 000 (87)
Mouse 6 2 978 (2 758-3 215) 20 500 (19 000-22 200) (59)
a CI = confidence interval.
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animals exposed to a defined dose (LT50) was found to be 12.2 hours (95% con-
fidence limits 11.8-12.5 hours) at 3 700 ppm (25 500 mg/m3) for mice.
In NTP (208) a highest non-lethal dose of 2 445 ppm (16 850 mg/m3) and
lowest lethal doses of 2 613 and 3 786 ppm (26 100 mg/m3) is mentioned for mice
and rats, respectively, when these animals have been exposed for 4 hours.
Rowe et al. (236) report non-lethality for 10- or 14-hour exposures of rats to
2 000 ppm (13 800 mg/m3) and 4-hour exposure of rats to 3 000 ppm (20 700
mg/m3), while lethality was found when exposure to the latter dose lasted 5 hours
or longer. 12 000 ppm (82 700 mg/m3) did not give rise to death when exposure
lasted 0.2 hour; complete survival was also found at 1 600 ppm (11 020 mg/m3)
for 5 hours.
Kennedy and Graepel (142) mention in their study an approximate lethal
concentration, which is the concentration at which mortality was first observed,
in rats of 6 000 ppm (41 340 mg/m3) for a 4-hour exposure.
Inhalation: Neurotoxicity
Most notably are the short-term neurotoxic effects of respiratory exposure. PER
has been used in the past for human anaesthesia (83), and it is, therefore, not
surprising that effects related to this application are abundantly reported in the
literature on acute respiratory toxicity. Various short-term neurobehavioral effects
have been observed, among them hyperactivity (excitability), hypoactivity,
hypotonia, loss of reflexes, lateral position, drowsiness, trembling, ataxia and
“drunken” stupor (3, 119). At doses approaching the lethal dose, respiration is
affected. Failure of respiration is the direct cause of death. Concise summaries of
a number of original publications are presented in Table 15.
Inhalation: Cardiac arrhythmia
Epinephrine-induced cardiac arrhythmias have been observed in rabbits during
respiratory exposure for 1 hour to 5 200 ppm (35 800 mg/m3) PER (34). The
author of the original publication considers the influence of PER on this endpoint
to be weak (compared with trichloroethylene and methylchloroform, which were
investigated for this effect by the same author, although the results were published
elsewhere). Little more than half of the exposed rabbits showed an increased
sensitivity. Furthermore, the arrhythmias did only occur early in the exposure
period, and after 15-30 minutes of exposure the rabbits appeared to adapt and no
longer responded to the same degree. In contrast to the effects observed with
trichloroethylene and methylchloroform, the sensitivity of the animals did not
increase after administration of Lilly 18947, an inhibitor of the oxidative
metabolism to TCA and TCE. This is not surprising, in view of the marginal
oxidative metabolism of PER in mammals.
No epinephrine-induced arrhythmias have been observed in beagle dogs
exposed for 10 minutes to 5 000 or 10 000 ppm (34 500 or 68 900 mg/m3) (the
latter treatment was not well tolerated) (232).
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Inhalation: Hepatotoxicity
Several acute respiratory studies have revealed clear-cut hepatotoxicity, expressed
in histopathological and biochemical changes. A number of studies are concisely
summarised in Table 16.
Table 16. Overview of studies on the acute respiratory hepatoxicity of PER in
experimental animals.
Species Exposure conditions Concise summary Reference
Rat 24 h after termination of acute
exposure, which causes high
mortality.
Slight cloudy swelling and diffusely
distributed fat globules in the livers.
(236)
Mouse Acute lethal concentrations. Cloudy swelling, anisokaryosis,
anisocytosis and infiltration of Kupffer
cells in livers.
Rat 24 h prior to, 1 h after, 24 h after
and 48 h after a 1-h exposure to
500, 1 000 and 2 000 ppm (3 450,
6 890 and 13 780 mg/m3).
Effects on rat serum enzymes indicating
hepatotoxicity, viz. SGOT, SGPT, serum
glucose-6-phosphatase (SG-6-P) and
serum ornithine carbamyl transferase
(SOCT). The highest concentration lead
to marked increases of the activities of
all four enzymes after 24 and 48 h. Less,
but still substantial increases were found
after exposure to 1 000 ppm (6 890
mg/m3). Marginal increases were found
when enzyme activity was measured
within 1 h after exposure, or when the
animals were exposed to 500 ppm (3 450
mg/m3).
(56)
Mouse 24 and 72 h after a 4-h exposure
to 200, 400, 800 and 1 600 ppm
(1 378, 2 756, 5 512 and 11 024
mg/m3).
A dose-dependent fatty infiltration in the
liver at all doses as well as a dose-
dependent increase of extractable fat at
400 ppm (2 756 mg/m3) and higher
doses. No effects on SOCT.
(153)
Mouse Till 20 h after a 3-h exposure to
800 ppm (5 512 mg/m3).
Clear-cut decrease (to 45% of control) of
liver adenosine triphosphate (ATP)
content in mice, which lasted till
observation was terminated (to 55% of
control after 20 h). Furthermore, marked
(up to 160%) and rather persistently
increased liver lipid levels and liver
triglyceride levels were found.
(211)
Mouse
and rat
4 h, 1 080 ppm (7 441 mg/m3). Centrilobular fatty degeneration and
increases of lipids and triglycerides in
livers of mice. No such changes occurred
in rats.
(128)
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Table 17. Oral LD50 values of PER.
Species LD50 (mg/kg body weight) Reference
Rat 2 438 (1 415-4 215)a (226)
Rat 4 460 (3 810-5 210)a (293)
Rat, male 3 835 (112)
Rat, female 3 004
Mouse 7 814 (pure PER)
9 607 (in herring oil)
(67)
Mouse 5 000 (290)
Mouse 4 700 (145)
a
 95% confidence limits.
Inhalation: Nephrotoxicity
Histopathological effects of acute respiratory exposure on the kidneys are
reported. Slight and irregular scattered necrotic and degenerative lesions were
observed upon the exposure to 2 978 ppm (20 500 mg/m3) for 6 hours (59, 100).
Inhalation: Immunotoxicity
Aranyi et al. (8) investigated the influence of PER inhalation (3 hours, 25 and 50
ppm) on mice mortality from Streptococcal pneumonia and mouse pulmonary
bactericidal activity to inhaled Klebsiella pneumonia. Both endpoints were
significantly affected; mortality increased and the bactericidal effect decreased.
Oral
The oral acute toxicity of PER has been amply investigated in rats, mice, dogs,
cats, foxes, cows, horses, sheep and pigs. Most of these studies are rather old,
some of them dating back to the period before and shortly after the second world
war, when interest in the toxicity of PER was mainly due to its use as anthelmintic
drug, see references in (35, 37, 74, 242).
Oral lethal doses for 50% of the exposed animals at single administration (LD50)
for rats and mice are listed in Table 17.
Although the other studies summarised by (3, 119) do not allow for the esti-
mation of LD50 values, they confirm that acute (within several days) death of the
exposed animals will only occur when doses of several grams per kilogram or
higher are administered.
The effects observed in oral acute toxicity studies are listed in Table 18. The
contents of this table should be interpreted with caution, because most studies
were carried out long ago and were of a rather limited nature (small numbers of
animals). Furthermore, a high incidence of pre-existing infections restricts the
value of some studies (119). However, in an overall sense, the table provides a
qualitative impression about overt macroscopic and microscopic effects that can
be expected in experimental animals shortly after the application of high oral
doses. The table identifies liver, kidneys, and spleen as important target organs.
Furthermore, indications for neurotoxicity are present.
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Table 18. Effects observed in oral acute toxicity studies (3, 35, 37, 74, 119, 242).
Dosea (mg/kg bw) Species Effects
500 Mouse Irreversible binding in hepatocytes.
500 Rat Increased relative weight of liver; increased enzyme-altered
foci in liver (γ-glutamyltranspeptidase activity), irreversible
binding in hepatocytes.
286-557 Dog Depression of heart and ventilation rate; shrivelling and
inflammation of small intestines; fatty infiltration of the liver;
severe ataxia; depression.
376-753 Cat Fatty infiltration of the liver; fatty changes (infiltration?) in
kidneys; congestion in liver spleen and kidneys; cloudy
swelling of hepatocytes; hepatic necrosis; restlessness,
drowsiness and unsteadiness in the hind limbs.
376-4 426 Fox Cloudy swelling of kidney tubule cells; fatty degeneration of
liver.
136-241
or 15 mg/animal
Cow Cloudy swelling, reticulation, centrilobular necrosis,
disassociation of hepatic cords and oedema in liver; hyaline
casts in kidneys and tubules; anorexia; inability to stand.
99-226 Horse Centrilobular oedema, necrosis, and cloudy swelling in liver;
hemosiderosis in spleen; congestion, cloudy swelling and
oedema in kidney.
331-1 254 Sheep Cloudy swelling, reticulation and fatty changes in periportal
regions of lobules (liver); cloudy swelling, reticulation and
atrophy and vacuolisation of kidney tubules.
a
 Rough indication of doses.
The study of Moslen et al. (198) deserves special attention, because it shows
that the acute hepatotoxicity of PER increases markedly after pretreatment of rats
with phenobarbitone or Aroclor-1254, a mixture of polychlorinated biphenyls
(PCBs) which, like phenobarbitone, stimulates biotransformation by inducing
mixed-function oxidases. Rats pretreated with Aroclor-1254 or phenobarbitone
were treated once by gavage with 0.75 ml/kg in mineral oil. The influence on
SGOT and SGPT activities, excretion of trichlorocompounds (as measure of
oxidative metabolism), mixed-function oxidases, and liver histopathology was
examined. Urinary excretion was increased 5-7 fold by the pretreatment with
either phenobarbitone or Aroclor-1254. Aroclor-1254 pretreatment did also lead
to a clear-cut increase of SGOT and histopathological effects, such as vacuolar
degeneration and necrosis. The study thus points to metabolites instead of PER as
the ultimate hepatotoxic agent. The absence of an increase of hepatotoxicity due
to phenobarbitone treatment is difficult to explain.
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Intraperitoneal
The LD50 of intraperitoneal exposure has been determined for mice and dogs (74,
90, 119, 145, 146). For the first species values of 5 671 and 4 600 mg/kg have
been reported, while a study with the second species yielded an LD50 of 3 163
mg/kg. The dose at which a described effect is found in 50% of the exposed
animals (ED50) determined in the same studies for ALT activity were 3 980 and
5 300 mg/kg for mice and 1 114 mg/kg for dogs.
A number of acute intraperitoneal studies were aimed at specific effects (41, 52,
109, 119, 199, 224). Measurement of enzyme activities in serum pointed to liver
damage in the rat and the guinea pig at doses between 452 and 3 011 mg/kg for
the first, and 200 and 400 mg/kg for the second species.
Rats treated intraperitoneally with PER (1.3 ml/kg) show an altered bile duct
pancreatic secretion (increased volume (5.8 times) and decreased protein concent-
ration (8.6 times)). Indications were obtained that this effect is not caused by an
interaction with the cholinergic system.
Renal damage was indicated in studies with mice and dogs by biochemical
changes (proteinuria; reduced phenolsulphthalein excretion) and histopathological
changes (swelling of tubules).
Effects on locomotor activity have been investigated and demonstrated for rats
at doses of 500 and 1 000 mg/kg.
Subcutaneous
Plaa et al. found a subcutaneous LD50 for mice of 5 g/kg (223). Histological
examination of liver and kidneys revealed changes of the centrilobular area (only
in the liver), including alterations of cell staining and cytoplasmic vacuolisations.
A clear prolongation of phenobarbitone-induced sleeping time was observed, the
ED50 for this effect being 4 477 mg/kg (223).
A minimum lethal dose of 2.2 g/kg was found for the rabbit (119).
Intravenous
A minimum lethal intravenous dose of 85 mg/kg has been found for dogs (119).
The effects of intravenously administered PER on the vestibular-ocular reflex
of rats was investigated by Tham et al. (267). An excitation of this reflex was
found at blood concentrations equal to or higher than 0.9 mM (149 mg/l).
Rabbits, dogs and cats showed a clear increase of noradrenalin-induced cardiac
arrhythmias upon intravenous application of PER (147). A mean lethal dose for
cats of 81.4 mg/kg was found.
Intratracheal
The acute toxicity of PER after intratracheal instillation for rats has been
investigated by McCarty et al. (180). An approximate lethal dose of 450 mg/kg
was established. The same study yielded an oral LD50 of 2 600 mg/kg.
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6.2.3 Toxicity due to short-term exposure
Inhalation: Multi-endpoint studies
Rowe et al. investigated the effects of various subacute and semichronic respira-
tory exposure regimens on a number of endpoints in rats, rabbits, guinea pigs and
rhesus monkeys (236). Table 19 presents their results in a summarised form. The
following endpoints were investigated: mortality, behaviour, body weight, organ
weight, histopathological examination of a wide range of organs, lipids in liver,
free and esterified cholesterol in liver; estimated in blood were: urea-nitrogen,
total non-protein nitrogen, serum phosphatase, prothrombin clotting time (236). It
is not clear whether all these endpoints are included in the experiments presented
in Table 19. They were certainly not investigated in all animals involved. The
paper does not provide a complete and clear presentation of the experiments and
the results, which means that the results should be interpreted with caution.
Notwithstanding this shortcoming, due to its extensive nature, the study
provides a fairly global impression of the effects that can be expected upon the
subacute or semichronic respiratory exposure. It identifies the CNS and the liver
as targets for PER. Furthermore, it shows that in experimental animals concentra-
tions as low as 100 ppm (690 mg/m3) can induce adverse effects upon inhalation.
Inhalation: Hepatotoxicity
A number of studies showing hepatotoxicity are summarised in Table 20.
Inhalation: Nephrotoxicity
EPA (74) mentions a study of Brancaccio et al. (28; see also 119) in which the
renal function was investigated in rabbits, which were exposed 45 days to 2 280
ppm (15 710 mg/m3) (4 hours/day; 6 days/week). Concentrations of creatinine and
para-aminohippuric acid in the urine lead the authors to conclude that tubular
function was affected more than glomerular capacity. EPA (74) and HSE (119)
criticise the study (28) for the lack of information on raw data and statistical
methods.
In the study by Odum et al. (210, see under “Hepatotoxicity”) the effect of
PER in kidneys was investigated with light and electron microscopy. No histo-
pathological changes were found. Slight indications for increased peroxisomal
cyanide-insensitive palmitoyl CoA oxidation activity were obtained for female
mice; catalase activity in the kidneys was unaffected in both species. The authors
conclude that peroxisome proliferation does not significantly contribute to the
nephrotoxicity of PER, even in the relatively efficient TCA-producing mice.
The NTP (208) describes a study in which mice and rats were exposed for 13
weeks to 100, 200, 400, 800 and 1 600 ppm (689, 1 378, 2 756, 5 512 and 11 024
mg/m3). The mice showed renal tubular karyomegaly at all doses except the
lowest one. Only the kidneys of the highest rat dose-group were microscopically
investigated, and these did not show any lesions.
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Inhalation: Endocrinological effects
Mazza and Brancaccio (179) observed in rabbits slight increases (not statistically
significant) of adrenal hormones (both cortical and medullar) upon the exposure to
2 200 ppm (15 158 mg/m3) of PER 1 hour/day, 6 days/week for 15 days (from
reference 74). The enzyme levels increased gradually with number of exposures.
The studies of Kjellstrand et al. do not point to a clear interaction between PER
and testosterone (144, 143), see under “Inhalation: Effects on plasma butyryl-
cholinesterase”.
Inhalation: Immunotoxicity
EPA mentions a study in which 7 days of continuous exposure of rats to 185 ppm
(1 275 mg/m3) results in morphological changes in mast cells (“...increased
vacuolisation of the cytoplasm and conformational changes in granules with some
degranulisation” (74)). Furthermore, EPA (74) cites a study of Schmuter (243) in
which exposure of chinchillas to 1.5 and 15 ppm (10.3 and 103.4 mg/m3) (8-10
months, 6 days/week, 3 hours/day) results in significant changes in antibody
production to Salmonella typhosa. However, EPA (74) regards the study as too
poorly reported to enable the evaluation of these results.
Inhalation: Electrophysiological effects
An effect of respiratory exposure to PER on electroconductance and contraction
of muscles (maximum reductions of 10 and 24% for these endpoints, respectively)
has been described by Dmitrieva (54, cited in 74) for mice. The animals were
exposed for 3 months, 5 hours/day, to 15 or 75 ppm (103 or 517 mg/m3).
Dmitrieva and Kulshov (54, cited in 74) found effects on the EEG in rats exposed
to 15 ppm (103 mg/m3) for 5 months, 5 hours/day. EPA (74) concludes about
these studies that “these data should not be relied upon to develop a regulatory
strategy”, as “it is often difficult to interpret these results because of the
investigators´ reporting methods”.
Inhalation: Effects on behaviour and related effects
Clear effects on behaviour and related effects are reported in several subacute and
semichronic studies. They do not differ essentially from the effects observed in
acute studies in a quantitative or a qualitative sense. The tolerance observed by
Carpenter (35) after repeated exposures points to changes in either the biotrans-
formation of PER or the sensitivity of the neurological target to its effect.
Inhalation: Neurochemical effects
The overt neurological effects of PER have prompted a series of investigations
into possible biochemical changes caused by this compound in the brain. The
results of these studies are summarised in Table 21.
Taken together, the results presented in Table 21 suggest that long-term
respiratory exposure to PER leads to structural damage of the brain as a loss of
brain cells (possibly glial cells), as partly reversible changes in the composition
of cerebral membranes and as interference in the metabolism of the structural
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proteins of brain cells. It should be noted that the observed biochemical changes
are small and that the relation with functional changes is unknown. Furthermore,
much of the evidence has been obtained by a single research group using a rather
uncommon experimental animal (Mongolian gerbil). Some of the data have been
confirmed by the same research group in the rat model.
Inhalation: Effects on plasma butyrylcholinesterase
Kjellstrand et al. have investigated the effect of respiratory PER exposure of mice
on plasma butyrylcholinesterase (143, 144). Two exposure regimens were applied:
continuous exposure for 30 days and 16, 8, 4, 2 or 1 hour/day for 30 days. The
first regimen resulted in a maximum increase of 1.7-fold for females and 2.5-fold
for males, indicating a clear-cut effect of the PER inhalation on the activity of this
enzyme. Significant effects were observed at 37 ppm (255 mg/m3); the next lower
concentration (9 ppm or 62 mg/m3) did not result in an effect. The effect reached a
maximum at concentrations little higher than 37 ppm (255 mg/m3). The intermit-
tent exposure showed that decrease of concentration can be compensated for by an
increase of daily exposure time.
In a second study of the same authors (143), the question was addressed as to
whether the effects of PER on butyrylcholinesterase were caused by hepatotoxi-
city or had an endocrinological background. Mice were exposed continuously to
150 ppm (1 034 mg/m3) for one month. In addition, the influence of castration and
testosterone administration was investigated. The results of this study indicate
that the effect on butyrylcholinesterase activity is not directly correlated with the
effects of testosterone levels nor with liver toxicity.
Changes in butyrylcholinesterase activity by PER are difficult to interpret in a
functional sense, because the biochemical/biological role of this enzyme is largely
unknown. In addition, a poor correlation has been found between butyryl cholin-
esterase activity and plasma acetyl cholinesterase activity.
Inhalation: Haematological effects
Seidel et al. exposed female mice 6 hours/day, 5 days/week for up to 7.5 weeks to
135 ppm (930 mg/m3) of PER and for up to 11.5 weeks to 270 ppm (1 860 mg/m3)
of PER, followed by an exposure-free period of 3 weeks (249). They investigated
the effects of this treatment on a number of haematological parameters. In the
peripheral blood, reductions of the lymphocyte, monocyte and neutrophil counts
were observed, followed by an almost complete regeneration during the exposure-
free period. Reticulocytosis during and after exposure pointed to a compensatory
reaction of the red blood cell system.
No effects on the bone-marrow pluripotent stem cells were seen. The number of
erythroid-committed cells was suppressed and slight indications for a disturbance
of the granulocyte cell series were found (249).
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Oral: Multi-endpoint studies
Kaemmerer et al. (136) applied various dose regimens to rats. Their results are
summarised in Table 22.
Hayes et al. (112) administered PER via drinking water. Actually all PER
was offered to the animals as emulsion droplets and not in the dissolved state.
Theoretical doses applied were 14, 400 and 1 400 mg/kg/day for 90 days. The
results of this study are summarised in Table 23.
Even these rather high doses did not result in clear-cut effects on liver and
kidneys, important target organs, when administered via the drinking water.
Oral: Hepatotoxicity
No effects on histopathology and relative liver weight were seen in rats treated for
12 days by gavage with 500 mg/kg/day (245, 263).
In the study of Buben and O’Flaherty (31) PER dissolved in corn oil was
administered once a day, for 5 days per week, over a 6 week period, to mice, in
doses of 0, 20, 100, 200, 500, 1 000, 1 500 and 2 000 mg/kg. At 100 mg/kg and
higher doses, a dose-related increase of liver weight (up to 75%) and accumula-
tion of triglycerides (up to 8-fold) were observed. At higher doses liver glucose-6-
phosphatase was less active (starting at 500 mg/kg), while SGPT activity was
raised at 200 mg/kg and higher doses (up to 2.9-fold). The DNA content of the
liver was determined at 200 and 1 000 mg/kg; it was decreased by 17% at
the latter dose compared to the control. In addition, karyorrhexis, polyploidy,
degeneration and necrosis were observed at both doses upon histological exa-
mination, although, with the exception of degeneration, these effects were
minimal to slight, while degeneration was moderate to severe. The authors
established a NOAEL of 20 mg/kg.
The study by Buben and O’Flaherty comprised a detailed comparison of
metabolism (determined as urinary excretion of TCA and TCE) and hepatotoxi-
city (31). Good linear relationships were found between on one hand urinary
Table 22. Summary of the studies reported by Kaemmerer et al. (136).
Dose regimen Results
25 or 500 ppm in diet for 7 days
and/or 25 ppm in diet for 14 days
Increase of cytochrome P450 levels; at 25 ppm significant
after 14 days; at 500 ppm significant after 7 days.
25, 100, 200 or 500 ppm in diet
for 7 days
No effect of doses on anaesthesia induced by hexabarbitone.
25 or 400 ppm in diet for 1 day to
2 weeks
No effects on acetylation and elimination of 50 mg/kg sulpha-
dioxide intramuscular.
25 ppm in diet for 14 days or 500
ppm for 7 days
Effects on coagulation, i.e. increase of prothrombin time and
thrombin time; no change in thrombocyte number.
25, 200 or 500 ppm in diet for 7
days
No increase of mortality caused by Neguvon, 2,4-dinitro-
phenol or ouabain due to PER exposure.
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Table 23. Effects of PER emulsified in drinking water on rats (112).
Endpoint Effect Effective doses (mg/kg/day)
Relative body weight Decrease Males: 1 400
Females: 400 and 1 400
Kidney weight/body weight Increase Males: 400 and 1 400
Females: 1 400
Liver weight/body weight Increase 1 400
Serum parameters;. LDH, SGPT, SGOT,
ALP, 5’-NU, blood urea nitrogen, protein,
glucose, cholesterol, bilirubin, creatinine,
calcium, phosphorus, albumin, globulin,
sodium, potassium
Not treatment related
except an increase of
5’-NU.
Females: 400 and 1 400
excretion of metabolites and on the other hand SGPT, SG-6-P, triglycerides and
liver weight, thus presenting clear-cut indications that the toxicity is caused by
metabolites and not by PER itself, see also (198).
Schumann et al. (244) compared the hepatotoxicity of PER in mice and rats.
The animals were exposed by gavage to 100, 250, 500 or 1 000 mg/kg each day
of 11 days. All doses resulted in histopathological changes in the liver of mice
(described as “accentuated lobular pattern with hepatocellular swelling in the
centrilobular region”), while only marginal effects were found in the livers of rats
treated with the highest dose (described as “altered staining ability of the hepato-
cytes in the centrilobular region”). Furthermore, all doses led to a decrease in the
DNA concentration in the mouse livers, while such effect was not observed for
the rats. At the same time, a marked increase of DNA synthesis ([3H]thymidine
incorporation) was found in the mouse livers of all treated groups. Again, no such
effect was observed in the rat. The differences between the two species are
explained by the higher biotransformation capacity of the mouse compared to the
rat, if it is assumed, that the effects are caused by metabolites instead of the parent
compound.
Oral: Nephrotoxicity
The effects of PER (500 mg/kg, administered orally by gavage in corn oil, daily
for 4 weeks) on renal function and renal histopathology in rats have been investi-
gated by Bergamaschi et al. (17). The results of this study are summarised in
Table 24.
At first observation, these results look inconsistent, as histopathology points to
damage of the tubuli, while biochemistry points to glomerular damage. However,
in the discussion section of the paper in which this study is described (17), the
authors present a plausible explanation, based on a “tubular target selectivity” of
PER (PER appears to affect tubular segment S2 in particular).
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Table 24. Effects of oral PER treatment (500 mg/kg bw/day gavage during 4 weeks) on
renal function and renal histopathology in rats (17).
EffectsEndpoint
Female Male
Albuminuria (marker for
glomerular permeability)
Minor, but significant increase Marked increase (up to 15 times
of control)
Urinary excretion of α2u-
globulin (marker for tubular
dysfunction)
Marked increase (up to 4 times
of control)
Transient increase
Urinary excretion of retinol-
binding protein (marker for
tubular dysfunction)
Slight increase Increase (up to 2 times of
control)
Urinary excretion of
N-acetylglucosaminidase
Slight increase Transient, but significant
increase
Electrophoretic analysis of
proteinuria
Increase in low-molecular-
weight proteins
Increase in high-molecular
weight proteins
Histopathology Same effects as in the male but
much less severe
“Progressive increase in number
and size of phagolysosomes
(hyaline droplets) in proximal
convoluted epithelial cells”
The nephrotoxicity of PER has also been investigated by Goldsworthy et al.
(98). These authors exposed rats to PER by gavage (1 000 mg/kg/day) for 10
days. Endpoints examined were: renal α2u-globulin, protein-droplet accumulation
(PDA) and cell replication. Only the male rats showed increases of PDA (inclu-
ding crystalloid accumulation) in the cytoplasm of the P2 segment of the proximal
tubule. The P2 segment also showed an increased cell replication, which was
again seen only in the male. α2u-Globulin correlated well with PDA. Comparable
effects were observed in rats treated with pentachloroethane, but not in those
treated with trichloroethylene.
Oral: Peroxisome proliferation
The induction of peroxisomal enzyme activity (cyanide-insensitive palmitoyl CoA
oxidation, regarded to be a sensitive measure for peroxisome proliferation) by
PER (1 000 mg/kg; gavage once a day, over a period of 10 days) was investigated
by Goldsworthy and Popp (97) in liver and kidneys of rats and mice. A summary
of their results is presented in Table 25.
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Table 25. Effects on peroxisomal enzyme activity by oral gavage exposure to PER and
some other compounds for 10 days.
Compound Dose (mg/kg
bw/day)
Rat liver,
% of corn oil
Mouse liver,
% of corn oil
Rat kidney,
% of corn oil
Mouse kidney
% of corn oil
Corn oil 100 100 100 100a
Wy-14,643b 50 561a 1 223a 958a 689a
Trichloroethylene 1 000 180 625a 300a 360a
PER 1 000 142 428a 174 232a
Pentachloroethane 150 127 158 53 310a
TCA 500 284a 280a 175 305a
a
 Significantly different from corn-oil control, p<0.05, Newman-Keul’s multicompare test.
b
 Wy-14,643: positive-control compound; identity not specified.
The table shows PER to induce peroxisome proliferation in mouse liver and
mouse kidney, while no significant effects were found in the rat.
Oral: Haematotoxicity
The effects of very low oral doses of PER have been investigated by Marth et al.
(176, 177) and Marth (175). These authors dissolved PER in drinking water of
mice, resulting in doses of 0.05 and 0.1 mg/kg body weight/day for 7 weeks.
Histopathological examination revealed effects in the spleen at both dose levels;
no effects were observed in other examined organs, i.e. brain, liver and kidneys.
In the spleen the following changes were observed: pulpa cords rich in erythro-
cytes, many blood-formation centers in the red pulpa with megakaryocytes and
hemosiderin storage in the macrophages of the red pulpa.
The authors assume the effects in the spleen to be the result of premature
erythrocyte disintegration, which in its turn is caused by the interaction of the
apolar PER with the erythrocyte membrane. The spleen macrophages remove the
erythrocyte fragments from the bloodstream, and are thus subject to hemosiderin
deposition.
The exposure led to a decrease in body weight and an increase in relative spleen
weight and relative kidney weight. No weight changes were observed for the liver
and the brain. Neither were swelling or enlargement of the liver observed.
Effects on the hemopoietic system were reflected by clear-cut increases of LDH
activity, peripheral blood count and microscopic examination of the bone marrow.
No increase of SGPT or changes of the proportion among serum proteins were
found, indicating unaffected liver function. Lipoprotein electrophoresis showed a
clear-cut change in the proportion among classes of lipoproteins (HDL, VLDL
and LDL). Furthermore, a decrease of cholesterol was found, which is assumed by
the authors to be the result of an inhibition of HMG CoA reductase.
Oral: Tumour initiation and promotion
Story et al. (262) investigated the initiating and promoting properties of PER in
an oral rat model. The rats were partly hepatectomised and subjected to various
exposure regimens. The investigated endpoint was the occurrence of enzyme-
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altered foci in the liver. According to the authors, the foci are assumed to be
potentially capable of developing into trabecular hepatocellular carcinomas (i.e.
they were regarded as putative preneoplastic lesions). Initiating properties were
investigated by scoring the number of foci after one intraperitoneal treatment
with PER (maximum tolerated dose: 6 mmol/kg), followed by a long-term oral
treatment with phenobarbitone in drinking water (7 weeks), while the number
of foci occurring after one intraperitoneal treatment with diethylnitrosamine,
followed by daily oral gavage (5 days/week for 7 weeks) of PER in corn oil (6
mmol/kg), was taken as an indicator for promoting activity. PER induced
an increase of foci in rats subjected to the second exposure regimen. Thus, the
outcome of this study suggests PER to have promoting and not initiating
properties.
Comparable studies have been carried out by Lundberg et al. (170) and
Holmberg et al. (115), although these were only concerned with promotion (rat,
initiator: diethyl nitrosamine). They did not confirm the finding of the aforemen-
tioned study (262), in the sense that no indications for promoting properties were
found. Moreover, Maronpot et al. did not find such indications in a pulmonary
tumour promotion assay with mice (174).
Intraperitoneal
Bernard et al. (19) investigated the nephrotoxicity of 5 intraperitoneal PER injec-
tions per week for 2 weeks in rats (1 000 mg/kg body weight/injection). Endpoints
were β-N-acetylglucosaminidase, β2-microglobulin and albumin in urine. No
treatment-related effects were observed. Under the same conditions cyclohexane
exposure caused a clear-cut increase of β2-microglobulin. Thus, this study does
not indicate an effect of PER on the functioning of the tubuli or the glomeruli.
6.2.4 Toxicity due to long-term exposure and carcinogenicity
Inhalation
Rampy et al. [(229), study is only published in the form of an abstract; unpub-
lished details and results were available to the authors of the EPA publication
(74); summary presented here is based on (74)] exposed rats (Sprague Dawley) to
0, 300 and 600 ppm (2 067 and 4 134 mg/m3) of PER for 12 months (6 hours/day,
5 days/week; followed by an observation period of 19 months). An increase of
mortality was found for male rats between the 5th and the 24th month in the 600-
ppm group (characterised as “slight” in references 69, 119), while no exposure-
related mortality was demonstrated in the female group. The mortality in the
males is attributed to “spontaneous advanced chronic renal disease”. Histopatho-
logy revealed increased numbers of inflammatory cells in the kidneys and focal
progressive nephrosis in the exposed rats of both sexes at the highest exposure
level. Other endpoints investigated were: body weight, mortality, haematology,
urine analysis, clinical chemistry, cytogenetics, organ weights, gross histological
tissue changes including tumour incidence.
Slight indications were obtained for haematological effects in females. How-
ever, these could not be confirmed by a second determination carried out some
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days later. Other endpoints appeared to be unaffected by the exposure, including
tumour incidence.
EPA (74) does not draw specific conclusions from this study as to the carcino-
genicity of PER upon respiratory exposure. In the HSE review (119), it is
concluded that evaluation of this property is not possible, due to the summarised
presentation, which is lacking the necessary details, and the relatively short
exposure period. However, the EPA publication (74) is based on unpublished and
probably more detailed results, which would mean that one year of respiratory
exposure to 600 ppm of PER does not have a carcinogenic effect in rats.
A study on the carcinogenicity of PER in B6C3F1 mice and F344 rats (50 of
each sex per dose) after respiratory exposure was carried out within the frame-
work of NTP (208). The rats were exposed to 0, 200 and 400 ppm (1 378 and
2 756 mg/m3), the mice to 0, 100 and 200 ppm (689 and 1 378 mg/m3). Exposure
lasted 103 weeks; the animals were exposed 6 hours/day, 5 days/week.
The rats showed high incidences of karyomegaly and cytomegaly in tubular
cells of the proximal convoluted tubules. Furthermore, the treatment induced
thrombosis of the nasal cavity, squamous metaplasia (only in males), adrenal
medullar hyperplasia (only in males), adrenal cortical hyperplasia (only in
females), and forestomach ulcers (only in males). A not significant increase of
tubular-cell adenoma and adenocarcinoma was found for the male rats (1/49, 3/49
and 4/50 for 0, 200 and 400 ppm respectively). Moreover, a significant increase of
mononuclear cell leukaemia was found for both male and female rats (males:
28/50, 37/50 and 37/50 for 0, 200 and 400 ppm respectively; females: 18/50,
30/50 and 29/50 for 0, 200 and 400 ppm respectively). In view of the high and
variable incidence of this form of cancer in F344 rats and the high control
incidence in this study, it is doubtful whether the observed increase (although
significant when considered within the limited scope of the experiment) does
really point to a treatment-related effect, see also (69, 119). However, NTP’s
Board of Scientific Counselors considered the incidence of rat leukaemia to be a
valid finding (3), because of the shorter time to the onset of the disease and its
greater severity in the treated animals as compared to the control animals.
 The treatment of mice induced liver degeneration and necrosis, kidney casts,
tubular-cell karyomegaly, nephrosis (in females only) and acute passive lung
congestion. The mice (both sexes) showed a statistically significant increase of
hepatocellular carcinoma (see Table 26), part of which had metastasised to other
organs.
So, these studies show PER to be a clear-cut liver carcinogen for mice, while
indications were obtained for the compound to exert a carcinogenic effect in the
kidneys of male rats.
The ATSDR (3) mentions the following limitations: “numerous instances of
mice and rats loose from their cages within the exposure chambers, with the
potential for aberrations in exposure and animal identification”.
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Table 26. Hepatocellular neoplasms in B6C3F1 mice exposed to PER via inhalation;
reproduced from (3).
Control 100 ppm (690 mg/m3) 200 ppm (1 378 mg/m3)
Male Female Male Female Male Female
Hepatocellular
adenoma
12/49
(24%)
3/48
(6%)
8/49
(16%)
6/50
(12%)
19/50
(38%)
2/50
(4%)
Hepatocellular
carcinoma
7/49
(14%)
1/48
(2%)
25/49
(51%)
13/50
(26%)
26/50
(58%)
36/50
(72%)
Hepatocellular
adenoma or
carcinoma
17/49
(35%)
4/48
(8%)
31/49
(63%)
17/50
(34%)
41/50
(82%)
38/50
(76%)
Dermal
Van Duuren et al. (66) investigated the carcinogenic and tumour initiating activity
of PER in ICR Swiss mice upon dermal application. Thirty female mice were
treated 3 times/week with acetone solutions of the test compound (applied to the
shaved skin) for at least 440 days. Doses were 54 and 18 mg/mouse/day. This
treatment did not significantly alter the number of skin tumours.
In a second experiment 30 female mice were treated once with PER, followed
by treatment with phorbol myristate acetate for at least 428 days. Also this regi-
men did not reveal a significant influence of PER on the tumour incidence.
Oral
The carcinogenic effects of oral treatment of PER were investigated by the
National Cancer Institute (202; see also 3, 69, 119). Groups of 50 male and 50
female B6C3F1 mice and Osborne-Mendel rats were treated with PER in corn oil
by gavage. The control groups and the vehicle-treated groups consisted of 20
animals of each sex.
The mice were treated with 536 and 1 072 mg/kg/day (males) and 386 and 772
mg/kg/day (females), for 5 days/week over a period of 78 weeks. The indicated
values represent TWAs, because the actual dosage had to be adjusted during the
study due to severe toxicity. The exposure period was followed by an observation
period of 12 weeks.
The incidence of hepatocellular carcinoma increased from about 10% (2/20,
2/17, 0/20, 2/20, in females and males of controls and vehicle-treated groups
respectively) to 40% (19/48) and 65% (32/49) in the low-dose group and 40%
(19/48) and 56% (27/48) in the high-dose group, for females and males, respec-
tively. In a number of animals the carcinomas metastasised to the lungs (1/49
of the low-dose females, 3/49 of the low-dose males and 1/48 of the high-dose
females) or to the kidneys (1/18 of the untreated males). Tumours appeared much
earlier in the PER treated groups than in the control or the vehicle-treated groups.
A dose related increase of mortality was observed. 50% survival periods were 78,
43, 60 and 50 weeks for high and low-dose males and high and low-dose females
respectively, while 50% survival periods were over 90 weeks in all control and
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vehicle-treated groups. Nearly all treated mice showed nephropathy and the high
mortality early in the study was probably caused by this effect. The nephropathy
consisted of degenerative changes in the proximal convoluted tubuli at the junc-
tion of the cortex and the medulla, with cloudy swelling, fatty degeneration and
necrosis of the tubular epithelium and hyaline intraluminal casts. No treatment-
related liver lesions were reported, which is surprising in view of the clear-cut
hepatotoxicity of PER for mice demonstrated in other studies.
Female and male rats were treated with 474 and 949 mg/kg/day (TWA) and 471
and 941 mg/kg/day (TWA) respectively, 5 days/week over a period of 78 weeks
followed by a 32-week observation period. No tumour induction could be attri-
buted to the treatment. A high mortality was observed in the early part of the
study (50% survival periods in males: 88, 72 and 44 weeks for control, low dose
and high dose respectively; 50% survival period in females: 102, 66 and 74 weeks
for control, low dose and high dose respectively). No indications of hepatotoxicity
were obtained. At autopsy 79% of the treated animals was affected by nephro-
pathy.
The ATSDR (3) mentions the following shortcomings of these studies:
1) Smaller control groups than exposed groups 2) Dose adjustments because of
nephropathy, which indicate that the maximum tolerated dose was exceeded
3) Pneumonia due to intercurrent infectious disease in both rats and mice.
Maltoni and Cotti (172; see also 69) treated 40 male and 40 female rats by
gavage with 500 mg/kg/day (in olive oil), for 4 to 5 days/week over a period of
104 weeks. Observation lasted to death. Control groups consisted of 50 female
and 50 male rats, which were treated with the vehiculum only. No increase in
tumour incidence was observed. Only male rats (32%) showed renal damage:
cytomegaly or karyomegaly in renal tubular cells.
Herren-Freund et al. (113) investigated the hepatocarcinogenicity in mice of
the major metabolite of PER, viz. TCA. This compound was given to 22 mice in
their drinking water at a concentration of 5 g/l for a period of 61 weeks. 7/22
mice developed hepatocellular carcinomas and 8/22 developed hepatocellular
adenomas, while only 2 out of 22 control mice developed hepatocellular adeno-
mas and no hepatocellular carcinomas were observed in the control group. This
finding strongly suggest that the hepatocarcinogenicity of PER in mice is in fact
caused by the major metabolite of this compound.
Intraperitoneal
Repeated intraperitoneal injection of PER in mice did not result in lung surface
adenomas (268, see also 119); PER dissolved in tricaprylin; 3 injections/ week; 14
injections of 80 mg/kg or 24 injections of 400 mg/kg; animals killed 24 weeks
after the first injection).
6.2.5 Reproduction toxicity
Carpenter (35) investigated the effects of respiratory PER exposure on the fertility
and reproductive capacity of rats. The animals were exposed to 0, 70, 230 and 470
ppm (482, 1 585 and 3 238 mg/m3) 8 hours/day, 5 days/week over a period of 28
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weeks. No indications for a decreased fertility or reproductive capacity were
obtained, based on an analysis of the number of litters in the different exposure
groups.
In a two-generation reproduction study based on a standard protocol rats were
exposed by inhalation to 0, 100, 300 and 1 000 ppm PER (690, 2 070 and 6 900
mg/m3) 5 days/week, 6 hours/day for 11 weeks prior to mating for up to 21 days
during which exposure was daily. Evidence of toxicity was seen at an exposure
level of 1 000 ppm PER as shown by reduction in parental body weight gain
during the pre-paring period and lactation in both generations and during preg-
nancy in the second generation. Decreases in litter size and survival during
lactation were seen at 1 000 ppm but not at 300 ppm. This represents a toxic
effect, which in part, may have been maternally related.
Schwetz et al. (247) exposed rats and mice to 0 and 300 ppm (2 067 mg/m3)
PER on days 6-15 of gestation (7 hours/day; 17 test animals and 30 control
animals). For rats, exposure resulted in a significant decrease of maternal body
weight; no significant effects on liver weight were found. No effects were found
on the following endpoints: numbers of litters, corpora lutea, implantation sites,
live foetuses, sex ratio, foetus weight, foetus length. A significant increase of
the resorption rate was observed (4% in control versus 9% in exposed rats).
Examination for soft-tissue anomalies and effects on skeleton did not reveal a
significant treatment-related effect.
The same endpoints were investigated by Schwetz et al. for mice (247). The
following difference between control and exposed were found: increase of mater-
nal liver weight, decrease of foetus weight, delayed ossification of the skull and
the sternebra, increase of the incidence of split sternebra, and increased subcuta-
neous oedema. The results point to the absence of teratogenic effects in both rats
and mice, while for mice they indicate foetotoxicity.
Beliles et al. (15) and Hardin et al. (110) subjected pregnant rats to four expo-
sure regimens (20 rats/regimen): exposure to I) 500 ppm (3 445 mg/m3) on days 0-
18 of gestation, II) 500 ppm 3 weeks before mating and on days 0-18 of gestation,
III) 500 ppm 3 weeks before mating and on days 6-18 of gestation, IV) 0 ppm on
days 0-18 of gestation and V) 0 ppm 3 weeks before mating and on days 6-18 of
gestation.
Treatment-related maternal effects were restricted to elevated kidney weights
(11%) in group II and elevated liver weights in group III (histological examination
and necropsy). No indications of foetotoxicity or teratogenicity were obtained.
The same authors performed a strictly comparable study with rabbits, which did
not yield clear significant treatment-related effects, except for an increase of
placental abnormalities in the group exposed at days 7-21.
Nelson et al. (204) exposed groups of 13-21 rats to 900 ppm (6 200 mg/m3) on
days 7-13 or 14-20 of gestation or to 100 ppm (690 mg/m3) on days 14-20 of
gestation. A sham-exposed group was taken for each exposed group. The pups
were examined for a series of behavioural and neurochemical effects and for
effects on the histopathology of the brain. Furthermore, gross pathology and liver
and kidney histopathology were examined in the dams.
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The only maternal effects found were reduced feed intake and weight gain in
the 900 ppm-days 7-13 group. Gross pathology and histopathology revealed no
indications for treatment-related effects. No reference is made to the birth of
deformed pups. The number of live-born pups was not affected by the treatment.
Behavioural tests pointed to a decreased neuromuscular function of the pups
exposed during days 7-13 of gestation when they were between 10 and 14 days
old. However, the pups exposed later during gestation performed better than the
controls in another test for neuromuscular function. Neurochemistry revealed a
decrease of acetylcholine in the brains of 21-days old animals of both 900 ppm
groups, and of dopamine in the brains of 21-days old animals of the 7-13 days-900
ppm group. No neurochemical effects were observed in new-born rats. Exposure
to 100 ppm did not result in behavioural effects. No effects on brain histopatho-
logy were observed.
The outcome of this study suggests that exposure during pregnancy may result
in an affected function of the CNS.
Frederiksson et al. (86) treated mice orally to PER (5 and 320 mg/kg body
weight/day) between days 10 and 16 postnatally. When they were 60 days old, the
mice showed changes in spontaneous motor activity. The results suggest neuro-
developmental toxicity in mice resulting in persistent alterations in behaviour.
6.2.6 In vitro studies (except genotoxicity and cell transformation)
Effects on synaptosomal membranes
The effect of PER on synaptosome membrane-bound enzymes has been investi-
gated by Korpela (149). Synaptosomes isolated from rat brain were exposed to
PER, and the activity of the following enzymes were determined: acetylcholin-
esterase, total ATPase and magnesium-activated ATPase ((Mg2+) ATPase). Slight
but significant inhibitions were observed. Aromatic solvents and, in particular,
1,1,2,2-tetrachloroethane appeared to be stronger inhibitors.
Edelfors and Ravn-Jonsen (72) investigated the effects of PER on 1) the activity
of the enzyme (Ca2+/Mg2+) ATPase in a preparation of synaptosomal membranes
isolated from the rat brain and 2) the fluidity of the isolated membranes. PER
exerted a biphasic effect on the enzyme activity. At lower concentrations an
increase was found, while above a certain concentration, the activity tended to
decrease again. Furthermore, a slight decrease of the membrane fluidity was
observed.
Effects on erythrocytes
The results of Holmberg et al. (116) show that PER and other volatile anaesthetic
compounds have a protecting effect on erythrocytes, which are subjected to hypo-
tonic hemolysis. This effect appeared to be correlated with the octanol/water
partition coefficient. It is hypothesised by the authors, that the effect is based on
a solvent-induced increase of the membrane stability of the erythrocytes.
These effects have also been found by other authors, and a correlation with
anaesthetic effect has been demonstrated (248).
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Korpela and Tähti (150) determined the activity of cholinesterase in human
erythrocyte membranes and the effect of PER thereon. A strong inhibition was
found (remaining activity less than 40% at a dose of 4 000 ppm (27 650 mg/m3);
the dose unit is not clear).
Hidalgo et al. (114) investigated lipid peroxidation and haemoglobin break-
down in rat erythrocytes in vitro upon the exposure to a series of halo compounds,
including PER. Oxyhaemoglobin was taken as an index for remaining haemo-
globin, while lipid peroxidation was measured as the concentration of thiobarbi-
turic-acid-reactive substances (TBARs). Both, haemoglobin breakdown and lipid
peroxidation were found to depend strongly on the halo compound tested. PER
induced a significant breakdown, while the increase (4 times compared with the
control) of TBARs was not significant.
Effects on hepatocytes
Kefalas and Stacey (140) did not find effects of PER on lipid peroxidation
(assayed as TBARs), enzyme leakage (LDH and ALT) and leakage of potassium
ions in hepatocytes isolated from rats. However, on coincubation with carbon
tetrachloride, the compounds had a potentiating effect on the leakage of the two
enzymes caused by carbon tetrachloride. Indications of a decrease of (Mg2+)
ATPase were found upon exposure to PER alone.
Intercellular communication
PER and other chlorinated hydrocarbons with anaesthetic properties sensitise the
heart to epinephrine-induced arrhythmias. Toraason et al. (270) tested the hypo-
thesis that the underlying mechanism of this effect is the inhibition of intercellular
communication between the cardiac myocytes. This they did by investigating the
effect of the compounds on intercellular communication between cardiac myo-
cytes in vitro. They found a clear inhibition for all compounds tested, including
PER. The inhibition was strongly correlated with the octanol/water partition
coefficient. PER was found to be an effective inhibitor, with an EC50 value of
0.39 mM, compared with 21.05 found for methylene chloride (the least effective)
and 0.2 for pentachloroethane (the most effective).
6.2.7 Genotoxicity and cell transformation
The genotoxicity and cell transformation studies carried out with PER have been
extensively reviewed in the past (3, 69, 74, 119, 231, 277). Together, these
reviews give a clear impression of the genotoxic properties of the compound. This
section is largely based on these reviews. In addition, some more recent publica-
tions, as well as publications which are deemed of particular importance for
interpretation and evaluation, will be treated in more detail.
In vitro studies: Bacteria
EPA (74) mentions one study, which indicates mutagenicity in bacteria (36). An
induction of histidine prototrophic mutants was found in Salmonella typhimurium
TA100 (spot test with undiluted compound). However, EPA (74) concludes that
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the publication in question cannot be used for “risk characterisation”, because it
lacks information on the purity of the compound. In particular the presence of
stabilisers might lead to a false positive.
Other studies on the mutagenicity in bacteria did in general not yield positive
results (13, 40, 105, 111, 151, 173, 188, 255, 289, 291). Strains used in these
studies were the usual set of Salmonella strains, the less commonly used
Salmonella strains UTH 8413 and UTH 8414, and Escherichia coli K12. The
influence of mammalian metabolism was investigated by using rat, hamster or
mice liver homogenates from animals treated with either Aroclor-1254 or pheno-
barbital as inducers of hepatic biotransformation enzymes. PER was tested in the
fluid or the vapour phase. In some of these studies indications for mutagenicity
were obtained with commercial or technical samples. However, the same studies
yielded negative results when highly purified PER was tested, which shows that
the mutagenicity is caused by other compounds than PER. PER was negative in a
SOS-repair assay with Escherichia coli (SOS-chromo test).
In vitro studies: Yeasts
PER has been extensively tested for genotoxicity in Saccharomyces cerevisae
by Bronzetti et al. (29). The following endpoints were studied: point mutations,
mitotic gene conversion, and mitotic gene recombination. The results do not
indicate a significant genotoxic effect. Other studies yielded negative, equivocal
or borderline results (severe toxicity, lack of adequate positive controls, unknown
purity (69, 119).
In vitro studies: Mammalian cells, genotoxicity
PER failed to induce mutations in mouse lymphoma cells (L5178Y/+/-), sister
chromatid exchanges in Chinese hamster ovary cells, and chromosomal aberra-
tions in Chinese hamster ovary cells (88, 208).
Furthermore, negative results were obtained in tests for the induction of un-
scheduled DNA synthesis in human lymphocytes, W-38 human cells and rat and
mouse hepatocytes (14, 43, 188, 291). However, a positive result at toxic doses is
reported for hepatocytes (species not specified) in an abstract (251). The PER
used in this study was stabilised.
In vitro studies: Mammalian cells, cell transformation
PER was found to be negative in a cell-transformation assay with BALB/c-3T3
cells (274). The same study yielded positive responses for other halogenated
compounds, such as vinyl chloride and 1,1,1-trichloroethane, indicating that the
cells were capable of metabolic activation of related compounds. Milman
investigated PER with the same type of cell transformation assay, with the same
negative result. Furthermore, negative results were obtained in an assay with
BHK 21/C13 cells (188). A positive result was scored in an assay with rat embryo
cells F1706p108 (227). The cells used in the latter assay were infected with
Rauscher leukaemia virus.
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In vivo studies with insects
No positive effects were obtained upon testing in the sex-linked recessive lethal
test with Drosophila melanogaster. The animals were exposed to PER via inhala-
tion, feeding or injection (14). Furthermore, no effects on the chromosomes were
found in this test animal (14).
In vivo studies with mammals: Host-mediated assay
EPA (74) mentions one study, which shows positive results in a host-mediated
assay employing the Salmonella typhimurium strains TA1950, TA1951, and
TA1952 in mice (36). However, EPA (74) concludes that the publication in
question cannot be used for “risk characterisation”, because it lacks information
on the purity of the compound. A positive result was also found in another host-
mediated assay (14). The substance tested had a rather low purity (91.43%), which
means that the effect can be caused by other compounds. (e.g. stabilisers).
Bronzetti et al. (29) performed a host-mediated assay with mice and yeast
(unusual protocol, lack of positive control), without positive results.
In vivo studies with mammals: Cytogenetic studies
Chromosomal aberrations were studied in the bone marrow of rats exposed to up
to 600 ppm (4 134 mg/m3) for 12 months and in the bone marrow of mice exposed
by single or repeated intraperitoneal injections (14, 36, 229). One study yielded an
equivocal increase (the test substance had a low purity); the other were negative.
In vivo studies with mammals: Sperm-head abnormalities
Three sperm-head abnormality tests are described in the literature, carried out
with Chinese hamsters, mice or rats (14, 184). A positive result was only found in
mice. However, the test material used was of a low purity.
In vivo studies with mammals: Dominant lethality
A negative result was obtained in a dominant-lethal test with rats (100-500 ppm
(689-3 445 mg/m3), 7 hours/day, 5 days) (14).
In vivo studies with mammals: Unscheduled DNA synthesis
No unscheduled DNA synthesis was induced in rat kidney cells after oral
exposure to 1 000 mg/kg (98).
In vivo studies with mammals: Single-strand breaks
Walles (286) found single strand breaks in the liver and kidneys, but not in the
lungs of mice treated with PER (99.8%; one injection; 4-8 mmol/kg) by intraperi-
toneal injection. A remarkable finding was that PER showed a higher potency
than trichloroethylene. The latter compound is oxidised to TCA more rapidly and
to a greater extent than PER. This might imply that it is not oxidative biotransfor-
mation alone, which leads to the DNA damage.
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6.2.8 Summary
Irritation, sensitisation, and acute toxicity:
• PER has been shown to possess skin-irritating and eye-irritating properties
in studies with experimental animals.
• No indications for skin sensitisation were obtained in a guinea-pig split-
adjuvant test.
• No indications for respiratory sensitisation were obtained in the multitude of
respiratory toxicity studies carried out with PER, although these were not
specifically aimed at the observation of this effect.
• The acute lethality of PER has been investigated for various mammalian
species after oral, respiratory, intraperitoneal, intratracheal and subcutaneous
exposures. LD50 values, LC50 values and minimum lethal doses show the acute
toxicity of PER to be rather low. Several grams per kilogram have to be
administered to cause lethality via the oral, subcutaneous or intraperitoneal
route. For the intravenous route, these doses are considerably lower (mini-
mum lethal dose for dogs: 85 mg/kg). An intratracheal study yielded an
approximate lethal dose of 450 mg/kg. Respiratory LC50 values varied
between 3 000 and 6 000 ppm (20 700-41 340 mg/m3) (duration: 2-8 hours).
• Acute lethality is due to respiratory failure following deep coma.
• Acute respiratory exposure of experimental animals may lead to various
neurotoxic effects, among them hyperactivity, hypoactivity, hypotonia, loss
of reflexes, lateral position, drowsiness, trembling, ataxia, “drunken” stupor,
anaesthesia and coma. The lowest observed effective dose was 90 ppm (620
mg/m3). Indications for neurotoxicity were also obtained after acute oral,
intraperitoneal, and intravenous exposure. Complete anaesthesia requires
exposure to several thousand ppm for at least a few minutes.
• A weak stimulating effect on epinephrine-induced cardiac arrhythmias has
been observed in rabbits after respiratory exposure to 5 200 ppm (35 800
mg/m3) for 1 hour. The effect was expressed more clearly after intravenous
injection.
• Acute exposure may lead to clear-cut hepatotoxicity expressed in histo-
pathological and biochemical changes, among them, increase of liver weight,
cloudy swelling, fatty infiltration, congestion, infiltration of Kupffer cells,
necrosis, fatty degeneration, increases of triglycerides and lipids, aniso-
karyosis, anisocytosis, increases of serum-enzyme activities. In general these
effects were observed at doses approaching those causing anaesthesia or
lethality.
• Acute exposure may lead to clear-cut nephrotoxicity expressed in histo-
pathological and biochemical changes, among them, scattered necrotic and
degenerative lesions, fatty changes, congestion, cloudy swelling and vacuo-
lisation of tubule cells, hyaline casts, oedema, reticulation, atrophy and
proteinuria. In general, these effects were observed at doses approaching
those causing anaesthesia or lethality.
• Other effects observed after acute exposure are: affected respiratory immunity
against bacterial infections (respiratory exposure of mice to 25 and 50 ppm
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(172 and 345 mg/m3)) and change of pancreatic secretion (intraperitoneal, 1.3
ml/kg, rat).
Toxicity due to short-term exposure:
• The effects on behaviour and related neurotoxicological effects which are
observed in short-term studies, do not differ essentially in a qualitative or
quantitative sense from the effects observed in acute respiratory toxicity
studies. Lower concentrations can to a certain extent be compensated for by
longer exposure. However, repeated exposure leads to tolerance, indicating
changes on a toxicodynamic (sensitivity of the endpoint) or a toxicokinetic
level (biotransformation).
• Short-term respiratory exposure3 of experimental animals leads to various
neurochemical effects in the brain, among them small, partly reversible
changes in fatty-acid pattern of phospholipids (rats, gerbils and guinea pigs),
slight decreases of the DNA concentration in specific parts of the brain (rat,
gerbil), changes in concentrations of neural and glial cytoskeletal proteins
(rat, gerbil) and decreases of the amount of acetyl choline in the rat striatum.
The lowest observed effect level was 60 ppm (413 mg/m3): 4 months of
continuous exposure resulted in a decreased DNA concentration in gerbil
brains.
• Respiratory exposure of mice to 37 ppm (255 mg/m3) resulted in an increase
of butyrylcholinesterase activity. The significance of this finding is unknown.
• Marked signs of hepatotoxicity, histopathological as well as biochemical, are
observed after short-term exposure to PER. In addition to the effects observed
in the acute studies, the following can be mentioned: damage to cytoplasmic
and mitochondrial structures of parenchyma cells, peroxisome proliferation,
decreases of cell glycogen content, deposition of glycoproteins in blood
vessels, changes of the DNA and the RNA content, parenchymatous degene-
ration and increase of cytochrome P450 levels. As the severity of the effects
seems to correlate with the rate of oxidative metabolism, they are most
probably caused by products of this metabolic pathway. TCA has been
identified as an important hepatotoxic metabolite of PER. In particular, this
compound is held responsible for the peroxisome proliferation induced by
PER in mouse liver. Because of its high rate of oxidative metabolism, the
mouse is by far the most sensitive species investigated so far. A subacute oral
study with mice and rats showed clear effects for the first species at 100
mg/kg body weight (the lowest dose investigated), while only marginal
effects were found at the highest dose in rats (1 000 mg/kg body weight).
Another subacute study yielded an oral NOAEL of 20 mg/kg body weight for
mice, the next higher dose being 100 mg/kg. One study reveals for mice a
significant increase of liver weight upon 30 days of continuous exposure to
concentrations as low as 9 ppm (62 mg/m3).
                                    
3 In some of these studies the animals were continuously exposed, which makes it difficult to allocate these
studies to the category ”short term” or ”long term”.
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• Nephrotoxic effects due to short-term exposure to PER include increased
weight and size, congestion, cloudy swelling, tubular karyomegaly, changes
in urine concentrations of creatinine and para-aminohippuric acid, albumin-
uria, urinary excretion of α2u-globulin, electrophoretic shifts in composition
of excreted proteins, PDA in tubule cells and peroxisome proliferation. In
general it can be stated that doses causing nephrotoxic effects are higher than
those causing hepatotoxic effects. Like hepatotoxicity, nephrotoxicity is
characterised by a marked interspecies variation. Moreover, in rats the effects
vary clearly with sex, males being more sensitive than females. Continuous
exposure to 200 ppm (1 378 mg/m3) for 13 weeks is the lowest effective
respiratory dose in a short-term study. It was found with mice; the next lower
dose of 100 ppm (690 mg/m3) did not lead to renal toxicity; the critical effect
was tubular karyomegaly. At least three mechanisms can be put forward to
explain the nephrotoxicity of PER. The induction of peroxisome proliferation
by PER is not restricted to the liver, but occurs in the kidneys as well. It
is probably also in these organs caused by the most important oxidative
metabolite, TCA. A possible second mechanism is related with the other
biotransformation pathway: the conjugation with glutathione, which can be
followed by the formation of cyto- and genotoxic products in the kidneys by
β-lyase. Finally accumulation of α2u-globulin (PDA) in the cells of the
proximal tubuli can be mentioned as a third mechanism, which has so far only
been found to occur in male rats, and not in female ones, or in animals of
either sex belonging to other animal species. One study suggests that peroxi-
somal proliferation (the first mechanism) does not contribute much to the
nephrotoxicity upon respiratory exposure, while the strong male-rat specifi-
city of the third mechanism is extensively documented. As toxicity is also
observed in female rats and in both sexes of other species, it can thus be
concluded that the second, or other, as yet unidentified, mechanisms play an
important role.
• Very low concentrations in drinking water lead to histopathological effects in
the spleen of mice, which are presumable caused by premature erythrocyte
breakdown. Furthermore, respiratory exposure of mice (135 and 270 ppm, or
930 and 1 860 mg/m3) caused reversible effects on lymphocyte, monocyte
and neutrophile counts. Exposure to 185 ppm (1 275 mg/m3) of rats resulted
in effects on mast cells.
• One study points to a tumour-promoting effect of PER. The number of
enzyme-altered foci in the liver of partly hepatectomised mice increased
when a single treatment with an initiator was followed by repeated oral
administration of PER.
Toxicity due to long-term exposure and carcinogenicity:
• Mice showed a statistically significant increase of hepatocellular carcinoma
upon respiratory and oral exposure.
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• TCA, the major metabolite of PER, induces hepatocellular carcinomas and
adenomas in mice upon oral administration, which strongly suggests that the
hepatocarcinogenicity of PER is actually caused by TCA.
• A not significant increase of tubular cell adenoma and adenocarcinoma was
found for male rats upon respiratory exposure. Moreover both sexes of this
species showed a significant increase of mononuclear cell leukaemia, a type
of cancer with a high background incidence in the applied strain.
• PER did not induce skin tumours in a dermal topical carcinogenicity study
and a dermal initiation/promotion study, both carried out with mice.
• Besides carcinogenicity, the chronic studies revealed overt hepatotoxicity and
nephrotoxicity. In case of the rat, a clear sex dependence of nephrotoxicity
was observed, males being more sensitive than females.
• The sensitivity of the mouse for the hepatocarcinogenic effects of PER can
most probably be attributed to the higher rate of the oxidative biotrans-
formation in this organism resulting in the peroxisome proliferator and
carcinogen TCA.
• The sex-specificity of nephrotoxicity and the induction of kidney tumours can
most probably be attributed to the male-specific formation of protein droplets
in tubular cells.
Teratogenicity and reproduction:
• On the whole, teratogenicity studies do not point to overt teratogenic effects.
In some, signs of foetotoxicity were found. One study points to foetal skeletal
abnormalities. Another one shows neurological effects in pups of exposed
dams. Dose levels were much higher than the lowest levels causing hepato-
toxic, nephrotoxic or neurotoxic effects.
• A two-generation reproduction study showed effects on the number of pups
born alive, number of pups per litter, pup survival and pup body weights.
Some of these reproduction effects may, in part, be caused by maternal
toxicity. However also these effect levels were higher than the lowest levels
causing hepatotoxic, nephrotoxic or neurotoxic effects.
In vitro studies:
• PER inhibits ATPase, magnesium-activated ATPase and acetylcholinesterase
and decreases membrane fluidity in synaptosomes isolated from rat brain.
However the effects observed were only slight.
• Treatment with PER protects erythrocytes against hypotonic hemolysis,
which is probably the result of an increase of membrane stability. Further-
more the compound inhibits erythrocyte cholinesterase and induces
haemoglobin breakdown.
• Indications for a decrease of magnesium-activated ATPase in rat hepatocytes
were found upon exposure to PER.
• PER appears to be an effective inhibitor of intercellular communication
between cardiac myocytes, which might explain its potency to induce
arrhythmias.
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Genotoxicity and cell transformation:
• PER has been extensively tested for genotoxic effects with many combina-
tions of endpoints and test organisms. This includes in vivo tests with
mammals focused on one or more of the following endpoints: chromosomal
aberrations in bone marrow, sperm-head abnormalities, dominant-lethal
mutations, unscheduled DNA synthesis in kidney cells and DNA single-
strand breaks in liver, kidneys and lungs.
• Most tests show clear-cut negative results. Positive results were reported for
the following tests: two tests with bacteria (11 negative), an unscheduled
DNA-synthesis test with hepatocytes (two tests negative), a sperm-head
abnormality test (two negative), a test for DNA single-strand breaks in liver
and kidneys.
• Most positive tests were poorly reported or were carried out with impure
PER, while the effects scored were often equivocal. The importance of
impurities is illustrated by testing pure PER alongside technical or otherwise
impure PER, which yielded only positive effects for the latter.
• The induction of unscheduled DNA synthesis in hepatocytes and single-
strand breaks in the liver may reflect local genotoxicity caused by the
postulated first product of oxidative metabolism, the very reactive and
mutagenic oxirane. Likewise, the single-strand breaks in the kidney could be
caused by the local formation of mutagenic products from the conjugation
pathway, see (23, 24).
• Nevertheless, in view of the great number, as well as the types of negative
tests, the committees conclude that PER is virtually devoid of genotoxic
properties in mammals.
7. Existing guidelines, standards and evaluations
7.1 General population
The ATSDR (3) has derived the following minimal risk levels (MRLs) for
inhalatory and oral exposure of the general population to PER. Acute respiratory
exposure: 0.6 ppm (4.1 mg/m3); intermediate-duration respiratory exposure
(subacute to semichronic): 0.0009 ppm (0.0062 mg/m3); intermediate-duration
oral exposure: 0.1 mg/kg/day.
The Integrated Risk Information System (IRIS) has established an oral
reference dose of 0.01 mg/kg/day (75).
The Science Advisory Board of EPA regards the evidence for carcinogenicity
strong enough to place PER between the categories “probable human carcinogen”
and “possible human carcinogen” (3, 74). However, this classification is presently
under review.
IARC classifies PER as “probable carcinogenic to humans”, i.e. the compound
is placed in category 2A (124). The IARC concludes that there is “limited
evidence in humans for the carcinogenicity of tetrachloroethylene”, while there is
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“sufficient evidence in experimental animals for the carcinogenicity of tetrachloro-
ethylene”.
EPA’s Office of Drinking Water has set a maximum contaminant level (MCL)
for drinking water of 0.005 mg/l (3).
No acceptable daily intake (ADI) is allocated by the Joint FAO/WHO Expert
Committee on Food Additives (JECFA) (79).
7.2 Working population
7.2.1 Occupational exposure limits
Occupational exposure limits established for PER in a number of countries are
listed in Table 27.
Table 27. Limits for occupational exposure to PER in a number of countries.
Concentration Time relation Note ReferenceCountry
ppm mg/m3
The Netherlands 35 240 8-h TWA A (265)
Germany A, B (51)
USA, ACGIH 25 170 8-h TWA C (1)
100 685 15-min TWA
USA, OSHA 100 8-h TWA D (3)
200 Ceiling (3)
300 F
USA, NIOSH -/0.4 - REL/LOQ E (3)
Sweden 10 70 8-h TWA G (264)
25 170 15-min TWA (264)
Denmark 10 70 8-h TWA A, G (10)
United Kingdom 50 345 8-h TWA (120)
100 689 15-min TWA
Finland 10 70 8-h TWA (121)
Iceland 10 70 8-h TWA A (282)
Norway 6 40 8-h TWA A, G (9)
A: Skin notation.
B: Kategorie III B, i.e., suspected carcinogen. No “MAK-Werte” was established because of the
uncertainty about the formation of genotoxic metabolites in the kidneys due to glutathione
conjugation at relatively low exposure levels. For the time being, it is advised to use the “BAT-
Werte” (biological limit value; see Table 28) as an “Orientierunggrosse” (orientation value).
C: Animal carcinogen. The TLV is based on subjective symptoms and discomfort reported in
human-volunteer studies, in particular eye irritation, dizziness and incoordination, at 100-200 ppm.
Furthermore, it is considered that this TLV provides a large margin of safety with respect to
possible liver injury.
D: Final-rule limit.
E: Potential occupational carcinogen. Minimise workplace exposure.
F: 5 minutes peak in any 3 hours.
G: In the list of substances considered to be carcinogenic.
REL/LOQ: Recommended exposure limit/limit of quantitation.
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7.2.2 Biological limit values
Biological limit values have been defined in the USA and Germany (Table 28).
Table 28. Biological limit values in the USA and Germany.
Country Indicator
compound
Matrix Time of sampling Concentration Reference
USA PER Expired
air
Prior to last shift of workweek 5 ppm (34.5 mg/m3) (1)
USA Blood Prior to last shift of workweek 0.5 mg/l
USA TCA Urine End of workweek 3.5 mg/la
Germany PER Blood Prior to next shift 1 mg/l (51)
a
 Regarded by the ACGIH as a non-specific value, the quantitative interpretation of which is ambi-
guous; it has a semi-quantitative value, and is, therefore, only suitable for screening purposes.
8. Hazard assessment
8.1 Assessment of health hazard
PER causes eye irritation in humans at concentrations of about 690 mg/m3 (100
ppm), exposure concentrations that are found in occupational environments. Due
to adaptation, possible complaints are expected to have a transient character at
lower doses. Skin irritation is only reported after intensive skin contact with
liquid PER, for instance through submersion or wearing PER-soaked clothes. No
publications were found about irritation problems under normal occupational
conditions.
The sensitising properties of PER are considered low.
In a few long-term human exposure studies, hepatotoxicity was observed
between 1 378 and 2 756 mg/m3 (200-400 ppm). Although experimental animal
studies clearly demonstrate the hepatotoxicity of PER, a quantitative extrapolation
from these studies to the human occupational situation is difficult. This is due to
the high oxidative biotransformation capacity of PER in the liver of experimental
animals, which leads to the formation of the proven hepatotoxic endproduct TCA.
Furthermore, the rate of oxidative biotransformation is much slower in humans
than in experimental animals, in particular mice. Thus, these animal studies are
less relevant for the human situation.
 Adequate human data on nephrotoxicity are lacking. Working in dry-cleaning
facilities is only accompanied by biochemical changes, which suggest nephro-
pathy. Due to the differences in biotransformation in case of nephrotoxicity, the
results of experimental animal studies are inadequate for extrapolation to humans
as well.
None of the epidemiological studies concerned with cancer mortality or
incidence yielded conclusive results. Animal studies on carcinogenicity of PER
have limited relevance for the human situation because of species susceptibility.
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Furthermore, the hepatocarcinogenicity in mice and the possible nephrocarcino-
genicity in male rats were clearly not confirmed by the extensive epidemiological
data base. The occurrence of an apparently not life-style related increased inci-
dence of oesophagus cancer in a PER-only cohort deserves further attention.
Although the outcome of a study on the semen quality of dry cleaners and their
reproductive success in humans suggests an adverse effect, the available data on
the effects of PER on reproductive capacity do not allow definitive conclusions
since exposure to other solvents cannot be excluded. Moreover, such an effect is
not confirmed by the only available animal experiment concerned with this
endpoint.
Foetotoxicity (skeletal abnormalities in mice at 2 067 mg/m3 or 300 ppm) and
developmental toxicity (decreases in litter size and survival during lactation in rats
at 6 900 mg/m3 or 1 000 ppm) in animals occur at dose levels, which are well
above those inducing other adverse effects.
The available data strongly suggest that human neurological functions are
adversely affected at exposure levels of about 690 mg/m3 (100 ppm) and higher.
Most neurotoxicological effects (headache, dizziness, lightheadedness, flushing,
difficulty in speaking, sleepiness, loss of inhibitions, exhilaration, feelings of
elation, impaired motor coordination) observed in humans appear to be reversible.
Furthermore, adaptation is reported. Some human studies and studies with
experimental animals suggest that exposure to PER levels below 690 mg/m3 (100
ppm) or even below 345 mg/m3 (50 ppm) may lead to adverse neurological
effects. In a volunteer study, at 345 mg/m3 (50 ppm) PER, an increase in visual
evoked potential and visual contrast sensitivity threshold was observed, whereas
in another study increased serum prolactine levels and a poor neurotoxicological
response were observed at median PER levels of about 100 mg/m3 (15 ppm).
However, both committees regard these studies as inconclusive, mainly because
of methodological shortcomings as poor statistics, presentation of data, low
number of exposed persons or the subjective character of reported symptoms.
Still, they warrant extra caution in setting exposure limits.
8.2 Groups at extra risk
The available toxicological information on PER does not point to groups of
humans which are at extra risk.
8.3 Scientific basis for an occupational exposure limit
Based on currently available toxicological information, the committees regard
neurotoxicity as the most sensitive effect of human respiratory exposure to PER.
An overview of the database reveals that neurotoxicological effects can be
expected to occur in humans at exposure to concentrations of about 690 mg/m3
(100 ppm), the LOAEL. At these concentrations also eye irritation is observed.
From the available data the committees are of the opinion that a skin absorption
may contribute significantly to the systemic effects of PER.
93
10. Summary
de Raat K. The Nordic Expert Group for Criteria Documentation of Health Risks
from Chemicals and the Dutch Expert Committee on Occupational Standards.
133. Tetrachloroethylene (PER). Arbete och Hälsa 2003;14:1-110.
At ambient temperatures, tetrachloroethylene (PER) is a colourless liquid with an
ethereal odour. It is used as a solvent in dry cleaning, extraction and vapour
degreasing of metals, as an intermediate in chemical synthesis, an anthelminthic, a
heat-exchange fluid, and as a grain-fumigation agent.
A high respiratory absorption has been observed in humans. Dermal exposure
of liquid PER can substantially contribute to the body burden. In humans, the
major part of absorbed PER is exhaled unchanged, while only a small fraction is
metabolised. The major metabolite trichloroacetic acid is excreted in the urine.
PER accumulates in adipose tissue.
PER is a skin- and eye-irritating compound. Controlled exposure of volunteers
to 75-80 ppm resulted in very slight irritation of the eyes, nose and throat during
the first few minutes of exposure. Human case studies show that skin sensitisation
may occasionally occur under occupational conditions. There are no clear indi-
cations for respiratory sensitisation.
Short-term inhalation exposure gives rise to a series of clear-cut neurotoxic
effects in man. PER causes a reversible depression of the central nervous system.
High doses lead to coma, followed by respiratory failure and death.
Overall, central nervous system effects can be expected in humans at short-term
exposure to approximately 100 ppm. Reported effects include headache, dizzi-
ness, lightheadedness, flushing, difficulty in speaking, sleepiness, loss of
inhibitions, exhilaration, feelings of elation, and impaired motor coordination.
Some inadequately performed studies suggest neurological effects below 100 ppm
(15 ppm median level).
Temporary liver and kidney damage has been reported in cases of acute
poisoning of humans by inhalation and in a few long-term human exposure
studies, hepatotoxicity was observed at 200-400 ppm.
No clear signs of teratogenicity were found in animal studies at high doses,
however, some indication of foetotoxicity was observed.
The results from genotoxicity testing warrant the conclusion that exposure to
PER, does not present a genotoxic risk to humans.
Several epidemiological studies deal with the effects of PER exposure on
cancer incidence or cancer mortality but the results are inconclusive. Interpre-
tation is often hampered by concomitant exposure to other solvents and limited
by lack of control for lifestyle-related factors.
Keywords: cancer, hepatotoxicity, irritation, neurotoxicity, occupational exposure
limit, perchloroethylene, review, risk assessment, tetrachloroethene, tetrachloro-
ethylene
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11. Summary in Swedish
de Raat K. The Nordic Expert Group for Criteria Documentation of Health Risks
from Chemicals and the Dutch Expert Committee on Occupational Standards.
133. Tetrachloroethylene (PER). Arbete och Hälsa 2003;14:1-110.
Vid rumstemperatur är tetrakloretylen (PER) en färglös vätska med eterisk lukt.
PER används som lösningsmedel vid kemtvätt, vid extraktion och ångavfettning
av metaller, som intermediär vid kemisk syntes, läkemedel vid maskinfektion,
som köldmedium och vid rökning av säd.
Ett högt upptag via lungorna har observerats hos människa. Hudexponering för
PER i vätskeform kan bidra väsentligt till kroppsdosen. Merparten av absorberad
PER kommer hos människa att utandas i oförändrad form. Endast en liten del
metaboliseras. Huvudmetaboliten triklorättiksyra utsöndras i urinen. PER
ackumuleras i fettväv.
PER irriterar hud och ögon. Kontrollerad exponering av frivilliga försöks-
personer för 75-80 ppm gav upphov till mycket lätt irritation i ögon, näsa och hals
under de första minuterna av exponeringen. Fallrapporter visar att hudsensibili-
sering kan uppstå vid yrkesexponering. Det finns inga klara indikationer på
respiratorisk sensibilisering.
Korttidsexponering via inandning ger upphov till flera klart neurotoxiska
effekter hos människa. PER ger upphov till reversibel depression av centrala
nervsystemet. Höga doser leder till koma och död.
Sammantaget kan centralnervösa effekter på människa förväntas vid korttids-
exponering för cirka 100 ppm. Rapporterade effekter är bland annat huvudvärk,
svindel, yrsel, rodnad, talsvårigheter, sömnlöshet, minskade hämningar, känslor
av upprymdhet och glädje samt försämrad koordination. Några ofullständigt
genomförda studier antyder neurologiska effekter under 100 ppm (15 ppm
medianvärde).
Tillfälliga lever- och njurskador hos människa har rapporterats vid fall av akut
förgiftning via inandning. I ett fåtal långtidsstudier på människa har levertoxicitet
observerats vid 200-400 ppm.
Inga tydliga tecken på teratogenicitet har setts i djurförsök vid höga doser, men
vissa indikationer på fostertoxicitet har observerats.
Resultaten från genotoxicitetsstudier tyder på att exponering för PER inte utgör
någon genotoxisk risk för människa.
Flera epidemiologiska studier behandlar effekterna av PER-exponering på
cancerincidens eller dödligheten i cancer, men resultaten är svårbedömda.
Tolkningen försvåras ofta av samtidig exponering för andra lösningsmedel och
bristande kontroll för livsstilsrelaterade faktorer.
Nyckelord: cancer, gränsvärden, hepatotoxicitet, irritation, neurotoxicitet,
perkloretylen, riskvärdering, tetrakloreten, tetrakloretylen, översikt
95
12. References
1. ACGIH. Guide to occupational, exposure values 2002; TLVs and BEIs. Threshold limit
values and biological exposure indices, Cincinnati, OH: American Conference of Govern-
mental Industrial Hygienists, 2002.
2. Aitio A, Pekari K, Jarvisalo J. Skin absorption as a source of error in biological monitoring.
Scand J Work Environ Health 1984;10:317-320.
3. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for
tetrachloroethylene (update) ATSDR/TP-97/18. Atlanta, Georgia: U.S. Department of Health
Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry,
1997.
4. Altmann L, Bottger A, Wiegand H. Neurophysiological and psychophysical measurements
reveal effects of acute low-level organic solvent exposure in humans. Int Arch Occup Environ
Health 1990;62:493-499.
5. Anders MW. Glutathione-dependent bioactivation of xenobiotics: Implications for mutageni-
city and carcinogenicity. Princess Takamatsu Symp 1990;21:89-99.
6. Angerer J. Analytische Methoden zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Band 2,
Analyse im Biologischem Material. Verlag Chemie, Weinheim, 6. Lieferung, Ausgabe 1982.
7. Anttila A, Pukkala E, Sallmen M, Hernberg S, Hemminki K. Cancer incidence among
Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med 1995;37:797-
806.
8. Aranyi C, O’Shea WJ, Graham JA. The effects of inhalation of organic chemical air
contaminants on murine host defences. Fundam Appl Toxicol 1986;6:713-720.
9. Arbeidstilsynet. Administrative normer for forurensning i arbeidsatmosfære. Veiledning til
arbeidsmiljøloven. Oslo: Direktoratet for Arbeidstilsynet, 2001 (Bestillingsnr. 361).
10. Arbejdstilsynet. Exposure limit values for substances and materials. Copenhagen, Denmark:
The Working Environment Service: Instruction no. 3.1.0.2. 2002.
11. Aschengrau A, Ozonoff D, Paulu C, Coogan P, Vezina R, Heeren T, Zhang Y. Cancer risk
and tetrachloroethylene-contaminated drinking water in Massachusetts. Arch Environ Health
1993;48, 284-292.
12. Axelson O. Epidemiological studies of workers with exposure to tri- and tetrachloroethylenes
In: Chambers PL, Gehring P, Sakai F, eds. New Concepts and Development in Toxicology.
Amsterdam: Elsevier Science Publishers B.V., 1986.
13. Bartsch H, Malaveille C, Barbin A. Mutagenic and alkylating metabolites of halo-ethylenes,
chlorobutadiene and dichlorobutenes produced by rodent or human liver tissues. Evidence for
oxirane formation by P450 linked microsomal mono-oxygenases. Arch Toxicol 1979;41:249-
277.
14. Beliles RP, Brusick DJ, Mecler FJ. Teratogenic-mutagenic risk of workplace contaminants:
Trichloroethylene, perchloroethylene and carbon disulfide. US DHEW, Contract No. 210-77-
0074
15. Beliles RP, Brusick DJ, Mecler FJ. Teratogenic-mutagenic risk of workplace contaminants:
Trichloroethylene, perchloroethylene and carbon disulphide. US DHEW-NOSH PB 82-
185075.
16. Benoit FM, Davidson WR, Lovett AM, Nacson S, Ngo A. Breath analysis by API/MS -
human exposure to volatile organic solvents. Int Arch Occup Environ Health 1985;55:113-
120.
17. Bergamaschi E, Mutti A, Bocchi MC, Alinovi R, Olivetti G, Ghiggeri GM, Franchini I. Rat
model of perchloroethylene-induced renal dysfunction. Environ Res 1992;59:427-439.
18. Berlin M, Gage JC, Gullberg B, Holm S, Knutsson P, Eng C, Tunek A. Breath concentration
as an index of the health risk from benzene. Studies on the accumulation and clearance of
inhaled benzene. Scand J Work Environ Health. 1980 6:104-111.
96
19. Bernard AM, de Russis R, Normand JC, Lauwerys RR. Evaluation of the subacute
nephrotoxicity of cyclohexane and other industrial solvents in the Sprague-Dawley rat.
Toxicol Lett 1989;45:271-280.
20. Birner G, Rutkowska A, Dekant W. N-Acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine and 2,2,2-
trichloroethanol. Two novel metabolites of tetrachloroethylene in humans after occupational
exposure. Drug Metabolism and Disposition 1996;24:41-48.
21. Blair A, Decoufle P, Grauman D. Causes of death among laundry and dry-cleaning workers.
Am J Publ Health 1979;69:508-511.
22. Blair A, Tolbert P, Thomas T, Grauman D. Mortality among dry cleaners. Proceedings of the
4th Int. Symp. of Epidem. Como, 1985.
23. Bolt HM. Pharmacokinetic factors and their implication in the induction of mouse liver
tumors by halogenated hydrocarbons. Arch Toxicol 1987;Suppl. 10:190-203.
24. Bolt HM, Laib RJ, Filser JG. Reactive metabolites and carcinogenicity of halogenated
ethylenes. Biochem Pharmacol 1982;31:1-4.
25. Bonnet P, Francin J-M, Gradski D, Raoult G, Zissu D. Determination of the lethal
concentration-50 of the principal chlorinated hydrocarbons in the rat. Arch Mal Prof
1980;41:317-321.
26. Bonse C, Urban Th, Reichert D, Henschler D. Chemical reactivity, metabolic oxirane
formation and biological reactivity of chlorinated ethylenes in the isolated perfused rat liver
preparation. Biochem Pharmacol 1975;24:1829-1834.
27. Bosco MG, Figa-Talamanco I, Salerno S. Health and reproductive status of female workers in
dry cleaning shops. Int Arch Occup Environ Health 1987;59:295-301.
28. Brancaccio A, Mazza V, DiPaolo R. Renal function in experimental tetrachloroethylene
poisoning. Folia Med (Naples) 1971;54:233-237.
29. Bronzetti G, Bauer C, Corsi C, Del Carratore R, Galli A, Nieri R, Paolini M. Genetic and
biochemical studies on perchloroethylene in vitro and in vivo. Mutat Res 1983;116:323-331.
30. Brown DP, Kaplan SD. Retrospective cohort mortality study of dry cleaner workers using
perchloroethylene. J Occup Med 1987;29:535-541.
31. Buben J, O’Flaherty E. Delineation of the role of metabolism in the hepatotoxicity of
trichloroethylene and perchloroethylene: a dose effect study. Toxicol Appl Pharmacol
1985;78:105-122.
32. Böttger A, Elstermeier F. Belastung der Bevölkerung durch organische Lösungsmittel.
Abschlußbericht des Umwelt Bundesamtes zur Project Nr. 10606058 vom 31.05.89.
33. Cai SX, Huang MY, Chen Z, Liu YT, Jin C, Watanabe T, Nakatsuka H, Seiji K, Inoue O,
Ikeda M. Subjective symptom increase among dry-cleaning workers exposed to tetra-
chloroethylene. Ind Health 1991;29:111-121.
34. Carlson GP. Epinephrine-induced cardiac arrhythmias in rabbits exposed to tetrachloro-
ethylene. Toxicol Lett 1983;19:113-117.
35. Carpenter CP. The chronic toxicity of tetrachloroethylene. J Ind Hyg Toxicol 1937;19:323-
336.
36. Cerna N, Kypenova H. Mutagenic activity of chloroethylenes analyzed by screening system
tests. Mutat Res 1977;46:214-215.
37. Christensen BV, Lynch HJ. The effect of anthelminthics on the host. I. Tetrachloroethylene.
II. Hexylresorcinol. J Pharmacol Exp Ther 1933;48:311-316.
38. Clement International Corporation. Tetrachloroethylene (AAMRL-TR-90-072). Development
and validation of methods for applying pharmacokinetic data in risk assessment. Volume III
Ohio, USA: AAMRL, 1990.
39. Cohn P, Klotz J, Bove F, Berkowitz M, Fagliano J. Drinking water contamination and the
incidence of leukemia and non-Hodgkin’s lymphoma. Environ Health Perspect
1994;102:556-561.
97
40. Connor TH, Theiss JC, Hanna HA, Monteith DK, Matney TS. Genotoxicity of organic
chemical frequently found in the air of mobile homes. Toxicol Lett 1985;25:33-40.
41. Cornish HH, Ling BP, Barth ML. Phenobarbital and organic solvent toxicity. Am Ind Hyg
Assoc J 1973;34:487-492.
42. Costa AK, Ivanetich KM. Tetrachloroethylene metabolism by the hepatic microsomal
cytochrome P-450 system. Biochem Pharmacol 1980;29:2863-2869.
43. Costa AK, Ivanetich KM. Chlorinated ethylenes: their metabolism and effect on DNA repair
in rat hepatocytes. Carcinogenesis 1984;5:1629-1636.
44. Dallas CE, Chen XM, Muralidhara S. Use of tissue disposition data from rats and dogs to
determine species differences in input parameters for a physiological model for perchloro-
ethylene. Environ Res 1994;67:54-67.
45. Daniel JW. The metabolism of 36-Cl-labelled trichloroethylene and tetrachloroethylene in the
rat. Biochem Pharmacol 1963;12:705-802.
46. De Ceaurriz J, Desiles JP, Bonnet P, Marignac B, Muller J, Guenier JP. Concentration-
dependent behavioural changes in mice following short-term inhalation exposure to various
industrial solvents. Toxicol Appl Pharmacol 1983;67:383-389.
47. Dekant W, Berthold K, Vamvakas S, Henschler D, Anders MW. Thioacylating intermediates
as metabolites of S-(1,2,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine
formed by cysteine conjugate beta-lyase. Chem Res Toxicol 1988;1:175-178.
48. Dekant W, Haug R, Henschler D. Absorption, elimination and metabolism of tetrachloro-
ethylene. Arch Pharmacol 1985;Suppl. 329:R24.
49. Dekant W, Metzler M, Henschler D. Identification of S-1,2,2-trichlorovinyl-N-acetylcysteine
as urinary metabolite to tetrachloroethylene bioactivation through glutathione conjugation as
a possible explaination for its nephrotoxicity. J Biochem Tox 1986;1:57-72.
50. Dekant W, Vamvakas S, Berthold K, Schmidt S, Wild D, Henschler D. Bacterial beta-lyase
mediated cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcino-
genic alkanes trichloroethylene, tetrachloroethylene and hexa chlorobutadiene. Chem Biol
Interactions 1986;60:31-45.
51. DFG. Deutsche Forschungsgemeinmschaft (DFG). MAK- und BAT-Werte-Liste 2001.
Senatskommission zur Prufung gesundheitsschädlicher Arbeitsstoffe, Mitteilung 30. FRG,
Weinheim: VCH Verlagsgesellschaft mbH, 2001.
52. DiVincenzo GD, Krasavage WJ. Serum ornithine carbamyltransferase as a liver response test
for exposure to organic solvents. Am Ind Hyg Assoc J 1974;35:21-29.
53. Dmitrieva NV. Maximum permissible concentration of tetrachloroethylene in factory air. Gig
Sanit 1966;31:387-393.
54. Dmitrieva NV, Kuleshov EB. Changes in the bioelectric activity and electric conduction
properties of muscles subjected to the action of chlorinated hydrocarbons. Farmakol Toksikol
1971;31:228-230.
55. Doorgeest T. In: Meijer PB, De Mik G. Chronische Effecten Tengevolge van Blootstelling
aan Organische Oplosmiddelen. Voorburg, The Netherlands: Directorate General of Labour,
Ministry of Social Affairs and Employment, 1986;Rep. No. S29-1.
56. Drew RT, Patel JM, Lin F-N. Changes in serum enzymes in rats after inhalation of organic
solvents singly and in combination. Toxicol Appl Pharmacol 1978;45:809-819.
57. Dry-cleaned breast milk poisons baby. Medical World News 1978;19:6.
58. Duh R-W, Asal NR. Mortality among laundry and dry-cleaning workers in Oklahoma. Am J
Public Health 1984;74:1278-1280.
59. Duprat P, Bonnet P. Study on the organic lesions in the mouse produced by chlorinated
aliphatic solvents administered by inhalation. INRS Bulletin de documentation 1979;1103:73-
101.
60. Duprat P, Delsant L, Gradiski D. Irritant potency of the principal aliphatic chloride solvents
on the skin and ocular mucous membranes of rabbits. Eur J Toxicol 1976;3:171-177.
98
61. Dutch Normalisation Institute. NEN2947: Air quality, Occupational atmosphere; General
method for determination of toxic damp or gases by active sampling using absorption tube,
liquid desorption and gas chromatochraphy. Dutch Normalisation Institute, 1999.
62. Dutch Normalisation Institute. NEN2948: Air quality, Occupational atmosphere; General
method for determination of toxic damp or gases by active sampling using absorption tube,
thermic desorption and gas chromatochraphy. Dutch Normalisation Institute, 1999.
63. Dutch Normalisation Institute. NEN2950: Air quality, Occupational atmosphere; General
method for determination of toxic damp or gases by gas diffusion sampling using direct
readable dosimetry. Dutch Normalisation Institute, 1999.
64. Dutch Normalisation Institute. NEN2964: Air quality, Occupational atmosphere;
Determination of the concentration of gaseous chlorated carbons by active sampling using
absorption tube, liquid desorption and gas chromatochraphy. Dutch Normalisation Institute,
2000.
65. Dutch Normalisation Institute. NEN2965: Air quality, Occupational atmosphere;
Determination of the concentration of gaseous chlorated carbons by active sampling using
absorption tube, thermic desorption and gas chromatochraphy. Dutch Normalisation
Institute, 2000.
66. Van Duuren BL, Goldschmidt BM, Loewengart G, Smith AC, Melchionne S, Seldman I,
Roth D. Carcinogenicity of halogenated olefinic and aliphatic hydrocarbons in mice. J Natl
Cancer Inst 1979;63:1433-1439.
67. Dybing F, Dybing O. The toxic effect of tetrachloromethane and tetrachloroethylene in oily
solution. Acta Pharmacol 1946;2:223-226.
68. Eberhardt H, Freundt KJ. Perchloräthylenvergiftung. Arch Toxicol 1966;21:338.
69. ECETOC. Tetrachloroethylene: Assessment of human carcinogenic hazard. Technical Report
No. 37. Brussels: European Centre for Ecotoxicology and Toxicology of Cemicals, 1990.
70. Echeverria D, White RF, Sampaio C. A behavioral evaluation of PCE exposure in patients
and dry cleaners: a possible relationship between clinical and preclinical effects. J Occup
Environ Med 1995;37:667.
71. Edelfors S, Ravn-Jonsen A. Calcium uptake in rat brain synaptosomes after short-term
exposure to organic solvents: a pilot study. Acta Pharmacol Toxicol (Copenh). 1985;56:431-
434.
72. Edelfors S, Ravn-Jonsen A. Effect of organic solvents on nervous cell membrane as measured
by changes in the (Ca2+/Mg2+) ATPase activity and fluidity of synaptosomal membrane.
Pharmacol Toxicol 1992;70:181-187.
73. Elcombe CR. Species differences in carcinogenicity and peroxisome proliferation due to
trichloroethylene: a biological human hazard assessment. Arch Toxicol 1985;Suppl. 8:6-17.
74. EPA. Drinking water criteria document for tetrachloroethylene (final). PB86-118114.
Springfield: US Environmental Protection Agency, National Technical Information Service,
U.S. Department of Commerce, 1986.
75. EPA. Integrated Risk Information System. Cincinnati, OH: US Environmental Protection
Agency, Office of Health and Environmental Assessment, Environmental Criteria and
Assessment Office, 1990.
76. Eskenazi B, Wyrobek AJ, Fenster L, Katz DF, Sadler M, Lee J, Hudes M, Rempel DM. A
study of the effect of perchloroethylene exposure on semen quality in dry-cleaning workers.
Am J Ind Med 1991;20:575-591.
77. Eskenazi B, Fenster L, Hudes M, Wyrobek AJ, Katz DF, Gerson J, Rempel DM. A study of
the effect of perchloroethylene on the reproductive outcome of wives of dry-cleaning
workers. Am J Ind Med 1991;20:593-600.
78. Essing H-G. Feldstudie zur Frage der Hepato- und Nephrotoxizität des Perchloräthylens nach
langjähriger berufliche Exposition. Arbeitsmedizin, Sozialmedizin, Präventivmedizin Band 59
Stuttgart: AW Gentner Verlag, 1975.
99
79. FAO/WHO. Food and Agriculture Organization/World Health Organization. In: Summary of
evaluations performed by the Joint FAO/WHO Expert Committee on Food Additives
(JECFA). 1956-1993 (first through forty-first meetings). USA: ILSI Press, 1994:T-4.
80. Fender H. Chromosomenanalytische Undersuchungen bei Textilreinigern. In: Arndt D, Obe
G (Hrsg) Cytogenetische Methoden im Rahmen des Populationsmonitoring, MMV Verlag,
München, 1993:71-76.
81. Fernandez J, Guberan E, Caperos J. Experimental human exposure to tetrachloroethylene
vapor and inhalation in breath after inhalation. Am Ind Hyg Assoc J 1976;37:143-150.
82. Ferroni C, Selis L, Mutti A, Folli D, Bergamaschi E, Franchini I. Neurobehavioral and
neuroendocrine effects of occupational exposure to perchloroethylene. Neurotoxicology
1992;13:243-247.
83. Foot EB, Bishop K, Apgar V. Tetrachloroethylene as an anesthetic agent. Anesthesiology
1943;4:283-292.
84. Franchini I, Cavatorta A, Falzoi M, Lucertini S, Mutti A. Early indicators of renal damage in
workers exposed to oganic solvents. Int Arch Occup Environ Health 1983;52:1-9.
85. Frantz SW, Watanabe PG. Tetrachloroethylene: Balance and tissue distribution in male
Sprague-Dawley rats by drinking water administration. Toxicol Appl Pharmacol 1983;69:66-
72.
86. Fredriksson A, Danielsson BR, Eriksson P. Altered behaviour in adult mic orally exposed to
tri- and tetrachloroethylene as neonates. Toxicol Lett 1993;66:1:13-19.
87. Friberg L, Kylin B, Nyström A. Toxicities of trichloroethylene and tetrachloroethylene and
Fujiwara’s pyridine - alkali reaction. Acta Pharmacol Toxicol 1953;9:303-312.
88. Galloway SM, Armstrong MJ, Reuben C, Colman S, Brown B, Cannon C, Bloom AD,
Nakamura F, Ahmed M, Duk S, Rimpo J, Margolin BH, Resnick MA, Andeson B, Zeiger E.
Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells:
evaluations of 108 chemicals. Environ Mol Mutagen 1987;10, Suppl. 10:1-175.
89. Gearhart JM, Mahle DA, Greene RJ, Seckel CS, Flemming CD, Fisher JW, Clewell HJ 3rd.
Variability of physiologically based pharmacokinetic (PBPK) model parameters and their
effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). Toxicol
Lett 1993;68:131-144.
90. Gehring PJ. Hepatotoxic potency of various chlorinated hydrocarbon vapours relative to their
narcotic and lethal potencies in mice. Toxicol Appl Pharmacol 1968;13:287-298.
91. Gennari P, Naldi M, Motta R, Nucci MC, Giacomini C, Violante FS, Raffi GB. Gamma-
glutamyltransferase isoenzyme pattern in workers exposed to tetrachloroethylene. Am J Ind
Med 1992;21:661-671.
92. Ghantous H, Danielsson BR, Dencker L, Gorczak J, Vesterberg O. Trichloroacetic acid
accumulates in murine amniotic fluid after tri- and tetrachloroethylene inhalation. Acta
Pharmacol Toxicol (Copenh) 1986;58:105-114.
93. Gilli G, Bono R, Scursatone E. Volatile halogenated hydrocarbons in urban atmosphere and
in human blood. Arch Eniviron Health 1990;45:101-106.
94. Gold JH. Chronic perchloroethylene poisoning. Can Psychiat Assoc J 1969;14:627-630.
95. Goldberg ME, Johnson HE, Pozzani UC, Smyth HF Jr. Effect of repeated inhalation of
vapours of industrial solvents on animal behaviour. I. Evaluation of nine solvent vapours on
pole climb behaviour in rats. Ind Hyg J. 1964;25:369-375.
96. Goldbloom AA, Boyd LJ. Tetrachloroethylene fatality. Case report of a patient with
infectious (virus) hepatitis and hookworm infestion. Ind Med Surg 1954;23:116-119.
97. Goldsworthy TL, Popp JA. Chlorinated hydrocarbon induced peroxisomal enzyme activity in
relation to species and organ carcinogenicity. Toxicol Appl Pharmacol 1987;88:225-233.
98. Goldsworthy TL, Smith-Oliver T, Loury DJ. Assessment of chlorinated hydrocarbon-induced
genotoxicity and cell replication in rat kidney cells. Environ Mol Mutagen 1988;11, Suppl.
11:39.
100
99. Gordon SM, Wallace LA, Pellizari ED, O´Neill HJ. Human breath measurements in clean-air
chamber to determine half-lives for volatile organic compounds. Atmos Environ
1988;22:2165-2170.
100. Gradiski D, Bonnet P, Raoult G. Comparative acute inhalation study of the principal
chlorinated aliphatic solvents. Arch Mal Prof 1978;39:249-257.
101. Grant WM. Toxicology of the eye. Springfield: Thomas, 1962.
102. Green T. Species differences in carcinogenicity: the role of metabolism in human risk
evaluation. Teratog Carcinog Mutagen 1990;10:103-113.
103. Green T, Odum J. Structure/activity studies of the nephrotoxic and mutagenic action of
cysteine conjugates of chloro- and fluoroalkenes. Chem Biol Interact 1985;54:15-31.
104. Green T, Odum J, Nash JA, Foster JR. Perchloroethylene-induced rat kidney tumors: An
investigation of the mechanisms involved and their relevance to humans. Toxicol Appl
Pharmacol 1990;103:77-89.
105. Greim H, Bonse G, Radwan Z, Reichert D, Henschler D. Mutagenicity in vitro and potential
carcinogenicity of chlorinated ethylenes as a function of metabolic oxirane formation.
Biochem Pharmacol 1975;24:2013-2017.
106. Guberan E, Fernandez J. Control of industrial exposure to tetrachloroethylene by measuring
alveolar concentrations: Theoretical approach using a mathematical model. Br J Ind Med
1974;31:159-167.
107. Haerer AF, Udelman HD. Acute brain syndrom secondary to tetrachloroethylene ingestion.
Am J Psychiat 1964;12:78-79.
108. Hake CL, Stewart RD. Human exposure to tetrachloroethylene: Inhalation and skin contact.
Environ Health Perspect 1977;21:231-238.
109. Hamada N, Peterson RE. Effects of chlorinated aliphatic hydrocarbons on excretion of
protein and electrolytes by rat pancreas. Toxicol Appl Pharmacol 1977;39:185-194.
110. Hardin BD, Bond GP, Sikov MR, Andrew FD, Beliles RP, Niemeier RW. Testing of selected
workplace chemicals for teratogenic potential. Scand J Work Environ Health 1981;7, Suppl.
4:66-75.
111. Haworth S, Lawlor T, Mortelmans K, Speck W, Zeiger E. Salmonella mutagenicity test
results for 250 chemicals. Environ Mutagen 1983;5, Suppl. 1:1-142.
112. Hayes JR, Condie LW, Borcelleca JF. The subchronic toxicity of tetrachloroethylene
(perchloroethylene) administered in the drinking water of rats. Fundam Appl Toxicol
1986;7:119-125.
113. Herren-Freund SL, Pereira MA, Khoury MD, Olson G. The carcinogenicity of trichloro-
ethylene and its metabolites trichloroacetic acid and dichloroacetic acid, in mouse liver.
Toxicol Appl Pharmacol 1987;90:183-189.
114. Hidalgo FJ, Zamora R, Tappel AL. Damage to red blood cells by halocompounds. Toxicol
Lett 1990;52:191-199.
115. Holmberg B, Ekström T, Högberg J, Lundberg I, Nilsson K, Walles S, Warholm M. Five
industrial chemicals investigated for tumor promoting activity in the rat liver. Toxicol Lett
1986;31, Suppl. 14-7 :197.
116. Holmberg B, Jakobson I, Malmfors T. The effect of organic solvents on erythrocytes during
hypotonic hemolysis. Environ Res 1974;7:193-205.
117. Honma T, Hasegawa H, Sato M, Sudo A. Changes of free amino acid content in rat brain
after exposure to trichloroethylene and tetrachloroethylene. Ind Health 1980;18:1-8.
118. Honma T, Sudo A, Miyagawa M, Sato M, Hasegawa H. Effects of exposure to trichloroethy-
lene and tetrachloroethylene on the contents of acetylcholine, dopamine, norepinephrine and
serotonin in rat brain. Ind Health 1980;18:171-178.
119. HSE. Health and Safety Executive. Tetrachloroethylene (tetrachloroethene,
perchloroethylene: Toxicity review 17. London, United Kingdom: Health and Safety
Executive, HMSO Publications Centre, 1987.
101
120. HSE. Health and Safety Executive. Occupational Exposure Limits 2000. EH40/2000.
Sudbury (Suffolk), United Kingdom: HSE Books, 1998:31.
121. HTP-arvot 2002. Tampere: Sosiaali- ja terveysministeriö, 2002. ISBN 952-00-1107-2.
122. Hughes JP. Hazardous exposure to some so called safe solvents. JAMA 1954;156:234-237.
123. IARC. International Agency for Research on Cancer. Tetrachloroethylene. In: IARC
Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 20.
Lyon: International Agency for Research on Cancer, 1979.
124. IARC. International Agency for Research on Cancer. Dry cleaning, some chlorinated solvents
and other industrial compounds. IARC Monographs on the Evaluation of the Carcinogenic
Risk of Chemicals to Humans. Vol. 63. France, Lyon: World Health Organization, 1995.
125. Ikeda M. Metabolism of trichloroethylene and tetrachloroethylene in human subjects.
Environ Health Perspect 1977;21:239-245.
126. Ikeda M, Imamura T. Biological half-life of trichloroethylene and tetrachloroethylene in
human subjects. Int Arch Arbeitsmed 1973;31:209-224.
127. Ikeda M, Koizumi A. Cytogenetic and cytokinetic investigation on lymphocytes from
workers occupationally exposed to tetrachloroethylene. In: Holmstedt B, Lauwerijs R,
Mercier M, Roberfroid M, eds. Mechanisms of Toxicity and Hazard Evaluation. Amsterdam:
Elsevier/NorthHolland Press, 1980.
128. Ikeda T, Nagano C, Okada A. Hepatotoxic effects of trichloroethylene and perchloroethylene
in the rat and mouse. (EPA translation TR-78-0135) Igaku to Seibutsugako 1969;79:123-129.
129. Ikeda M, Otsuji H, Imamura T, Komoike Y. Urinary excretion of total trichloro-compounds,
trichloroethanol, and trichloroacetic acid as a measure of exposure to trichloroethylene and
tetrachloroethylene. Br J Ind Med 1972;29:328-333.
130. Imamura T, Ikeda M. Lower fiducial limit of urinary metabolite level as an index of
excessive exposure to industrial chemicals. Br J Ind Med 1973;30:289-292.
131. International Organization for Standardization. Workplace air - Determination of vaporous
chlorinated hydrocarbons - Charcoal tube/solvent desorption/gas chromatographic method.
International Standard ISO 9486:1991 (E) Geneve: International Organization for
Standardization, 1991.
132. IPCS. The International Programme on Chemical Safety (IPCS). Environmental Health
Criteria 31. Tetrachloroethylene. World Health Organization, Geneva, 1984.
133. Isacson P, Bean JA, Splinter R, Olson DB, Kohler J. Drinking water and cancer incidence in
Iowa. III. Association of cancer with indices of contamination. Am J Epidem 1985;121:856-
869.
134. Jakobson I, Wahlberg JE, Holmberg B, Johansson G. Uptake via the blood and elimination of
10 organic solvents following epicutaneous exposure of anesthesized pigs. Toxicol Appl
Pharmacol 1982;63:181-187.
135. Jang J-Y, Kang SK, Chung HK. Biological exposure indices of organic solvents for Korean
workers. Int Arch Occup Environ Health 1993;65:S219-222.
136. Kaemmerer K, Fink J, Kietzman M. Studies on the pharmacodynamics of perchloroethylene.
Tierarzt 1982;63:171-182.
137. Kaplan SD. Dry-cleaner worker exposed to perchloroethylene; A retrospective cohort
mortality study. Cincinnati, OH: US Department of Health, Education and Welfare; Contract
No. 210-77-0094, 1980.
138. Karlsson JE, Rosengren LE, Kjellstrand P, Haglid KG. Effects of low-dose inhalation of three
chlorinated aliphatic organic solvents on deoxyribonucleic acid in the gerbil brain. Scand J
Work Environ Health 1987;13:453-458.
139. Katz RM, Jowett D. Female laundry and dry cleaning workers in Wisconsin: a mortality
analysis. Am J Publ Health 1981;71:305-307.
140. Kefalas V, Stacey NH. Potentiating effects of chlorinated hydrocarbons on carbontetra-
chloride toxicity in isolated rat hepatocytes. Toxicol Appl Pharmacol 1991;109:171-179.
102
141. Kendrick JF. Treatment of hookworm disease with tetrachloroethylene. Am J Trop Med
1929;438-488.
142. Kennedy GL, Graepel GJ. Acute toxicity in the rat following either oral or inhalation
exposure. Toxicol Lett 1991;56:317-326.
143. Kjellstrand P, Bjerkemo M, Adler-Maihofer M, Holmquist B. Effects of solvent exposure on
testosterone levels and butyrylcholinesterase activity in mice. Acta Pharmacol Toxicol
(Copenh) 1985;57:242-249.
144. Kjellstrand P, Holmquist B, Kanje M. Perchloroethylene: Effects on body and organ weights
and plasma butyrylcholinesterase activity in mice. Acta Pharmacol Toxicol 1984;54:414-424.
145. Klassen CD, Plaa GL. Relative effects of various chlorinated hydrocarbons on liver and
kidney function in mice. Toxicol Appl Pharmacol 1966;9:139-151.
146. Klassen CD, Plaa GL. Relative effects of various chlorinated hydrocarbons on liver and
kidney function in dogs. Toxicol Appl Pharmacol 1967;10:119-131.
147. Kobayashi S, Hutcheon DE, Regan J. Cardiopulmonary toxicity of tetrachloroethylene. J
Toxicol Environ Health 1982;10:23-30.
148. Koppel C, Arndt I, Arendt U, Koeppe P. Acute tetrachloroethylene poisoning: Blood
elimination kinetics during hyperventilation therapy. J Toxicol Clin Toxicol 1985;23:103-
115.
149. Korpela M. Inhibition of synaptosome membrane-bound integral enzymes by organic
solvents. Scand J Work Environ Health 1989;15:64-68.
150. Korpela M, Tähti H. Effects of organic solvents on erythrocyte membrane acetyl
cholinesterase activity. Arch Toxicol Suppl 1985;8:148-151.
151. Kringstad KP, Ljungquist PO, De Sousa F, Stromberg LM. Identification and mutagenic
properties of some chlorinated aliphatic hydrocarbons in spent liquor from Kraft pulp
chlorination. Environ Sci Technol 1981;15:562-566.
152. Kronevi T, Wahlberg JE, Holmberg B. Skin pathology following epicutaneous exposure to
seven organic solvents. Int J Tiss React 1981;3:21-30.
153. Kylin B, Reichard H, Sümegi I, Yllner S. Hepatotoxicity of inhaled trichloroethylene,
tetrachloroethylene and chloroform. Single exposure. Acta Pharmacol Toxicol 1963;20:16-
26.
154. Kylin B, Sumegi I, Yllner. Hepatotoxicity of trichloroethylene and tetrachloroethylene. Long-
term exposure. Acta Pharmacol Toxicol 1965;22:379-385.
155. Kyrklund T, Alling C, Kjellstrand P, Haglid KH. Chronic effects of perchloroethylene on the
composition of lipid and acyl groups in the cerebral cortex and hippocampus of the gerbil.
Toxicol Lett 1984;22:343-349.
156. Kyrklund T, Haglid KG. Brain lipid changes after organic solvent exposure. Ups J Med Sci
Suppl 1990;48:267-277.
157. Kyrklund T, Kjellstrand P, Haglid KG. Lipid composition and fatty acid pattern of the gerbil
brain after exposure to perchloroethylene. Arch Toxicol 1987;60:397-400.
158. Kyrklund T, Kjellstrand P, Haglid KG. Effects of exposure of Freon 11, 1,1,1-trichloroethane
or perchloroethylene on the lipid and fatty-acid composition of rat cerebral cortex. Scand J
Work Environ Health 1988;14:91-94.
159. Kyrklund T, Kjellstrand P, Haglid KG. Long-term exposure of rats to perchloroethylene, with
and without a post-exposure solvent-free recovery period: effects on brain lipids. Toxicol Lett
1990;52:279-285.
160. LaFuente A, Mallol J. Thioethers in urine during occupational exposure to tetrachloro-
ethylene. Br J Ind Med 1986;43:68-69.
161. Lagakos SW, Wessen BJ, Zelen M. Analysis of contaminated well water and health effects in
Woburn, Massachusetts. J Am Stat Assoc 1986;81:583-596.
103
162. Lauwerys R, Herbrand J, Buchet JP, Bernard A, Gaussin J. Health surveillance of workers
exposed to tetrachloroethylene in dry-cleaning shops. Int Arch Occup Environ Health
1983;52:69-77.
163. Lebret E, Van de Wiel HJ, Bos HP, Noij D, Boleij JSM. Volatile organic compounds in
Dutch homes. Environ Int 1986;12:323-332.
164. Lemburg P, Sprock I, Bretschneider A, Storm W, Gobel U. A new concept of therapy in
accidental intoxications with halogenated hydrocarbons. Vet Hum Toxicol 1979;21:37-40.
165. Levine B, Fierro MF, Goza SW, Valentour JC. A tetrachloroethylene fatality. J Forensic Sci
1981;26:206-209.
166. Ling S, Lindsay WA. Perchloroethylene burns. Br Med J 1971;3:115.
167. Lob M. The dangers of perchloroethylene. Int Arch Gewerbepath Gewerbehyg 1957;16:45-
52.
168. Lorenz H, Weber E, Walter G, Haaß A, Steigerwald F, Buchter A. Nachweis von
Hirnschädigungen durch Tetrachlorethen. Zentralbl Arbeitsmed 1990;40:355-364.
169. Lukaszewski T. Acute tetrachloroethylene fatality. Clin Toxicol 1979;15:411-415.
170. Lundberg I, Högberg J, Kronevi T, Holmberg B. Three industrial solvents investigated for
tumor promoting activity in the rat liver. Cancer Lett 1987;36:29-33.
171. MacKenzie Peers A. Method 5. The determination of trichloroethylene and tetrachloro-
ethylene in air. In: Fishbein L, O’Neill IK, eds. Environmental carcinogens - Selected
methods of analysis Vol. 7. Some halogenated hydrocarbons. IARC Scientific Publications
No 68. Geneve: International Agency for Research on Cancer, 1985.
172. Maltoni C, Cotti G. Results of long-term carcinogenicity bioassays of Sprague-Dawley rats
administrated by ingestion. Acta Oncol (Madr) 1986;1:11-26.
173. Margard W. In vitro bioassay of chlorinated hydrocarbon solvents. Batelle Laboratories.
Unpublished document for Detrex Chemical Industries. Unpublished.
174. Maronpot RR, Shimkin MB, Witschi HP, Smith LH, Cline JM. Strain A mouse pulmonary
tumor test results for chemicals previously tested in the National Cancer Institute
carcinogenicity tests. J Natl Cancer Inst 1986;76:1101-1112.
175. Marth E. Metabolic changes following oral exposure to tetrachloroethylene in subtoxic
concentrations. Arch Toxicol 1987;60:293-299.
176. Marth E, Stunzer D, Binder H, Mose JR. Tetrachloroethylene; A study of the effect of low
concentrations of 1,1,2,2-tetrachloroethylene on the organism of the mouse. Zbl Bakt Hyg, I
Abt Orig B 1985;181:525-540.
177. Marth E, Stunzer D, Binder H, Mose JR. Tetrachloroethylene; A study of the effect of low
concentrations of 1,1,2,2-tetrachloroethylene on the organism of the mouse. Examinations of
tetrachloroethylene-residues in various organs and establishment of histologic changes of the
examined organ Zentralbl Bakteriol Mikrobiol Hyg [B] 1985;181:541-547.
178. Mazza V. Enzymatic changes in experimental tetrachloroethylene poisoning. Folia Med
(Naples) 1972;55:373-381.
179. Mazza V, Brancaccio A. Adrenal cortical and medullar hormones in experimental tetra-
chloroethylene poisoning. Folia Med (Napoli) 1971;54:204-207.
180. McCarty LP, Flannagan DC, Randall SA, Johnson KA. Acute toxicity in rats of chlorinated
hydrocarbons given via the intratracheal route. Hum Exp Toxicol 1992;11:173-177.
181. McLaughlin JK, Blot WJ. A critical review of epidemiological studies of trichloroethylene
and perchloroethylene and risk of renal-cell cancer. Int Arch Occup Environ Health
1997;70:222-231.
182. McLaughlin JK, Malker HS, Stone BJ, Weiner JA, Malker BK, Ericsson JL, Blot WJ,
Fraumeni JF, Jr. Occupational risks for renal cancer in Sweden. Br J Ind Med 44;1987:119-
123.
104
183. Meckler LC, Phelps DK. Liver disease secondary to tetrachloroethylene exposure. JAMA
1966;197:144-145.
184. Mennear JH. NTP Technical report on the toxicology and carcinogenesis studies of
tetrachloroethylene (perchloroethylene) in F344/N rats and B6C3F1 mice (Inhalation
Studies). DHSS-NIH Report 85-2657.
185. Metz V, Graben N, Bock KD. Symptoms and differential therapy of tetra-(=per-) chloro-
ethylene poisoning by ingestion or inhalation. Med Welt 1982;33:892-894.
186. Meuling WJA, Ebens R. Biological monitoring of tetrachloroethylene in a laundry facility (in
Dutch). MBL 1986-24A Rijswijk, The Netherlands: Medical Biological Laboratory TNO,
1986.
187. Meyer HJ. Bronchopulmonary changes induced by trichloroethylene and other halogenated
hydrocarbons. Bronches 1973;23:113-124.
188. Milman HA, Story DL, Ricio ES. Rat liver foci and in vitro assays to detect initiating and
promoting effects of chlorinated ethanes and ethylenes. Ann NY Acad Sci 1988;534:521-530.
189. Mitoma C, Steeger T, Jackson SE, Wheeler KP, Rogers JH, Milman HA. Metabolic
disposition study of chlorinated hydrocarbons in rats and mice. Drug Chem Toxicol
1985;8:183-194.
190. Monster AC. Difference in uptake, elimination, and metabolism in exposure to trichloro-
ethylene, 1,1,1-trichloroethane, and tetrachloroethane. Int Arch Occup Environ Health
1979;42:311- 317.
191. Monster AC. Biological monitoring of chlorinated hydrocarbon vapors. J Occup Med
1986;28:583-588.
192. Monster AC, Boersma G, Steenweg H. Kinetics of tetrachloroethylene in volunteers:
Influence of exposure concentration and work load. Int Arch Occup Environ Health
1979;42:303-309.
193. Monster AC, Houtkooper JM. Estimation of individual uptake of trichloroethylene, 1,1,1-
trichloroethane and tetrachloroethylene from biological parameters. Int Arch Occup Environ
Health 1979;42:319-323.
194. Monster A, Regouin-Peeters W, van Schijndel A, van der Tuin J. Biological monitoring of
occupational exposure to tetrachloroethene. Scand J Work Environ Health 1983;9:273-281
195. Monster AC, Zielhuis RL. Tetrachloroethene (tetrachloroethylene, perchloroethylene, perc.).
In: Alessio L, Berlin A, Roi R, Boni M, eds. Human biological monitoring of industrial
chemical series: benzene, cadmium, chlorinated hydrocarbon, solvents, lead, manganese,
titanium, toluene. Directorate General for Employment and Social Affairs, Luxembourg
Office for Official Publications of the European Communities. EUR 8476 EN:1983.   
196. Morgan B. Dangers of perchloroethylene. Br Med J 1969;2:513.
197. Morgan A, Black A, Belcher DR. Studies on the absorption of halogenated hydrocarbons and
their excretion using 38Cl tracer techniques. Ann Occup Hyg 1972;15:273-283.
198. Moslen M, Reynolds E, Szabo S. Enhancement of metabolism and hepatotoxicity of
trichloroethylene and perchloroethylene. Biochem Pharmacol 1977;26:369-375.
199. Motohashi Y, Miyazaki Y, Takano T. Assessment of behavioral effects of tetrachloroethylene
using a set of time-series analysis. Neurotoxicol Teratol 1993;15:3-10.
200. Mutti A, Alinovi R, Bergamaschi E, Biagini C, Cavazzini S, Franchini I, Lauwerys RR,
Bernard AM, Roels H, Gelpi E, Rosello J, Ramis I, Price RG, Taylor SA, De Broe M, Nuyts
GD, Stolte H, Fels LM, Herbort C. Nephropathies and exposure to perchloroethylene in dry-
cleaners. Lancet 1992;340:189-193.
201. Nakamura K. Mortality patterns among cleaning workers. Jpn J Ind Health 1985;27:24-37.
202. National Cancer Institute (NCI). Bioassay of tetrachloroethylene for possible carcinogenicity.
NCI TR 23. Cincinatti, OH: US Department of Health, Education and Welfare, 1977.
105
203. NEG. The Nordic Expert Group for Documentation of Occupational Exposure Limits.
7. Tetrachloroethylene (in Swedish). Arbete och Hälsa 1979:25, Arbetarskyddsstyrelsen,
Solna.
204. Nelson BK, Taylor BJ, Setzer JV, Hornung RW. Behavioral teratology of perchloroethylene
in rats. J Environ Pathol Toxicol 1980;3:233-250.
205. Nicolis GD, Helwig EB. Exfoliate dermatitis. A clinicopathological study of 135 cases. Arch
Dermatol 1973;108:788-797.
206. NIOSH. National Institute for Occupational Safety and Health (NIOSH). Manual of
Analytical Methods, Vol 3. Washington DC: Government Printing Office, 1977.
207. NLM. Toxic Chemical Release Inventory. Bethesda, MD. National Library of Medicin.
National Toxicology Information Program, 1990.
208. NTP. National Toxicology Program. Toxicology and carcinogenesis studies of
tetrachloroethylene (perchloroethylene) (CAS No. 127-18-4) in F344/N rats and B6C3F1
mice (inhalation studies). National Toxicology Program - technical report series no. 311
Research Triangle Park, North Carolina, 1986.
209. Odum J, Green T. Perchloroethylene metabolism by glutathione pathway. Toxicologist
1986;7:1077.
210. Odum J, Green T, Foster JR, Hext PM. The role of trichloroacetic acid and peroxisome
proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat.
Toxicol Appl Pharmacol 1988;92:103-112.
211. Ogata M, Tomokuni K, Watanabe S. ATP and lipid contents in the liver of mice after
inhalation of chlorinated hydrocarbons. Ind Health 1968;6:116-119.
212. Ohtsuki T, Sato K, Koizumi A, Kumai M, Ikeda M. Limited capacity of humans to
metabolize tetrachloroethylene. Int Arch Occup Environ Health 1983;51:381-390.
213. Olsen J, Hemminki K, Ahlborg G, Bjerkedal T, Kyyronen P, Taskinen H, Lindbohm ML,
Heinonen OP, Brandt L, Kolstad H, Halvorsen BA, Egenæs J. Low birthweight, congenital
malformations, and spontaneous abortions among dry-cleaning workers in Scandinavia.
Scand J Work Environ Health 1990;16:163-168.
214. Opdam JJG, Smolders FJF. Alveolar sampling and fast kinetics of tetrachloroethene in man.
I Alveolar sampling. Br J Ind Med 1986;43:814-824.
215. Opdam JJG, Smolders FJF. Alveolar sampling and fast kinetics of tetrachloroethene in man.
II Fast kinetics. Br J Ind Med 1987;44:26-34.
216. Palacek I. So-called chemical asthma. Arh Hig Rada Toksikol 1970;21:161-166.
217. Patel R, Janakiraman N, Towne WD. Pulmonary edema due to tetrachloroethylene. Environ
Health Perspect 1977;21:247-249.
218. Pegg DG, Zempel JA, Braun WH, Watanabe PG. Disposition of tetrachloro(14C)ethylene
following oral and inhalation exposure in rats. Toxicol Appl Pharmacol 1979;51:465-474.
219. Pekari K, Aitio A. Method 27; Determination of tetrachloroethylene in blood. In: Fishbein L,
O’Neill IK, eds. Environmental carcinogens - Selected methods of analysis Vol. 7. Some
halogenated hydrocarbons. IARC Scientific Publications No 68. Geneve: International
Agency for the Research on Cancer, 1985.
220. Pellizari ED, Sheldon LS, Bursey JT. Method 25; CG/MS determination of volatile
halocarbons in blood and tissue. In: Fishbein L, O’Neill IK, eds. Environmental carcinogens
- Selected methods of analysis Vol. 7. Some halogenated hydrocarbons. IARC Scientific
Publications No 68. Geneve: International Agency for Research on Cancer, 1985.
221. Pellizari ED, Zweidinger RA, Sheldon LS. Method 24; GC/MS determination of volatile
hydrocarbons in breath samples. In: Fishbein L, O’Neill IK, eds. Environmental carcinogens
- Selected methods of analysis Vol. 7. Some halogenated hydrocarbons. IARC Scientific
Publications No 68. Geneve: International Agency for Research on Cancer, 1985.
106
222. Pezzagno G, Imbriani M, Ghittori S, Capodaglio E. Urinary concentration, environmental
concentration, and respiratory uptake of some solvents: effect of the work load. Am Ind Hyg
Assoc J 1988;49:546-552.
223. Plaa GL, Evans EA, Hine CH. Relative hepatotoxicity of seven halogenated hydrocarbons. J
Pharmacol Exp Ther 1958;123:224-229.
224. Plaa GL, Larson RE. Relative nephrotoxic properties of chlorinated methane, ethane and
ethylene derivatives. Toxicol Appl Pharmacol 1965;7:37-44.
225. Popp W, Muller G, Baltes-Schmitz B, Wehner B, Vahrenholz C, Schmieding W,
Benninghoff M, Norpoth K. Concentrations of tetrachloroethene in blood and trichloroacetic
acid in urine in workers and neighbours of dry-cleaning shops. Int Arch Occup Environ
Health 1992;63:393-395.
226. Pozzani UC, Weil CS, Carpenter CP. The toxicological basis of threshold limit values: 5. The
experimental inhalation of vapour mixture by rats, with notes upon the relationship between
single dose inhalation and single dose oral data. Am Ind Hyg Assoc J 1959;20:364-369.
227. Price PJ, Hassett CM, Mansfield JL. Transforming activities of trichloroethylene and
proposed industrial alternatives. In Vitro 1979;14:290-293.
228. Rabbini GH, Gilman RH, Kabir I, Mondel G. The treatment of Fasciolopsis buski infection
in children: a comparison of thiabendazole, mebendazole, levamisole, pyrantel pamoate,
hexylresorcinol and tetrachloroethylene. Trans Roy Soc Trop Med Hyg 1985;79:513-515.
229. Rampy LW, Quast JF, Balmer MF. Results of long-term inhalation toxicity study on rats of
perchloroethylene (tetrachloroethylene) formulation. In: Plaa GL, Duncan WAM, eds.
Proceedings of the first international congress on toxicology. New York: Academic Press,
1978.
230. Rao KS, Betso JE, Olson KJ. A collection of guinea pig sensitisation test results - grouped by
chemical class. Drug Chem Toxicol 1981;4:331-351.
231. Reichert D. Biological actions and interactions of tetrachloroethylene. Mutat Res
1983;123:411-429.
232. Reinhardt CF, Mullin LS, Maxfield ME. Epinephrine-induced cardiac arrhythmia potential of
some common industrial solvents. J Occup Med 1973;15:953-955.
233. Riggin RM. Method 12. Determination of volatile organic compounds in ambient air using
Tenax adsorption and gas chromatography/mass spectrometry. In: Fishbein L, O’Neill IK,
eds. Environmental carcinogens - Selected methods of analysis Vol. 7. Some halogenated
hydrocarbons. IARC Scientific Publications No 68. Geneve: International Agency for
Research on Cancer, 1985.
234. Riihimäki V, Pfäffli P. Percutaneous absorption of solvent vapours in man. Scand J Work
Environ Health1978;4:73-85.
235. Rosengren LE, Kjellstrand P, Haglid KG. Tetrachloroethylene: levels of DNA and S-100 in
the gerbil CNS after chronic exposure. Neurobehav Toxicol Teratol 1986 ;8:201-206.
236. Rowe VK, McCollister D, Spencer HC, Adams EM, Irish DD. Vapor toxicity of
tetrachloroethylene for laboratory animals and human subjects. AMA Arch Ind Hyg Occup
Med 1952;5:566-579.
237. Ruder AM, Ward EM, Brown DP. Cancer mortality in female and male dry-cleaning
workers. J Occup Med 1994;36:867-874.
238. Saland G. Accidental exposure to perchloroethylene. N Y State J Med 1967;67:2359-2361.
239. Sandground JH. Coma following medication with tetrachloroethylene. JAMA 1941;117:440-
441.
240. Savolainen H, Pfäffli P, Tengen M, Vainio H. Biochemical and behavioural effects of
inhalation exposure to tetrachloroethylene and dichloromethane. J Neuropathol Exp Neurol
1977;36:941-949.
107
241. Savolainen H. Pharmacokinetics, pharmacodynamics and aspects of neurotoxic effects of four
inhaled aliphatic chlorohydrocarbon solvents as relevant in man. Eur J Drug Metab
Pharmacokinet 1981;6:85-90.
242. Schlingman AS, Gruhzit OM. Studies on the toxicity of tetrachloroethylene a new
anthelminthic. J Am Vet Med Assoc 1927;71:189-209.
243. Schmuter LM. The effect of chronic action of low concentrations of chlorinated hydrocarbons
in the production of various classes of immunoglobulins. Hyg Sanit 1972;37:36-40.
244. Schumann AM, Quast JF, Watanabe PG. The pharmacokinetics and macromolecular
interactions of perchloroethylene in rats as related to oncogenicity. Toxicol Appl Pharmacol
1980;55:207-219.
245. Schumann AM, Watanabe PG, Reitz RH, Gehring PJ. The importance of pharmacokinetic
and macromolecular events as they relate to mechanisms of tumorigenicity and risk
assessment. In: Plaa G, Hewitt WR, eds. Toxicology of the liver. Target Organ Toxicology
Series: Raven Press, 1982.
246. Schutz A, Coenen W. Tetrachlorethylen. In: Messung von Gefahrstoffe, BIA-Arbeitsmappe.
FRG, Bielefeld: Berufsgenossenschaftliches Institut für Arbeitssicherheit -BIA- des
Hauptverbandes des gewerblichen Berufsgenossenschaft e.V, Erich Schmidt Verlag, 1989.
247. Schwetz BA, Leong BKJ, Gehring PJ. The effect of maternally inhaled trichloroethylene,
perchloroethylene, methyl chloroform, and methylene chloride on embryonal and fetal
development in mice and rats. Toxicol Appl Pharmacol 1975;32:84-96.
248. Seeman P, Roth S. General anesthetics expand cell membranes at surgical concentrations.
Biochim Biophys Acta 1972;255:171-177.
249. Seidel HJ, Weber L, Barthel E. Hematological toxicity of tetrachloroethylene in mice. Arch
Toxicol 1992;66:228-230.
250. Seiji K, Jin C, Watanabe T, Nakatsuka H, Ikeda M. Sister chromatid exchanges in peripheral
lymphocytes of workers exposed to benzene, trichloroethylene and tetrachloroethylene, with
reference to smoking habits. Int Arch Occup Environ Health 1990;62:171-176.
251. Shimada T, Swanson A, Lever P. The evaluation for genotoxicity of several halogenated
solvents. Environ Mutagen 1983;5:447.
252. Skender LJ, Karacic V, Prpic-Majic D. A comparative study of human levels of trichloro-
ethylene and tetrachloroethylene after occupational exposure. Arch Environ Health
1991;46:174-178.
253. Smith EM, Miller ER, Woolson RF, Brown CK. Bladder cancer risk among laundry workers,
dry cleaners, and others in chemically related occupations. J Occup Med 1985;27:295-297.
254. Spirtas R, Stewart PA, Lee JS. Retrospective cohort mortality study of workers at an aircraft
maintenance facility. I. Epidemiological results. Br J Ind Med 1991;48:515-530.
255. Stanford Research Institute International. Salmonella test results on tetrachloroethylene.
Prepared for dr. Harry Milman, project officer. 1983. Unpublished, cited in (74).
256. Stewart RD. Acute tetrachloroethylene intoxication. J Am Med Assoc 1969;208:1490-1492.
257. Stewart RD, Baretta ED, Dodd HC, Torkelson TR. Experimental human exposure to
tetrachloroethylene Arch Environ Health 1970;20:225-229.
258. Stewart RD, Dodd HC. Absorption of carbon tetrachloride, trichloroethylene, tetrachloro-
ethylene, methylene chloride, and 1,1,1-trichloroethane through the human skin. Am Ind Hyg
Assoc J 1964;25:439-446.
259. Stewart RD, Erley MS, Schaffer BS, Kalbfleisch J, Newton PE. Accidental vapor exposure to
anesthetic concentrations of a solvent containing tetrachloroethylene. Industrial Medicine and
Surgery 1961;30:327-330.
260. Stewart RD, Gay HH, Erley DS, Hake CL, Schaffer AW. Human exposure to tetrachloro-
ethylene vapor. Arch Environ Health 1961;2:40-46.
108
261. Stewart RD, Hake CL, Wu A, Kalbfleisch J, Newton PE. Effects of perchloroethylene/drug
interaction on behavior and neurological function. Cont No CDC 201-75-0059 Cincinatti:
U.S. Department of Health, Education, and Welfare, Public Health Services, NIOSH, 1977.
262. Story DL, Meierhenry EF, Tyson CA, Milman HA. Differences in rat-liver enzyme-altered
foci produced by chlorinated aliphatics and phenobarbital. Toxicol Ind Health 1986;2:351-
362.
263. Stott WT, Watanabe PG. Differentiation of genetic versus epigenetic mechanisms of toxicity
and its application to risk assessment. Drug Metabol Rev 1982;13:853-873.
264. Swedish National Board of Occupational Safety and Health. Status Book of the Swedish
National Board of Occupational Safety and Health: Occupational Exposure Limit Values
2002. Solna, 2002.
265. Ministerie van Sociale Zaken en Werkgelegenheid (SZW). Nationale MAC-lijst 1997-1998.
The Hague, The Netherlands: Servicecentrum Sdu Uitgevers, 2002:41.
266. Taskinen H, Anttila A, Lindbohm ML, Sallmen M, Hemminki K. Spontaneous abortions and
congenital malformations among the wives of men occupationally exposed to organic
solvents. Scand J Work Environ Health 1989;15:345-352.
267. Tham R, Bunnfors I, Eriksson B, Larsby B, Lindgren S, Odkvist LM. Vestibulo-ocular
disturbances in rats exposed to organic solvents. Acta Pharmacol Toxicol (Copenh)
1984;54:58-63.
268. Theiss JC, Stoner GD, Shimkin MB. Test for carcinogenicity of organic contaminants of
United States drinking waters by pulmonary tumour response in A mice. Cancer Res
1977;37:2717-2720.
269. Tinston DJ. Perchloroethylene: multigeneration inhalation study in the rat. Report of Zeneca
Central Toxicology Laboratory. Report no: CTL/P/4097. Zeneca Central Toxicology
Laboratory Alderley Park Macclesfield Cheshire, United Kingdom, 1995.
270. Toraason M, Breitenstein MJ, Wey HE. Reversible inhibition of intercellular communication
among cardiac myocytes by halogenated hydrocarbons. Fund Appl Toxicol 1992;18:59-65.
271. Trense E, Zimmerman H. Fatal inhalation poisoning with chronically acting tetrachloro-
ethylene vapours. Zentralbl Arbeitsmed Arbeitsschutz 1969;19:131-137.
272. Tsuruta H. Percutaneous absorption of organic solvents; (1) Comparative study of the in vivo
percutaneous absorption of chlorinated solvents in mice. Ind Health 1975;13:227-236.
273. Tsuruta H. Percutaneous absorption of organic solvents; (2) A method for measuring
penetration rate of chlorinated solvents through excised rat skin. Ind Health 1977;15:131-
139.
274. Tu AS, Murray TA, Hatch KM. In vitro transformation of BALB/c-3T3 cells by chlorinated
ethanes and ethylenes. Cancer Lett 1985;28:85-92.
275. Tuttle TC, Wood GD, Crether CB, Johnson, BL, Xintaras C. A behavioral and neurological
evaluation of dry cleaners exposed to perchloroethylene. Cont No HSM 99-73-35 Cincinatti:
U.S. Department of Health, Education, and Welfare, Public Health Services, NIOSH, 1977.
276. Vail JT. False-negative reaction to patch testing with volatile compounds (letter). Arch
Dermatol 1974;110:130.
277. Vainio H, Waters MD, Norppa H. Mutagenicity of selected organic solvents. Scand J Work
Environ Health 1985;11 (Suppl 1):75-82.
278. Vamvakas S, Bruning T, Thomasson B, Lammert M, Baumuller A, Bolt HM, Dekant W,
Birner G, Henschler D, Ulm K. Renal cell cancer correlated with occupational exposure to
trichloroethene. J Cancer Res Clin Oncol 1998;124:374-382.
279. Vartiainen T, Pukkula E, Rienoja T, Haeseler E. Population exposure ti tri- and tetrachloro-
ethene and cancer risk: two cases of drinking water pollution. Chemosphere 1997;27:1171-
1181.
280. Vaughan TL, Stewart PA, Davis S, Thomas DB. Work in dry cleaning and the incidence of
cancer of the oral cavity, larynx, and oesophagus. Occup Environ Med 1997;54:692-695.
109
281. Vemmer H, Rohleder K, Wieczoreck H, Haeseler E. Perchloroethylene in the tissues of
fattening pigs (German) Landwirtsch Forsch 1984;37:36-43.
282. Vinnueftirlit ríkisins. Mengunarmörk og a∂ger∂ir til a∂ draga úr mengun á vinnustö∂um.
Vinnueftirlit ríkisins, Iceland, 1999.
283. Vyskocil A, Emminger S, Tejral J, Fiala Z, Ettlerova E, Cermanova A. Study on kidney
function in female workers exposed to perchloroethylene. Hum Exp Toxicol 1990;9:377-380.
284. Wallace L, Pellizari ED, Hartwell TD, Sparacino C, Zelon H. Personal exposure to volatile
organics and other compounds indoors and outdoors-the TEAM study, Paper 83.912 Proc of
the 76th Ann Natl Conf of the Air Pollut Control Assoc, Atlanta, GA, 19-24 June 1983.
285. Wallace LA, Pellizzari ED, Hartwell TD, Sparacino CM, Sheldon LS, Zelon H. Personal
exposures, indoor-outdoor relationships, and breath levels of toxic air pollutants measured for
355 persons in New Yersey. Atmos Environ 1985;19:1651-1661.
286. Walles SAS. Induction of single-strand breaks in DNA of mice by trichloroethylene and
tetrachloroethylene. Toxicol Lett 1986;31:31-35.
287. Walker JT, Burnett CA, Lalich NR, Sestito JP, Halperin WE. Cancer mortality among
laundry and dry cleaning workers. Am J Ind Med 1997;32:614-619.
288. Wang S, Karlsson JE, Kyrklund T, Haglid K. Perchloroethylene-induced reduction in glial
and neuronal cell marker proteins in rat brain. Pharmacol Toxicol 1993;72:273-278.
289. Warner JR, Hughes TJ, Claxton LD. Mutagenicity of 16 volatile organic chemicals in a
vaporization technique with Salmonella typhimurium TA100. Environ Mol Mutagen 1988;11,
Suppl. 11:111.
290. Wenzel DG, Gibson RD. A study of the toxicity and the anthelminthic activity of n-
butylidene chloride. J Pharmacol 1951;3:169-176.
291. Williams GM and Shimada T. Evaluation of several halogenated ethane and ethylene
compounds for genotoxicity. Final report for PPG Industries, Pittsburgh, Pennsylvania.
Unpublished.
292. Windham GC, Shusterman D, Swan SH, Fenster L, Eskenazi B. Exposure to organic solvents
and adverse pregnancy outcome. Am J Ind Med 1991;20:241-259.
293. Withey RJ, Hall JW. The joint toxic action of perchloroethylene with benzene in rats.
Toxicology 1975;4:5-15.
294. Wright WH, Bozicevick J, Gordon LS. Studies on oxyuriasis. V Therapy with single doses of
tetrachloroethylene. JAMA 1937;109:570-573.
295. Yllner S. Urinary metabolites of 14C-tetrachloroethylene in mice. Nature 1961;191:820.
296. Ziglio G, Beltramelli G, Pregliasco F, Ferrari G. Metabolites of chlorinated solvents in blood
and urine of subjects exposed at environmental level. Sci Total Environ 1985;47:473-477.
110
13. Data bases used in the search for literature
Literature was retrieved from the on-line databases: MEDLINE, TOXLINE, and
Chemical Abstracts. An additional search has been carried out in February 1996.
From the papers published between February 1996 and June 2002 only the ones
influencing hazard evaluation have been included in the report.
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